ࡱ> Z\UVWXYM ,bjbj== "WWHlb'b'b'b'D'MSj((((((((RRRRRRR$T VHR-(((((R7((S777( ((R7(R7 7dANP(( ~J.N"b'4(OP$S0MSOW7WP7DynaPulse Physicians Reference Hypertension and CVD/CHF Management with Noninvasive Hemodynamic Profiles (Clinical applications and Case Studies) By The DynaPulse Research Team (2000-2008) DynaPulse Education Series Information for DynaPulse users Provided by DynaPulse/Pulse Metric, USA October 2008 Introduction Management of Hypertension as well as cardiovascular disease (CVD) and congestive heart failure (CHF) using Hemodynamic profiles and responses is a new trend in advanced patient monitoring and disease prevention. The basic idea of hemodynamic monitoring had been summarized by Fetnat Fouad-Tarazi and Joseph L. Izzo, Jr, in Hypertension Primer, 2nd ed., Chapter 45, published by American Heart Association 1999, described the classical example of applying clinical hemodynamic values in high blood pressure control. It assumed that arterial blood pressure (BP), or Mean Arterial Pressure (MAP), is a product of cardiac output (CO) and systemic vascular resistance (SVR), MAP = CO*SVR, and applies this relationship to better understanding of the causes of high BP, and to effective treatments, for example, with antihypertensive drugs, such as beta-blockers, ACE inhibitors, alpha and beta adrenergic blockade, etc. In the article, they also pointed out that many other factors, such as stress, vascular structure and endothelial functions, as well as age, gender, race, personal life-style, etc. may all play essential roles in hypertension, which would need further investigations. During the past two decades, several noninvasive hemodynamic monitoring technologies, which measure CO, BP and other vascular properties, were developed and reported their clinical value of improving cares to hypertensive patients (see References for related publications). Most recently, DynaPulse, a cuff-sphygmomanometry based method, applies Pulse Dynamics waveform analysis principle, has demonstrated and validated its capability of deriving cardiac output (CO) simultaneously with BP, MAP, SVR, systemic vascular compliance (SVC), brachial artery compliance, distensibility and resistance (BAC, BAD and BAR), LV(dP/dt)Max, and other hemodynamic parameters. These simultaneously obtained hemodynamic values allows physicians to correlate the dynamic changes of each parameters for evaluation of physiological conditions of a patients circulation system. For over ten years, DynaPulse has been used in US on several large cohort studies, including the BOGALUSA heart study of Tulane University Hospital, SWAN study of Pittsburgh University School of Public Health, etc., which normal population were studies and the Normal Range for DynaPulse Hemodynamic parameters were established. These Normal hemodynamic values allow better evaluation and assessment of patients hemodynamic profiles by physicians. (See References for related publications). In this Physicians Reference, we summarize and define the hemodynamic parameters and their values that reported by DynaPulse hemodynamic profiling via on-line DynaPulse Analysis Center (DAC). We also summarize and share the experiences and sample hemodynamic cases, from Dr. Michael Gutkin, a hypertension specialist, how he has been using DynaPulse hemodynamic profiles in his practice to evaluate patients circulation system and to apply it to achieve a better anti-hypertension drug therapy. Also included in Appendix are case studies and comments from other leading physicians in the advanced hypertension and cardiovascular disease patient managements with hemodynamic values. DynaPulse Hemodynamic Parameters and Values DynaPulse Hemodynamic Report: Sample Figure and explanations  After taking a complete recording of blood pressure and pulse waveforms with a DynaPulse device, and transmitting the waveforms for analysis through Internet/web based algorithms via the DynaPulse Analysis Center (DAC) service, DynaPulse BP waveform and hemodynamic parameters, obtained simultaneously, are reported in (1-5) areas: Area 1: Showed auscultatory (K-sound) equivalent Systolic, diastolic and heart rate, and the Pulse Dynamic pulse waveform for visual identification of a good pulse signal or bad signal with irregular heart beat or motion artifacts. Area 2: Showed Pulse Dynamic blood pressures, systolic, diastolic and MAP that are closely related to central aortic pressures, and pulse pressure. Area 3: Showed cardiac or heart functions, which include heart rate, ejection time, contractility, cardiac output, stroke volume and their indexes, according to the equations described below. Area 4: Showed systemic vascular compliance and resistance as derived from cardiac output and other pressure parameters, according to the equations described below. Area 5: Showed brachial artery compliance, distensibility and resistance, according to the equations described below. * Each DynaPulse parameter value, area 2-5, is provided with (dimension) and a Normal Range for either (Male) or (Female), and graphically indicated in scale of 1 to 5 when compare to the normal range. Normal ranges for both genders were established using DynaPulse data collected in several large cohort studies in the US, age from 18 to 90 with ~70% white in population. ** Simultaneously obtained hemodynamic parameters are coherent to each other and make possible to correlate their directional changes or trends for evaluation the dynamics of a circulation system, which is essential and the key advantage of DynaPulse vs. other noninvasive hemodynamic monitoring methods. Definitions of DynaPulse Hemodynamic Parameters: I. BLOOD PRESSURE Systolic (SBP) is the measurement of standard clinical systolic blood pressure. Measured using standard oscillometric algorithms, and closely represents values taken by auscultatory techniques using mercury cuff sphygmomanometry and Korotkoff sounds (K1). Diastolic blood pressure (DBP) is the measurement of standard clinical diastolic blood pressure. Measured using standard oscillometric algorithms, and closely represents values taken by auscultatory techniques using mercury cuff sphygmomanometry and Korotkoff sounds (K4). End Systolic blood pressure measures central arterial blood pressure at end-systole. Measured using proprietary Pulse Dynamics waveform pattern-recognition algorithms. End Diastolic blood pressure measures central arterial blood pressure at end-diastole. Measured using proprietary Pulse Dynamics waveform pattern-recognition algorithms. Mean Arterial Pressure (MAP) is the average blood pressure over time, measured using proprietary Pulse Dynamics pattern-recognition algorithms. It can also be estimated using MAP = 1/3 Systolic + 2/3 Diastolic. Pulse Pressure (PP) = Systolic Diastolic II. CARDIAC PARAMETERS Heart Rate (HR) is determined by the DynaPulse monitor LV Ejection Time is the duration of the systolic cycle LV dP/dt max is the maximum rate of pressure change in the LV, derived from arterial dP/dt max LV Contractility is an index of cardiac contractility derived from LV dP/dt max Cardiac Output (CO) is the volume of blood ejected by the left ventricle per minute. It is calculated using proprietary algorithms and a model based on LV dP/dt, HR, and an empirically derived scaling factor. Validation has been performed using thermo-dilution and echocardiography. Cardiac Index = CO / BSA Where, BSA = Body Surface Area Stroke Volume (SV) = CO / HR Stroke Volume Index = SV / BSA III. SYSTEMIC VASCULAR PARAMETERS Systemic Vascular Compliance (SVC) = SV / PP Systemic Vascular Resistance (SVR) = MAP / CO IV. BRACHIAL ARTERY PARAMETERS Brachial Artery Compliance (BAC) is defined as dV/dP, derived using a physical model of the brachial artery segment Brachial Artery Distensibility (BAD) is defined as the compliance divided by the arterial volume [(dV/dP)/V], or the percentage change in volume per mmHg change in pressure Brachial Artery Resistance (BAR) = (MAP-DBP)/(Diastolic volume flow) V. ANTHROPOMETRIC PARAMETERS Body Surface Area (BSA) is defined by the standard DuBois equation Brachial Artery Diameter for the reference volume was estimated using an empirically derived model based on gender, height, weight, and MAP, and validated using B-Mode ultrasound (n = 1,250, r = 0.63, P < 0.05) DynaPulse Hemodynamic Values in Hypertension Provided below is a summary of clinical evaluations and explanations of how to use the DynaPulse resting hemodynamic parameters and values in hypertension treatments, and some examples. (By Dr. M. Gutkin): What does the DynaPulse apparatus measurement that is of convenient use to the treating physicians? Central (aortic) blood pressure, the end-systolic and end-diastolic, and mean arterial pressure (MAP). Cardiac output (CO), pulse rate and stroke volume. Total peripheral resistance (SVR) Brachial (muscular) artery rigidity (BA compliance and distensibility) Pulse pressure/stroke volume rates, a measure of rigidity of aorta, femoral segments, and common carotid arterials Systemic vascular compliance (SVC) Maximum left ventricular dP/dt (LV dP/dt max) What do these measurements tell us beyond our conventional measures of blood pressure, pulse pressure and pulse rate? Hypertension does not present a uniform hemodynamic pattern. Varying hemodynamic patterns have different therapeutic implications. Examples: High cardiac output with inappropriately normal peripheral resistance devotes the early phase of hypertension, which have not yet developed fixed vascular change opportunities for non-medicinal therapy. In light of the results of the TROPHY trial, the finding of normal cardiac output in this group could justify antihypertensive therapy at a blood pressure of 139/80 to 139/90. Normal cardiac output with high peripheral resistance a target for traditional pharmaco therapy. Low cardiac output with high peripheral resistance a marker of left ventricular hypertrophy with cavitary encroachment. High systolic blood pressure with normal peripheral resistance a marker of great vessel rigidity. Increased dP/dt max as a marker for anxiety and treatment with anxiolytic. Decreased dP/dt max as a sign of effective beta-blockade. How to tell when an artery is abnormally rigid? Arteries become more rigid as they are stretched. Hypertension excess tension on arterial wall. Arteries resist excessive tension. Is the rigidity due to excessive stretch on a normal artery? Causes of disproportionate arterial stiffness. In muscular (brachial) arteries. In elastic (aorta) arteries. Why is excess rigidity important? Aortic rigidity predicts cardiovascular disease and stroke even better than blood pressure. It wastes cardiac work or energy. Examples: Anti-hypertension therapy for DynaPulse hemodynamic values Blood Pressure (SBP/DBP)Cardiac Output (CO)Peripheral Resistance (SVR)Brachial Rigidity Distensibility (BAD)Systemic Vascular Compliance (SVC)LV dP/dt MaxImplications for Therapy150/100NormalHighIncreased as expectedIncreased as expectedNormalClassic antihypertension Therapy142/92HighNormalNormal as expectedNormal as expectedNormalNon-medicinal therapy and close observation warranted164/96HighHighIncreasedNormal as expectedNormalCalculate body mass index consider ACE/ARB183/106NormalHighIncreasedIncreased as expectedNormalClassic antihypertension Therapy174/82High with high stroke outputHighIncreased as expectedIncreasedNormalLoop diuretic and/or alpha blocker based therapy182/71NormalNormalIncreased more than expectedIncreased more than expectedNormalClassic antihypertension Therapy to include ACE/ARB plus nitrates154/102HighNormalIncreased as expectedIncreased as expectedHighBeta-blocker plus anxiolytic therapy Appendix A: DynaPulse Case Studies and Other Case Reports (Clinical Utilities) Through the efforts of numerous worldwide clinical studies, collaborations, and independent patient participation, Pulse Metric, Inc. has also identified many interesting cases in which the DynaPulse hemodynamic monitoring technology has enabled clinicians to more effectively manage and treat patients with cardiovascular disease. In this Case Studies section, we share the findings of such cases. Included below, for references, are some published case reports that applied hemodynamic monitoring in cares of hypertension and related cardiovascular diseases. DynaPulse Case Studies Case #1: Patient Background & History: A 36-year-old male, Chinese, has experienced symptoms with shortness of breath and palpitations, on and off, since early February of 2000. His physician recorded the following: ECG showed left axis deviation and premature ventricular contraction. Echocardiogram examination revealed mild mitral regurgitation and mild tricuspid regurgitation. Stress test was negative. He was quite well until June 5th, when the episode of palpitations reoccurred. ECG then showed frequent PVC. Ambulatory 24 hours Holter ECG revealed 16597 isolated PVC and 20 couplets PVC but no short runs of VT. Mexitil was prescribed and the patients condition stabilized. Since May 15th, 2000, he was further advised to monitor cardiac, blood pressure, and hemodynamic functions using DynaPulse at home. The patient is currently stable and receiving medication with propafenone (Rytmonorm) 150mg b.i.d. under diagnosis of cardiac arrhythmia. Propafenone is a class 1C drug that has sodium channel blocking activity and also beta-adrenergic blocking properties. DynaPulse Monitoring & Data Analysis: On May 15th, 2000, patient experienced an episode of arrhythmia. His physician, then, provided (prescribed) him with a DynaPulse 200M home monitoring device, and the patient was instructed to take a series of blood pressure measurements at home for a period of 15 days. Blood pressure and waveform data were collected by DynaPulse, and then transmitted to Pulse Metrics DynaPulse Analysis Center (DAC) for hemodynamic analysis. Blood pressures, Pulse Pressures (PP), Heart Rate (HR) and other hemodynamic parameters were recorded and analyzed during the observation period. A cardiac event (angina) was captured. Trending of changes in blood pressure, cardiac function, and vascular condition were analyzed and later evaluated. When compared to their normal mean values, PP and HR percentage changes were significantly different. PP and HR (Fig.1) were then plotted. The trend of proportional changes corresponding to time and the occurrence of the cardiac event are displayed. The percentage change of the PP/HR ratio against the mean was calculated as: ((pp/mean baseline PP) : ((hr/mean baseline HR) Results & Observations: One day before the onset of the cardiac event (angina), over 40% elevation in PP was observed. Then, at 15 minutes before patient reported angina, a significant drop (50%), which is 10% below the mean, occurred. 15 min. later after patient reported the episode of angina, PP dropped another 35%. The PP stabilized in 30 min following the medication. Comments & Opinions: The dramatic unidirectional shifting (85%) of PP within 24 hours from positive to negative vs. mean suggested the patient went from cardiovascular compensation to decompensation. The PP was stabilized following the medication in 30 min. Fig.2 shows the trend of PP/HR ratio changes. It indicates that before onset of the cardiac event, PP/HR ratio was significantly higher than the mean value(~2 times > normal range). Using the trend ratio change as cardiac function index could objectively provide a quantified indicator for predicting an upcoming event particularly among outpatients.  PMI R&D Report 2000 =========================================================== Case #2 Patient History: The patient is a 49-year-old hypertensive male who was diagnosed with paroxysmal atrial fibrillation in the fall of 1997. TEE was performed with successful DCC on December 11, 1997. However, the patient subsequently developed recurrent atrial fibrillation on December 20, 1997. Currently his symptoms persist and include occasional skipped beats, which occur mostly frequently during times of stress and fatigue. The patient experiences occasional dyspnea after the skipped beats and after climbing 2 flights of stairs. Other symptoms include fatigue, atypical left-sided chest discomfort described as a dull ache which is non-radiating in nature, and mild edema. Recently, persistent atrial fibrillation has occurred since August of 2000, resulting in episodes of awakening with a pause and jolt and periods of brief chest discomfort. The patient was treated with Amiodarone(800 mg/d) and Digoxin (0.25mg /qd), which was discontinued due to side-effects that included difficulty in speaking and a dramatic reduction in heart rate (40 bps). Procedure: The patient utilized the DynaPulse monitoring device to track his blood pressure and episodes of atrial fibrillation. A total of 212 DynaPulse hemodynamic measurements were obtained over a 9 month period, beginning in March of 2000. The hemodynamic measurements obtained included blood pressure (SBP, DBP, MAP, PP), cardiac function parameters (HR, LVdP/dt, LV contractility, and LV ejection time), systemic parameters (systemic vascular compliance and systemic vascular resistance), and brachial artery parameters (brachial artery compliance and brachial artery distensibility). In addition, pulse waveforms were also recorded for later morphological analysis. These data were obtained by the patient in his home and were analyzed retrospectively. A major focus of data analysis was to correlate associated hemodynamic changes with AF episodes over time. A blinded analysis of DynaPulse waveforms was performed to assess the devices ability to detect AF episodes, and the results were then correlated with the patients actual documentation of such events. Results: From a total of 212 DynaPulse measurements, 7 AF episodes were identified.  Normal Waveform AF Waveform Moreover, a significant reduction in LV contractility preceded all AF episodes, which was correlated to the patients reported atypical left-sided discomfort that also preceded the AF episodes. In all cases, the patients LV contractility dropped a minimum of 2 standard deviations from the overall mean, which occurred between 3 and 8 hours prior to onset of the episode (mean = 5.5 hours prior to onset of the episode). Comments: The sudden onset of atrial fibrillation (AF) may cause palpitations, angina pectoris and a decrease in cardiac output. Short-term predictability of the occurrence of AF for outpatients is difficult and has rarely been reported due to the lack of an appropriate tool to noninvasively measure hemodynamic changes. A decrease in LV contractility has been reported to occur during an AF event, and the results of this case study further indicate that a sudden decrease in LV contractility also occurs prior to the AF episode. Therefore, this study suggests that it may be possible to predict the occurrence of such cardiac events through the use of noninvasive hemodynamic monitoring technology. PMI R&D Report 2000 =========================================================== Case #3: Patient History: A 72-year-old white male has been diagnosed as hypertensive for about 30 years. Medical history includes prostate surgery in 1988, kidney stone removal in 1991, mini-stroke in 1992, chest pains in 1991 and 1998, and gallbladder removed in 1998. The patients daily medications include: Angiotensin II Inhibitor (Diovan, Novartis 160mg/day), Diuretic (Aldactone spironolactone 50mg/day) and beta blockade (Toprol-XL, Zeneca) for blood pressure reduction. Other medications include: Levoxyl, Aspirin, and Zantac plus Multi-Vitamin. The blood chemistry readings were normal with the exception of a higher than normal glucose range in February of 1998 (193) and triglycerides in March of 2000 (264). Hematology and differential are normal. In addition to mild hypertension, which is now under control, the patient has also experienced irregular heartbeats since November of 2000. Procedure: A total 372 DynaPulse measurements have been acquired over a period of 27 months, and include blood pressure (BP) other hemodynamic parameters such as Systemic Vascular Resistance (SVR), Brachial Artery Compliance (BAC), and Brachial Artery Distensibility (BAD). Measurements were collected by the patient himself at home and retrospectively analyzed. Results were compared to a normal population of males (N=877), and each individual parameter was trended and plotted against the patients medication history. Results: The results demonstrate an overall improvement in blood pressure and hemodynamic parameters, all of which are statistically significant. Patient reported episodes of arrhythmia as indicated by abnormal DynaPulse waveforms and verified via Holter monitoring. The patients SVR, BAC, and BAD were compared to those obtained from the same age group within the normal population, demonstrating a lower initial BAC and higher initial SVR. The patients Hemodynamic condition improved (as measured by SVR, BAC, and BAD), and these improvements were correlated to medication adjustments. Angiotensin II (Diovan, Novartis 160mg/day) alone did not result in significant changes of any parameter in the early treatment stage, however Angiotensin II combined with a diuretic (Aldactone spironolactone 50mg/day) resulted in a clear reduction of SVR and elevation of BAC and BAD. The extra addition of beta blockade (Toprol-XL, Zeneca) to the drug treatment regime resulted in maintenance of the reduced SVR while simultaneously further improving the patients BAC and BAD. Comments: Demonstration of the long-term effects of drug therapy on hemodynamic parameters has been scarcely reported largely due to the lack of appropriate tools and methodology. Monitoring changes in hemodynamic parameters such as SVR, BAC and BAD in chronic Cardiovascular Disease (CVD) patients over the course of treatment is essential for the optimization of therapy. Significant improvements in these hemodynamic parameters during the course of treatment were clearly documented in this case, demonstrating the clinical value of routine monitoring of blood pressure and hemodynamic changes. PMI R&D Report 2000 Other Case Reports*: Hemodynamic Clinical utilities Case A: Determining Whether Changes in the Medical Regimen are Warranted This 65 year old man with dilated cardiomyopathy of seven years duration, and a left ventricular ejection fraction of 12%, presented for a routine periodic evaluation. He denied any symptoms of heart failure over the preceding months, on a regimen of quinapril 20 mg bid, furosemide 80 mg qd, and digoxin 0.25 mg qd. The patient had been intolerant of beta-blockers in years past due to profound bradycardia. Physical examination was notable for a blood pressure of 120/90 mm Hg, a jugular venous pressure of 6 cm, a soft S4 gallop, and a chronic grade I/IV mitral regurgitant murmur. Non-invasive hemodynamic analysis revealed a CI of 1.7 and an SVR of 2249. In spite of the patients asymptomatic state, this change in his hemodynamics led to a recommendation to increase his quinapril to 40 mg bid. Upon repeat evaluation four weeks later, the blood pressure was 108/72 mm Hg, the jugular pressure 5 cm, and the cardiac examination unchanged. Non-invasive hemodynamic analysis showed a CI of 2.4 with a SVR of 1398. In view of achievement of these normal hemodynamic values, no changes were made in his medications on this visit. With the exception of minor changes in diuretic therapy, the patient has remained asymptomatic on this stable medical regimen for over two years. Case B: Assessing Hemodynamic Correlates of a Change in Symptoms This 71 year old woman with idiopathic dilated cardiomyopathy, an eight year history of symptomatic congestive heart failure, and an ejection fraction of 25% presented with complaints of fatigue, lethargy, and thirst on a regimen of lisinopril 20 mg qd, digoxin 0.125 mg qd, and bumetanide 2 mg qd. Examination showed a blood pressure of 84/60 mm Hg, a pulse in the 80s in chronic atrial fibrillation, a jugular pressure <5cm, clear lungs, no gallop, and no organomegaly or pedal edema. Non-invasive hemodynamics showed a CI of 2.5 with a SVR of 1497. As it was felt that her symptoms were likely related to volume depletion, diuretics were temporarily discontinued and she was scheduled for a follow up visit, with instructions to measure her weight daily in the interim. Two weeks later she presented with complaints of abdominal fullness and a 1 lb weight gain, without dyspnea or peripheral edema. The blood pressure was 100/80 mm Hg, the pulse 85, and the neck veins now 12 cm in height. There was a grade I/VI mitral regurgitant murmur and moderate hepatomegaly, with no peripheral edema. Hemodynamics showed a CI of 1.6 with a SVR of 2883. Despite the minimal weight gain, it was apparent that the patient was significantly volume overloaded and bumetanide was resumed at its previous dose. She was also instructed to begin metoprolol 25 mg qd after resumption of the bumetadine. Two weeks later a repeat evaluation revealed complaints of minimal dyspnea, with a blood pressure of 90/60 mm Hg, a heart rate of 90, a weight decrease of 1 lb down from the previous visit, and the neck veins now 8 cm in height. The CI was now 2.2 and the SVR 2710. Metroprolol was increased to 50 mg and subsequently to 100 mg daily. Evaluation four weeks later showed a blood pressure of 96/60 mm Hg, a pulse rate of 80, a weight decrease of one more pound, and an otherwise unchanged examination. The CI at this time was 2.7 with an SVR of 1626. The patients symptoms, physical findings, and hemodynamics remained stable over the ensuing two years on this medical regimen. Case C: Tracking Trends in Hemodynamic Parameters After Alterations in Drug Therapy This 79 year old man presented to the outpatient clinic on continuous home dobutamine. After a 30 year history of progressive dilated cardiomyopathy, with an ejection fraction of <15%, he was hospitalized for progressive heart failure despite aggressive outpatient medical management. Pulmonary artery catheterization revealed a CI of 1.3, which increased to 2.0 while on dobutamine. Multiple attempts at discontinuation of the drug proved futile and he was eventually discharged on an infusion of 5 mcg/kg/min of continuous dobutamine. After six weeks of continuous home dobutamine he presented for an outpatient visit. In addition to dobutamine, he was on spironolactone 25 mg qd, lisinopril 10 mg qd, digoxin 0.25 mg qd, and furosemide 80 mg qd. He felt well, was able to walk one mine without dyspnea, and now denied any symptoms of heart failure. The blood pressure was 110/67 mm Hg, the pulse in the 80s in chronic atrial fibrillation, the central venous pressure normal, and the remaining exam notable only for a grade II/VI mitral regurgitant murmur. Non-invasive hemodynamics showed a CI of 2.8 and a SVR of 1081. In view of these excellent hemodynamics and the patients asymptomatic status, dobutamine was discontinued in the office while undergoing continuous hemodynamic monitoring. Surprisingly, over the ensuing hours his hemodynamics remained unaltered despite discontinuation of the dobutamine infusion. The patient was sent home off IV dobutamine and on escalating doses of metroprolol. Over the ensuing weeks he remained clinically stable and repeat non-invasive hemodynamics showed a CI of 2.9 and SVR of 932, despite the reinstitution of metroprolol and the discontinuation of dobutamine. Three months later, a periodic follow up was done with the patient on metroprolol 100 mg qd, lisinopril 20 mg qd, spironolactone 25 mg qd, digoxin 0.25 mg qd, and furosemide 80 mg qd. He complained of fatigue but was still able to walk one mile without dyspnea, and denied having orthopnea or pedal edema. Physical examination revealed no evidence of volume overload but non-invasive hemodynamics showed a CI of 1.8 and SVR of 1752. In view of the increased SVR and reduced CI, lisinopril was increased to 20 mg bid and, in hopes of achieving further sympathetic withdraw, metroprolol was increased to 150 mg qd. The patient has been stable on this clinical regimen and remains asymptomatic. Case D: Establishing Baseline Hemodynamic Parameters After Alterations in Drug Therapy This 37 year old woman was referred for management of chemotherapy induced dilated cardiomyopathy initially manifest as pulmonary edema and hypotension. The ejection fraction was demonstrated to be 20%. Symptomatically she improved on digoxin 0.125 mg qd, furosemide 40 mg qd, isosorbide mononitrate 60 mg qd, lisinopril 20 mg bid, and amiodarone. Physical examination revealed a blood pressure of 94/76 mm Hg with overt pulsus alternans, a pulse rate of 108 and a loud S4 gallop, but no jugular venous distention or edema. Non-invasive hemodynamics showed a CI of 1.4 with systemic vascular resistance of 2900. Metroprolol was begun at a dose of 25 mg daily. One week later she returned, still complaining of fatigue but with no symptoms of dyspnea. The blood pressure was 80/60 mm Hg and the pulse 84; the pulsus alternans had resolved and the S4 gallop was unchanged. The CI was 2.1 and the SVR was 1500. Metroprolol was doubled to 50 mg daily. Over the ensuing weeks the metroprolol was increased to 100 mg daily and the CI rose to 2.4 with a SVR of 1475. Orthostatic hypotension became problematic so lisinopril was reduced to 10 mg daily and isosorbide mononitrate was discontinued. Over the next two months her symptoms improved and physical examination remained unremarkable except for a rise in the blood pressure to 130/60 mm Hg. At that point the CI was 2.4 with a SVR of 1338. Metroprolol was increased to 200 mg daily and digoxin was discontinued. Over the ensuing two years the patient did well on continued medial therapy and the ejection fraction rose to 0.35. In view of this, and the fact that her hemodynamic parameters did not change, her lisinopril and furosemide doses were reduced by half. She remains clinically stable. Case E: Measuring Hemodynamics on Periodic Follow up Visits This 80 year old man with ischemic dilated cardiomyopathy was referred for optimal medical management because of continuing problems with fatigue despite therapy with furosemide 40 mg bid, losartan 50 mg bid, doxazosin 2 mg qd, and amiodarone. Physical examination revealed a blood pressure of 122/70 mm Hg, a pulse of 60, flat neck veins, a grade III mitral regurgitant murmur, and a S4 gallop. There was no organomegaly or peripheral edema. Non-invasive hemodynamics showed a CI of 4.0 with a SVR of 770. It was recommended that he begin beta-blockade and in view of his low SVR, metroprolol (rather than carvedilol) was selected as the drug of choice, at an initial dose of 25 mg/day. Two months later he returned complaining of lethargy on this new regimen. The blood pressure was 70/48 mm Hg, the pulse 58, and the cardiac exam notable only for a soft mitral regurgitant murmur and a S4 gallop. The CI was 5.2 and the SVR was 428. Furosemide was discontinued and losartan was reduced to 50 mg qd. On subsequent visits the blood pressure rose to 110/78 mm Hg, the pulse was 52, and the remaining cardiac exam unchanged. The CI was now 4.8 and the SVR 751. On this regimen the patient felt remarkably better. Over the ensuing two years he remained clinically stable, on 100 mg of metroprolol daily, with unchanged hemodynamics. Case F: Using Hemodynamic Data in Patients with AV Sequential Pacemakers to Optimize Cardiac Output A 48 year old white female with a history of an aortic valve replacement and a right ventricular infarct requiring the insertion of a dual chamber pacemaker and heart failure symptoms NYHA Functional Class III-IV was evaluated for a heart transplant. Upon examination she complained of chronic dyspnea on exertion, orthopnea, and fatigue with a decrease in exercise capacity limited to 50 feet. These symptoms started after the aortic valve replacement and became progressively worse in the last two years. Reviewing her medical records it was found that she had a right ventricular infarction secondary to a surgical sacrifice of the right coronary artery. The latter required the insertion of a dual chamber pacemaker. In addition, she previously had ventricular arrhythmias treated with amiodarone. She was admitted to the telemetry unit for evaluation. Her past medical history was also significant for hypothyroidism. Her physical examination revealed a blood pressure of 100/80 mm Hg in both arms, a hart rate of 60, a right ventricular lift, tricuspid regurgitation, jugular venous pressure of 10 cm, and bilateral lower extremity edema. Medication at the time of admission were: coumadin 5 mg/day, synthroid 0.1 mg/day, torsemide 20 mg twice a day, aldactone 100 twice a day, and cordarone 200 mg once a day. Her ECG revealed sinus rhythm with a rate of 58 and a right bundle branch block. An echocardiogram revealed a dilated right ventricle and right atrium, a normal functioning prosthetic valve in the aortic position, and a normal left ventricular function. A non-invasive assessment of hemodynamic parameters was performed and revealed a CA of 4.2 L/min and a CI of 2.1. Her laboratory tests were normal and her TSH was within the normal limits. The decision was made to non-invasively measure her hemodynamic parameters continuously and interrogate the pacemaker, to change the settings, in order to achieve a better CO. Upon interrogation of the pacemaker, several modifications in its settings were performed and hemodynamic parameters were measured at the same time. When the rate was modified to 85 bpm and the AV interval was modified to 180 msec, the CO increased to 6.0 L/min and the CI to 3.2. The changes represented a 30% increase in these hemodynamic parameters; the patient had a brief episode of flushing that abated quickly. She was discharged the next day and at the time, she was walking 250-300 feet without dyspnea or fatigue. Two months later the patient continued to do well and hemodynamic parameters remained normal (CI of 3.0). Case G: Using hemodynamic data to help in the diagnosis of patients with decompensated heart failure A 48 year old female with known history of dilated cardiomyopathy, hypertension, and an embolic stroke presented with worsening dyspnea on exertion for the previous three months. She also complained of weight loss, loose bowel movements, and occasional dizziness. In addition, she had multiple admissions in the recent past for decompensated heart failure. A previous evaluation included an echocardiogram and left heart catheterization. Both studies demonstrated an abnormal ventricular function with ejection fraction of 30% and normal coronary arteries. Despite adequate treatment for heart failure she continued to be symptomatic and, therefore, was being seen for further evaluation and treatment. Physical examination was significant for sinus tachycardia (rate of 120), S3 gallop, and a slightly enlarged thyroid gland. A non-invasive assessment of hemodynamics was performed, revealing a CO of 11 L/min, CI of 5.0, and SVR of 640. Blood pressure was 130/70 mm Hg. Because of her history and as a result of her abnormal hemodynamic status, thyroid function tests were performed and the results were: TSH < 0.08 mU/L (nl 0.047-5 mU/L), thyroid hormone 3 uptake (T3U) >55% (nl 24-39%), thyroid hormone 4 (T4) 22.8% (nl 5-11.4%). Based on these results and history, the diagnosis of hyperthyroidism was entertained and methimazole 10 mg per day was started. The patient was discharged home and after a three-month follow up, heart failure symptoms were resolved. Hemodynamic parameters measured non-invasively demonstrated a normalization of CO and systemic vascular resistance. * referenced from ICD-9: 414.9 Chronic Ischemic Heart Disease; 428 Heart Failure; 786.5 Chest pain; 785.1 Palpitation, etc. sources, 2000-2003 Appendix B: Comments from physicians Dr. E. Urbina (031908): Hypertension experts realize that BP levels alone are insufficient in managing patients. There may be subtypes of BP (central sympathetic stimulation, renal angiotensin mediated, arterial stiffness abnormalities) and drugs affect vascular tone, stiffness and wave reflections in different manners. These observations may explain the beneficial effect on reversal of LVH seen with ACE and ARBs not seen with beta-blockers. Dr. A. Delgado (030208): Dear Dr.Chio: I am very happy with your'Clinical Assessment of Hypertension', specially because the entire literature still relies on the simple brachial measurements, whilehemodynamicsremain an specialized tool forbasic or clinical research,rarely obtained in routine medical practice. On the other hand,Istrongly support your approach, sendingaddition to your draft in simpler words as for GP physicians. Dr. Delgado, with his years of experiences, had suggested extending DynaPulse hemodynamic assessments with following additional clinical evaluations for advanced hypertension and CVD patient management: *Evaluation of drug effects on cardiovascular hemodynamic, including aortic index parameters (Augmentation Index, Time of Reflection Wave, and Pulse Wave Velocity) derived from the analysis of Supra-systolic DynaPulse tracing. Evaluation of Cardiovascular Response to Isometric Hand-Grip Test (HGT), defined as changes in cardiovascular hemodynamic (e"15% d" 25%) 3 minutes after starting the test in treated hypertensives. ECG/EKG evaluation **Ion Transport Studies (plasma, erythrocyte and Urine K/Na) Acknowledgments We sincerely thank the physicians/researchers of BOGALUSA Heart Study, SWAN Study and many other studies for their kind contribution to the establishment of normal ranges for DynaPulse hemodynamic parameters. We further thank Dr. Gutkin, Dr. Delgado, Dr. Urbina, and their clinical and research team, for sharing with us their valuable experiences and knowledge of using DynaPulse noninvasive hemodynamic profiling in hypertension and cardiovascular patient managements and cares. Mostly, we thank Dr. A. DeMaria, Dr. D. OConnor, Dr. M. Weber, Dr. J. Neutel, Dr. T Brinton, Dr. M Budoff, Dr. YT Lee, Dr. TC Su, Dr. TD Li, Dr. LL Sun, and all cardiologists/physicians and professors who had helped the validations of DynaPulse technologies and the development of its clinical applications since 1993. References and Related Publications: Chio SS, DeMaria AN, et.al., Development and Validation of a Noninvasive Method to Estimate Cardiac Output Using Cuff Sphygmomanometry. Clin. Cardiol. 2007; 30:615-620 Brinton TJ, Kailasam MT, Wu RA, Cervenka JH, Chio SS, Parmer RJ, DeMaria AN, O'Connor DT. Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk.Hypertension.1996;28:599- 603. Brinton TJ, Cotter B, Kailasam MT, Brown DL, Chio SS, O'Connor DT, DeMaria AN. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol. 1997;80:323-330. Brinton TJ, Walls ED, Chio SS. Validation of pulse dynamic blood pressure measurement by auscultation. Blood Press Monit. 1998;3:121-124. Boldt J, Clinical Review: Hemodynamic monitoring in the intensive care unit. Review, Critical Care 2002; 6: 52-59 Kumm S, Therapeutic Interventions for Hemodynamic Values, Course Materials, Unit 5, University of Kansas School of Nursing, June 1999 Flack JM, Noninvasive Hemodynamic Measurements an Important Advance in Individualizing Drug Therapies for Hypertensive Patients, Editorial Commentary, Hypertension. 2006; 47: 646-647 Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002;39:982-8. Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypertens. 2002;15:94S-97S. Gutkin M, Torres Minerva, Kassalow Nathan, et. al., Behavior of Brachial Artery Distensibility (BAD) and Resistance (BAR) in Relation to LV dP/dt max. J. of Clinical Hypertension, 2007; A11 (P-13, presented at ASH 22nd annual meeting, May 2007, Chicago) Boutouyrie P, et. al., Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients A Longitudinal Study. Hypertension. 2002; 39: 10-15 Stanley S. Franklin, MD; Shehzad A. Khan, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Daniel Levy, MD, Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? (The Framingham Heart Study). Circulation, 1999;100:354-360 Urbina EM, et. al., Overweight and hyperinsulinemia provide individual contributions to compromises in brachial artery distensibility in healthy adolescents and young adults. J. Am. Society of Hypertension 1(3) (2007) 200-207 Urbina EM, et. al., Impact of Multiple Cardiovascular Risk Factors on Brachial Artery Distensibility in Young Adults - The Bogalusa Heart Study. Am J Hypertens 2005;18:767771 Urbina EM, et. al., Brachial Artery Distensibility and Relationship to Cardiovascular Risk Factors in Healthy Young Adults: The Bogalusa Heart Study. Am. J. of Cardiol. 2002; 89: 946-951 Xie Q, Chio SS, et. al., Comparison of Normal Ranges for Pulse Dynamic Hemodynamic Parameters Between U.S. and Chinese Population, Presented at the 10th Conference on Health Problems Related to the Chinese in North America, San Francisco, July 2000 Budoff MJ, et. al., Measures of Brachial Artery Distensibility in Relation to Coronary Calcification. Am J. Hyperten. 2003; 16: 350-355 Motiwala S, Peixoto AJ, et. al., Reliability of a noninvasive device to measure systemic hemodynamics in hemodialysis patients. Blood Pressure Monitoring 2006; 11: 33-36 Neutel JM, Weber MA, et. al., Effect of Antihypertensive Monotherapy and Combination Therapy on Arterial Distensibility and Left Ventricular Mass. Am. J. Hyperten. 2004; 17:37-42 Julius S, Nesbitt S, Egan B, et al. A Feasibility of treating prehypertension with an angiotensin receptor blocker (ARB): The TROPHY Study. NEJM, March 14th, 2006 online publication Seasholtz TM, OConnor DT, et. al., Rho Kinase Polymorphism Influences Blood Pressure and Systemic Vascular Resistance in Human Twins Role of Heredity (ROCK Study). Hypertension. 2006; 47: 1-11 Su TC, et. al., Homocysteine, circulating vascular cell adhesion molecule and carotid atherosclerosis in postmenopausal vegetarian women and omnivores. Atherosclerosis. 2006; 184: 356-362 (DynaPulse Physicians Reference: Oct. 13, 2008)   !"FU fr2ORqrstu!|ym5B*CJ \aJ$phCJ5B*CJ$\aJ$ph B*ph5B*CJ \aJ ph5B*\phj5B*U\ph56B*\]ph 6CJ] 5>*CJ \ 56\]H*CJ 5CJ \56CJ$\]56CJ \]56>*CJ8\] 5CJ$\ 5CJH\%  !"FLmo$a$,9FGHUV RS12qrtu7$8$H$^`7$8$H$[$\$$a$BC !!sFqr & F7$8$H$ h^h7$8$H$7$8$H$^` h7$8$H$^h!.sFZrVg !!,!8!Z!}!!!!!!!I"n""#<#Y#q###o$-6.7......Y/Z///10200¶CJOJQJ^JaJCJaJ5OJQJ\^JaJ5CJOJQJ\^JaJ56CJ\]5B*CJ \aJ ph5B*\ph B*ph5>*B*CJ \aJ$phAV !7!8!Z!!!!!I"";#<#Y##o$p$$$l%m% 7$8$H$ & F7$8$H$m%%%9&l&&&o'''((R(($**+e++++,,P,,,,, & F & F & F,-1-N-O-q-r----6.7.P.d.......$If $$Ifa$[$\$ & F & F & F.../% $$Ifa$$$Ify֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?///1/8/Y/$If $$Ifa$Y/Z/a/" $$Ifa$$$If-֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?a/f/m/////$If $$Ifa$///" $$Ifa$$$Ifc֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?/////010$If $$Ifa$1020:0"t $$Ifa$$$If֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?:0A0F0P0f0m00$If $$Ifa$000" $$Ifa$$$IfZ֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?0011112222%2h2i24444444p7r789991=2=C=E=J=K=\=^=`=x=>>7A8A9AMAAAAEEII=J̸ÜåÜÐåÐåååÂñ}åå B*phjcDB*CJUaJph jDB*CJaJphB*CJ aJ ph5B*CJ\aJph B*CJph5B*\phaJB*CJaJph56B*CJ \]aJ ph5B*CJ$\aJ$ph56CJ$\]CJOJQJ^JaJCJaJ10000001$If $$Ifa$111"d $$Ifa$$$If֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?11&1C1`1g11$If $$Ifa$111" $$Ifa$$$If)֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?1111112$If $$Ifa$222"[$\$$$If֞0h (#'8'8''''8p%2 22 22 22 22 22 24a?2222h2i244444468:0=`=>7A9AMAAAAAE $7$8$H$a$ $7$8$H$a$7$8$H$[$\$EI=J?JLNNOOOORTX.[C[D[E[y[z[[[^ 0^`0^$&d7$8$H$Pa$ $7$8$H$a$ $7$8$H$a$7$8$H$=J>JL LNNNOOO-ORRTTXX.[/[C[x[y[z[[[[[]]`aaaƿ钿zvmaTa5>*B*CJH*\ph5>*B*CJ\phB*CJH*ph6CJ0J6>*CJ 6>*CJ6CJCJaJ,j05B*CJOJQJU\^JaJph5B*\phB*CJaJ ph B*ph B*CJph,j5B*CJOJQJU\^JaJph5B*CJ\aJphB*CJaJphjB*CJUaJph [^^``aaddffgg2i3iiikkvoxoEpGprsWsXsu`7$8$H$^aa3i*B*CJph6CJB*CJH*phCJ56>*B*CJH*\]ph56>*B*CJ\]ph5>*B*CJ\ph B*CJphB*CJH*ph*uuwwx xyy9z:zvzwz+}-}j~l~@B89` $^`a$$a$$^a$egݐސmnopqrstu^_x͖ & F7$8$H$ $7$8$H$a$ &dPpqu_x͖Ζϖ,-@Jם #&13˞֞oşǟ 2<ƨƨƨƨƨƨƨƨƨƨƝƨƨƨƨ6CJ 56CJ\ 5CJ\56CJ \]B*CJOJQJaJphDDD5CJ5CJ6CJOJQJ]^J5>*CJOJQJ\^JCJOJQJ^J 5>*\56CJ\]CJ$>,-~̝ם؝&qƞ˞̞o2 0^`0[$\$23-.vǡ;wx$ikڧۧԨ$a$7$8$H$ 0^`0<Lߠvšǡ YZfwȢʢآģƣviv6ik~ڧ^qsԨը<^_ B*CJaJphB*CJH*ph B*CJph5B*CJ\ph5CJ\aJ0J56CJ\]aJ 5CJH*\0JCJ0J5CJ\0J56CJ\]0J6CJ]6CJ 5CJ\CJ:Ԩը^_ wx;<*+, $-DM a$&d7$8$H$P$a$ 7$8$H$KM[]^x;Ԭ*+,CJCJaJ B*CJph5B*CJ\ph 6CJH*] 6CJ] 5CJ\CJ 1h/ =!"#$%cDDd*>,Y:h  C DA,DP_Hemo_Report_M1.bmpbCk h[CD8n{Ck h[PNG  IHDR%N_sRGB@}0PLTE׷镗Zׇeijmxvhl~b7 pHYsnu>yIDATxݏY'kNZ W5(͍$ zXwZE9( L)-@>uf7rz"m(/f6r@%J `]^(Hhռ@hD{횻L2ƒL5ksT-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-D]h%dkKs+ZR_S=W*(lyڮΏ)Ƽɺ?7lyRK㊸vQ>)}-UAڸWe15w]B{DLҊW̧(2~$-g(S%Mãv_ħ/=HҾvD cHwzd>}A̜F%W]'sevGXvrOv<*dt5\˕!9}XF?ZH<%8 R{2.ڮ('J|9<n'~d^;-+ Ѳ$s49S9%_4ׂ*87 )(#OkN+vt^;-!G!U#!=ԇ%2Qw78$}[jQE1j"!,?%=p6S~HVxεR@wncZVe #ӘaFhLKA5#a,=PGkp C9[ Z'.iY_K-KBpD?K M #z@9'>,"P3FP/)arD'Aw'Rugnt5EaGuq]coJy]aLuBSUZp%+q/݄܈cԹhSovF#O@{Z-T8Gg*}Ccv}QAr(p. E:xN\ eӮiۭjywHk@',? q?fǔ6ƒՆsw? \@X4TU*t,%jd)UJj9_"ĸ/ƻ#® b)N]SljDc<_xe3q|0/atr;J6(qVnO?׃.gN>ӱL@<ױrަ++)݃/[Ou6191]dij -7DMsW+[e#9n?T@7e9jײ^'ZOضOnf c{_"ϙ1X)6TJG1c(u`j}w@~\?ޝRw[IQ"wxb =/RZ >lN 80`']8Io4(LЛ1;#R6ђݵ!Ek@HCK<U)9]RM I@~Ac ?OXһlfO)3탏XH> ȚS"#t!xN0a)i ){ǻSVчPTԲ^$W ?>8v- rMpߕb^'~i(Aג>tr%92z*S@jnPpx9Y s Û*sʫeUY\.AŠ,~[WyN{\*Йb78|X3]o3:Od_s>)Bz`q.{5[&EK*5 Բ,:0GOwuFͬd&2V#et'{fd0i6$eR/;7f+}+rNL{QxDZޠ{1XEFWz~Ѥ2Q_u'm3Iw=Qw$Q%U%I^Zjy-^ZǀW}-\ː\y#~k-WD]\ȵK95k2F+Kw}筥ZjZjZjZjZjZjZjZjZjZjZ6-oZjZjZjZjZjZjZjZjZjZjZjZj ~"jZjZjZjZjZjZjDM0w-\D%݃nF#8 ͲM1Fw7K+ՙ4%R:*e|M?e-T%?8߂!~Znl JFe,KYH/jWd@h{#J -ZV(}21;XNA:`W,dvuKWůʁ߷񪶭+3Ơn],;e[QWY;jULA4Qj2*Q74MAŚVE/bdV~E+_jpiT͈^*lSu}M xOC fAƨ"5wE*.@9@:-7Du_(cǕ^K5^)dVFVj dw<۝vG٨v2NJge̮1Y-DKxxF}MQUS͂OVUjY'/2STh4@ Hu"TЛ劐D_]$=]x]'%=vK=_kV ]*|s*NV@?>G ^V48,o'THkw0c&1ع]zA`ut1XRjf!QLљ>ތ@oӎBɒF'VaG=+Z=:sÍ uDk D 8ǂ@WM'j6A! U Eu6%"fY"UM&!0NsR?]soZ4=ReK(Zjlq_(/7}r)6a.\_jHd`.ܢp[r{+!nZjyǥU/\@//~@!:檦wXEyz =zlzjyGϖ^EZ2Nnjz ]Qqko=Wo΢O/vKN2Nh~-ouH6XBBָeEZ=^^bOʼkEQ}U{S\Ra{pH4W=^v_~X˭`âL.&_\\;-%k_a^|ݢOã)ӉϳlxiɍSNM||*_|}4S2>P1}2I{5mZB/.Ryũ͢xڸ|NtxV{juG`vWyg/е6 000.2m nU$ݫ,U6_쒽ԫ.7NRahS"ڼ}][-05xq%4Zm|hw:27E!Ê~lTZft,GYx1x"½.{:~v^}ݟZͤckԆ+bg@6#DHPJ5]!qӧycWzKPϊy/Eiuip~x #CnB%|G Zx[ł=cv|9Aq~f9$.i}}?5t#鰂bo̓U=ޚ+n!䏶7:(D6hX v z9o78/S88cעt.uUb-,:WQ0,¿#bgDipqN^$tuX{cr ,Ss=/dgc~QR;kl[#_8.C2b~"L0q&q$l-bq/ҹB'}ο\x_uT{#Ŕ5ĊWҧJ X& Ugg-xA PLgQJc]J]/d[tI c:$~!YȄ{_4q͹; li݀ޅ1[td VFN97+Ϋ{+KpC>σ 3kbmşE:$vT/5}+?yW z\5FO2~JUj|  @Hq-W}A]TA}SD)V-"F?#r޶*r'q*> ZqoQ\X_U_t%OAO_uc#bbKuKv{V쁳 OAQLaAo۠փ[ p/' ~'T+vJQ,mVB̰3vmbL#)@rRr E1j(T\ n挫П\α|>RT=< Quct\oY+}83'_ѦÓ'xG@D{z1]V/~QqMy߆R+?,cCt'g&{[w~};Ř@C[%(S1. :H=RD M-kw̝Jq0+{-W.pAɸ2Q>Sx/lZ}$ ,;y0|8{-CD~?P&G/sPfe)x y [>(KM{%~E!;<;烼%p)_;A"{O?[,L8wf͔(ycUT9'R  f|J!0tQUcKswI>=}BgbL,1/O]q.4/M)O=5}Xa eAA+n]v d5 }> ЄxHd }&#ligK?-~+ߣ\kQSX寴;^@\ݹ LL}U*l#ackPԜe`Ji*H$?WП-`#&ntH16 )Aw:lZ\nBrHrTS}@<0[%렵Ս3TpCϹAy(W>ÁNҬjLv6PFXvs*ЊGh E"ATa-`'?);n௔9}kQ>sqrKGO4e|(Ƚt[㞹BbH%.DZQ> y>N-auJ(ǭSj21ř՘ƄQHǞ*z2sqrgq?N^ t/%_BCӅÄ*.| z 9옚u?U;7oM?%%8|ϷwqY{(>}I>1o|vq_ qg_>mm '^Y\+ _Q{杓F+[:w\u=͈ &szd^u35$ݞr^(4ikU`Q7{x z1Rpt|cKԐb##%`4 #[rǚBRkT :qE +6Gs$ۏz۬*[ %^(Jm=.2wL~Y/VK>^5v{|A{_vsݼixNHnA8aC+[;gZ`@>6]_ES grsaNif;$8Ŀ>WХT+Ϩ qey7E%J j;4[>c <[K]L\s~  ?Ev%%^Gr:D@1HĠq)vp= Ҏ|1{'جs-^oŸS],_C>BhvQ>Ͽ1 6N!/dqxmzEc.sz G&VΦ29,xͭ)GՃkڅ ݶ_ZB aQ?8썺i1)J>6Pz`e쥷g915C`['Euq-BX5@ѩ̧V„;cߋ 7Ig z'mU)o݌b?E^kczѿvDُf\>l?LfkpuMrb}5jY#f7u(b$}D;9L྘Rt?"Kzs:ߙ}t³'xdgLOs09ZU_=bw?D'D+]Z6,Y==z"#mnBDSZjZjZjZjZjZjZjZjZjZjZjK 䯥הh5ц.|(FYv3'm:ei M(W8SˏRy R˛+ʘos˯A/:$P1莻ٮӰIEgbYLScwRi+W.ZD'~n^kv֜ʊrG|?٘}oMkA N_SUEi_ٷ˗4^"X*c^GR'Q# /.E, o~{-8m?:$K8$t"K+-Ƙ5p\ߊfKa\" s9xA)`5D 3AhD&|IY;4(zf QtN#PH 4u44P/MqҴRɐ4jFMF uX(TַHb R;4⫆աp`8X2}|D^ k?xʾẃXu0_-|VvI̺rCCcvw'p̨K*S$vNjY̠j4!X ɵ5d)>K 4ISt:XǬa`] GYu [w u/ndVx @002Bvckq\xNSq!3~uQWakz OLawm ,s懤]R׬ FsD],;I &2t=LMɭ 85y骬Zj HERK-RK-RK-RK-RK-RK-RK-RK-RK-r12'>^k/):oG-\1i <5;<㶋#wVdkcA+rܺ7ziv%a-o3{WQ(5OԟRl_F!Pnw-~T+7xr;'?Z;*Y7*uXBܧntCo]ƪ@hX&V)_|u x>7Mu. Z r@ߒ7qg0I^ˢUK-H3w@s;}6X/r5TOw@hi)Bj/4uR'N)if]o }NTT#G-5,CT{_anWb>Gk= LbT"To!9ETc TCA4aA4$cun _ܕ]  _%/#G`/yomBm-~ ;-L R)zBr= bG4! iEJFP[[tCtKۅ _sW$:je1po[gI,AZbBe&ݏyAz AdQF7V%CѰZjY?MzV h*Afm9{f'?8n,7<7c8+gZxq3LŸ/|< wEPK-K3X4V{J;sa,mct`_5݄XniguX )V}N@kC}E-pVMk(?#jw '3ָe`D#7dVZnm" vy̾&~QBhr\=7,_3}7Eirx TK-JLe_QڒMpKR&XW"9Z''k= NC+f1{y vM+oXl贏0ϸjײFFpցMs9-Na{Gm";08Cii >̶H }@hNkײVg3<2Os`!{"޾.34Hq7-sƸGhGLw#)b#A_5|f^=7M9P6#~զZjAٖt(]%oG%aU {k:)}s4Ҿ\@126Ǟ 6({]㾖">/zD—Rkˆ#a ZݼDa3K78 Es|ewcfMjp㴯g"S.u~X:6.ul?FwDj-p_gdr5c)QK??bDmZv룖GTCoX6ʮ<}^<g3/C<'yS3ȇt [<7I^LU(D/y+{AhKM?kJȦ"m=\WqdByEkoD}y :IQLlG7XMWE j5/W")P_v vy{2˿dΦ!y)xR18tkqeB~ Ȱx$p!0 IvX$Lwdefܼ[ V6n o- OGq>ڃ}ȧ;|'N;~Q ӓn>·;ÝÓa6G9,1l:\k[1?٦9Rg g{zozϋ .W{֗wT_iCnz=?~pl:|} ;ai5Qvt$k6IGNΝ=FNMܣ7EVwT:a&'F냬S.Kcm ͏_m.\ Czn[X([_UmL4|Y1i=OemQJ<_N-^Gz{_9y?x;Hx: K#沆Z1[?Ul_Ww?48y|L~؂h>l Zck&]}u5^9J}e-d{DpV[~s|Å5oo_ڵ ?ٱ֞Rw uW&pç*gz9}sW&yr89cl9~i}ڭpp/3ŔVaqo:݃`/_8z`z} p?r/sUc꤅s?9x??\݋teln#CP7ІP%PxrHPȔil\95mҽ"Ѝ:<IcaﴽG:/6 .}2_q a_M`/{4KgǏ<[e' YxĻV0jNepg@'F"V^[OpD~xx`ۦ X8HHwjb DQE} r Fvװ`7;]7t~(ǒc Ŵ{ ܳP!P@|N-?BxDŽEҢT:,8D*-@qxc&zyo0xf{+YKs_;l=ǰb#G9H)~Iz99,*ω~{ě!51U(]̆C̤=c s )Ju1YOy/~ x#5тsy\_! #:D~t-?LVq(nkqDN ؍d Yx b!nRb=%Ds7\%ևwV{DH( ًfZ;O{'z?3ԵHVpEc,H vyo6<[<ż [E4T6~,w00tx3)>tOz.½sP}.'tj{_˲{/ \!}y}p\AHއBҺhHIY\?[1Uq/РE'P/0Gԯ>9ɪn@>]Ӟ#C:{}:>4-6}J]H5k 1uǰɔdq~ijF!\8Ya2q}mZ[A.}B3_l݀J2ØR jhTZX=Fv;nqoж,cE^:S}چ~3]NAGXqI~IJfSyT)F}G3ZnzRU[n^JZ澰4~:j:A\Gn:5ܗCy}y( Qb-BlM{گ$ZJW&F뷨#kpmWב5 [wҶkȵ rR?[:ff5/y1~7 o5dJN<jz1o*^y]v\7¼JωbSRqkmlZ5;dg*NN;;E10:<{4NrL`x8vdá9BӦ(d÷ʛʚ3 A*u'Y4nwr5_t(&;|3)-zλs죡$Qjh|:"oxY3ǼQwxwxΐxŁ9d0;cܢB}r[@t;ej 1޿M\ WĞf57t-\zXC~M…V7$Ci>#[h3IiX#>{)u\6 >xœ?tAAK9v+Mt$c!ŷ܏8\G wg Wi>cAAcpeAy.;<ø~4X}^{`]gs_ ~[= gWm<wqonIsCxN2Ug$%)o31Я8Y|Le9>OZ?nyh1L/Ns˥ Ný <)*8>i W.d V+B*or󡼏)(0  N zy c߭?Uɒ;yZޔĿݏ7?7_+׿fEQ-n7f#[vGh  }wݪ7%/?T_܏?m)!msᐸkYْ^3;Zޔ:_-iCc (˸߻gq_˲0/o>'o~G "ZZ p߰' |(/9[AE-?LηoEui෡|t~eƋ&O7%Źpo[Z#l麂%{oy΅>cZ<ý`׌}9]r:7*.>]ƽg,V.moBe!B [W\nuyh7v.|N-r+1'a9O;R ?W5ϩeYJ?Vq;6*8D`Jw̥tڰy_cyVvYeN\ҫ3Hk8}f\95Ґh X<9C%9VL ˥W]p kₔpߗe_xar ~qr{׎9KXkAL{˲8)g J2ZJq-xjnj{C.*O_ZGApΡg*@>ﲾپM5]2ev`Q[|7!\g_Ưgr܄Bp~:q )+UŸ7?f<ϿZ%Ld6(4јKGO㊪Wzw}cpfSQ:oq-O$?S:TߌFׄ;s3:C2);{gO@[X%o.'ylW$VX7;(^;`%AE1rk뒖^VONĵ CyL2K ֻ7 [ۮ6\\x_N_&Y\`+dV}4p8N"р\8ˆ$5Wh`Cٮ7C Yʖ-^|{foypw)/F|1 lvoyL)^EAp+Ǥ"{x Cxܯ@?XzmyӾ_˸_8}/zB6$|O0OkX|n6p Q5[j+fta}*&v{!q$E_^թq\vקWp_"s;Ÿav-;,ÙE[ Bߧ!%ܵ~[t)~0ݢf[g9R/g}\{A>7>ΗwJ}ᶰbM9)ݖm/\<ؼv 9N`/aXxZa:;2OzvcL]6 }L|?u?[kź1w+oukgTnN![x{@nN!iϏ<{ P=`_󡫦=)\ Nļp~VXO!W3L=w@k_fV﹟|1c6/︽GqV[s_ƵA|_ _B⹣Cx&G1I1凡oH96R䓼E,%sr+2~ZvVo.3ZZ]oZ*9nq![- Ñ_ %{rB c]/# #j j}:I\X:ƸJv>UD&Feh4\֯e7NiU,k^k=;~{p̩4N,:)r5|BU`\]5${vhH/m`q7dM WB+3OtiؼZS}%c>?Ux\bo6A_;0"p@XK9!F1D"_+LBۭ ]!y<"%ȉPB7LJ~7tpU}*z^Ÿ/_sۭה59sEWksOu"'N?Rr>WpON~GTOIs3c:. MХ{=Y\e{ZSx[! Q.}Y?!X:_ͽ6wC.QsNf?הdW j,=]Ά'r^]PO`d-K*?;ssg W[^4^w6jm7?@! =.w̘,q`a?>uF.-?۝ϩ ۭڅ;n';nZowfM_E$ϟAJ}[q> %#)4);5ϩU?F(\mbp~uVq^ײ,7+.stո*oޯypQsjY7UrzD9Y,9zaߛn}-U)޸ib˕;{:eYyL\^37ce~ZْiyAbx³8 p(˼78ɼunڠU'STА#P+}ݦYh+1ߗ =Q +mJJBR+#cf.ahaEMgQHmMBV cpMEKh7ޭPP$fD3 B: m6+p"  O|&[1G- #pdYG6.Z[C׋ Hq4 A瑢1o4r^,x%[c,pQ Ht>t `i)~dזI=n^KOszJCN{hJ=[{l59*w j<{o1iE[F79yqW>EQ<hU,ɿp3:^ 7p̺%b"m yڭޒ~iœ_pAĞh3#˺,F\j6؎àȇx Oxp-.Oh0ZLuȒrD`~q1t.]jsedHKLH>Hn v[%B&SnWMSUxs47(Ki^eu<ƽ/?F>}DZux=<< cؒ+;4OIaٱ,N˸u)Z\<':=g=Un0/:#?\o<"8Wk-dDHJiNJ{Rs4GxF*L$z!Sn:-^0{qk3e O YwNߒ~i܄Mָ$# &ɐ i_S8,sY=)J~E4gnuO!n+˄yZMvܺ?zwfl5^ e2F1{-fDjM_{w֩{}t ҿ~ d0eǽ[ѰvJG%˰a/If(DLoR|}T'3'8oUs}[O$Ґ.Wӗf-7^(^B!`6*9sgגˡtp>cêQDx UZM^(gxE}bS5OϹcfĽr@[IpezިWƏ_᭒7ϑ9Bqi<W&ߨvNߒƕy*+(_#r[[my$L }c⒡I>CHި}-KcK16=)t?Pʵ׆ܺNroIZ.Q^l/ig<Ʉ;Vͱܽu1cuZ}KɇCb+.(X㾖ey$߿O$sehނ+lZo^.>{%],MHaiuXC! \MIj||̈́ѧZby]ܗyC7CKr;8N!=5j4M(בeycpǗ_gVڸyN-Uy$x"9~ܢEow0 ,0)ay ׵o`s})&G+WṿE<'j=|]!Χl0D,|ҷ!u޸Or ."<K7x^qO4+#.2Gsd~Քd&w̶Oks()E$)f>1õ֪'[v"!Mw/2ɕ[ M…I Xz)Ġ<On~| 3Wp\i#;cux^C8US_@IWMaoeݚA{FG>2q7ܞI7n(%3?ـ_kaGkW(T~Ys>=1Su-KܳLGߥ'1Q̉R?wKؖU G>sózB> ,pV x~tȟ構ⴵhmIg`筏dJ$ɓۃcc4l4 |׉H6@WwkCDՌU%MM?g~#\_mYy_~;# FFN%/\'LƽB]MsJsyEy' `Ch9Hq9ED|>ó0 r0s3y~N/_~> hmD7J*otB9h8ߒhS-; <@F}?=lKy7-/cx ri_\]- ~ƮN=np wE6ˑ+sΓO (}?eӈqOrV\D!0txқ.d'L;S ;;Iț%hcBFiy42$o=Fcp6f~ `> g)9"w4{ V@YX&WPo\aQtF_z`;xvE\ njJofڻ߾.O|!I4&T#`Q裤U'iߟ堉3VJ$o2l>ly{5)Do M_-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-RK-\{4[-ĸl]7`JonAPeSE_ǥ"oPh!F>nTDkR]ܛ.?Dܷv`37(w@~"pٚJ[w;|GW_/yn6y-\X|7lg36NfjQ[\V]Ck7j7SM^o, <(G𱽘w6r}Z?_sgl|M.v.%Ԃ7q?A|ƨfӢT˻E]sjbt0o['fSp٢ۈ-V56S0.fUQ*n+uxT[P$@i~l^Deˊ+"ynIqIkQ]T2߃ncl/ږ`Pql>.CZ_$0%{dsul^"A^|H4g?!5W>5˒ˮPs d"X_G l{+/D;h>6 7;GacBl㤝ژ%M=ȗ]6jl/_͛ï6U"ƶhfn`x?\w-0sq-Hkq/[1P~|7 UǥΑZoٔwkP=ZK.ډ[ENo(>; Jڡ #M+lv[ V^|MQ7T&7aO'I1~3N\oo//yMXYl/T46Ard|s@~ֆp-]jsꖆmw wp#qy/6#J6|V^<7put$gR3(=7A O6lZ4dsy˒v{'lShs6'J7E!zCSe.B/9;;<&{yȿL/bO2T7#v  Tcxϩs({|6'~<3|4(Z]>‚~Q)juꧠ'q&$šg.EI{6ocKl4'}O w>w]  6 `IcyL&#pTp v_'ͼٺۼI-mIɒNQӤ_'QR@50\MF5OEz}cc]cDSEnԥ;a^E^,–ÜY,y;|'oM|p+!ӭN+oN7N':AӺEZM4g i:t T-M3m:ؤ77 v8rw\r`O!C)u -$gŕq-@ sܟ~`?wsP\~w>[I> :;yͻ[g:w*Urʖ5;u7 Ѥ:&4u3L)8X5S]h0 s؂^`\Sog%؁o. =QEΚGh_sEȟ~g3F?GћO`|Iްv] W~ %}|<| P8êE懋Ao?|,@`< n^>}&Aلp3`go%w;V953Py~_;$9l?2q%pvp( ) {m;Y t*=KLf:Nmݞɬ$1TX=ws Aa}4zy2lu}AG_{[} ?U loP(Z x@N-+>CT[Ѿz?YvQxp;/!h[<#']O^={9@K+iqrzicNG^2׻F.!%vYНFZbtNaLl`/Z˄I{ Nܒ C{y¹ukZ3H{ BBm&ifIkQtn:5j?Po.'p\31M:to,?"A+οozοcGg_4{o~2h,򛏾WヌXg_Ӽ׺MkMU^Gd}Ul*Ͽ˟;sMo@oNþx|}Y }[>gA†v,' e̟!X) C ]h%ϖ `k+8<,01jK1XI4tRVq:G(o02qlk1֥՛kCJH;֞ @tzOTκ4N F$mcf~" *PQ2#sPosPI :C *nۤw2WBg+yҙ?(iޟ'5A[}ڷ|6fy $||3h}M/ ZzT[3])]w|p_LL663lòOkn6t+(Z9Knx]8R vF?쒜Ĵn9;%k3b HYQXg8㋣T(벞HM!b%7R Y1|8kcfɋ1Ɣkzdog|y-c|΃V_Td:i*t+PZӠj{I]@Xk8uP=2AC،+%?^.rDؐLL +~̷\%w[̚5^ӗvPPT jnu@BeY_JQ:_W>mZUADa_}q5ޏ>/ #{j-TIh~sYL|"b Vfw$L WP}-i]*XN*<:kQuG5 s*-C-s՚ cbĔhͰ* 3O3m #v!Lf:f*uM|BW2s1l{BP_~Fe(Je.k k;k;IT<-Ŭ^6tl`2T fQM 9^B cJYRRV./JXˉըʴdM ޓ诎EgXDU} ^pM''NeKoF9k`+]O*5/[/Q6ꒅ콩I7ፗ$,5⍙{TwhBKN%fukohMڙvWFyX/0fMv,*6 T;kkoSIgF=i2qg|M&j!2e2V$f)ky?Xj-uIY(1*P5XP_i.i#S3.LӬX ƴS*Y%]z@-.QHy/e04$sC e*D(V]E2}v~LhF$lc>>U.z>ǤuabBː;EPsOn/:L\2F.,d了'^NR/UY66%kE2z 0jmb|˵hp*J=U`mi-f8b늛Iq- h6Cts镓UboQ^0H]q6OY5 VvJ;00[`iTEn QI#π`ډIMXlu #V@gW&9k+qΡXl0Ae+n笕bNL S0fT6^S 'omzsR$Rؒ>|iГ-sEӭcy>,<a5,) p9>% PJ.-3k>Έ] s34϶͍esel30hŭKPl 7hLeK <)/ڇ+˱Ӊ$gE_ωCJaw R(le j h̙y5m9&HaH,q3ƒpHO;&}\Ȍ s gξעM>ƒ6Xbr2sPB4D1s^ h)NhQGɜfڌ543 ` 9?unXF 2X3{RAs]`Ȇƶ|%j!/FO;%?NCac48:&7w `1GnU\fGiRJl2B^sN@9xd6[m2ݹekNWFV[Xި%*6Z^23ڶ[Z dڸ e.E'mdELa@.6e'ObOS|\?2k6=$3;s9!)17-X3<`Ҳۘd屮8CZK/oh{bezϱj rƀ)F I# y#12.],M\+jq"VO>Ml*jfX 5.S' ˈgzLM|E@lfhv19;۵s1gL>h2sŜ!J$ ޞ9VZ ;T8q-a\1DSj&V&@ݲ ڄM3X'm)Yd| sqJb6'i+;c]$2IDsbBepGG{v */@kṿ.19>_S"Id]&(sy- Miωyiyof|=%DLk2Cق#؎S4BQlj T\\˯'Αۣ# ʌ=m9[HҚ[$Ri1w&Q@ʹq&Cž6ڜCJ&ˊZ wf%ShY|*E4EBK,뤱Y.XFFJ Hs hRܖv.2(Q]@HqgIz:0 $NKc vM1BK-.5 $cW/娵ZNW13q4)65;%(ǽy0nscd  㱷k |Yx^]I1"O'SQ Oǒ@7N~|7j ?r+'µC 1KpPu\\i:ہETJ*ϱϪX/>ԗK}nx_+l89u۝j3Iv)ʉΰq? U/> Ki+obJYkW,7V4ٰ]TѪ5hi{U`Ŏ񦹫I)Dj*K!!?,͑H8 ᄉj4[[R=2w0+Og1*7r o|na1C$~]A`>pyT˱|?n)T:˛(c$ANsoIc\am5Ihz}珺Q!wHMA*&B{m6q&;g~*֓f凂 FuwQ6uC!b?kf?*rfЭ -p/QOdt|es}!:(UBSҠR3^Y|,e˚W^ %oVç~ ifN/w:UĊ,msM9C 2[ְZv;ܙћ>܆t}$& 46*G '%(sfwYmxNjK٢ V[|f㊰+YVJcC$q@W> wU]JUp+;w"*8vj~f+vf`6zU ԁ>Qji24eฃDk7m&AxHQ&ݏUX|R GMs$@ǤBj,^_u3av݆!ض$ص 0x$;ι4W|>-n P(fR:^PzYR?.ݑwʉ<|6ؿLԆ8Hܣśv-Uż}"rjYTWѶ u0ɣ$9mL fͺY%N`'VJd O𑜥fr$KE֚ n3`m˧{MpI7n&sY(I}W.([dK\BW!o\"?B3+'5$9uE|+92 ʾJn$/ p:TSKues#9UTS~oOt1-4 SQ v9:8yWFqID@vɽ*~@`7ij A\P c*Un.Sȸ#F9{bKkP;>UaL٪)4hmyBP'9 Z$YRgKW$jw+t;*d3ӰiOì0zGS^CSq \ᯤoQ//^T^Z-_ٕc+O̢Rɣ{Sc6̑M`@&~sɘ&Odo@Ǹ6 ؀OEԯqǟ'>uʖ*S 9[lkp 9W28 ܁5&ruĈ>%ƕMٴpnR΋cu%%͑T!8;r_![eS>iJeQMӆiJ\-gĘARdрm {*kyp#v76HFa<҅U@sO+~*\M G\EsrP*#ӘW;vٸ#8u ֆ{몺rB'\BR|yb*Jq)=f.18piZ'ME5wGOY]2kJM>\trdjYXYG)H$RUܷA}o3JWM>H$3K]NP)MJb\ʦ;ô l㠧AEl.;+dJ|ŗ1e[f\vuL+ySjZ%{\96t:qc̦k}T/"Įr2nc]ES1>BI5 *&xaρ>,1gZT3궃?2uݓ~ڲ{{n ㆿZ/ RZfu S1\f|źQM[3a(*4^ GZ7:KN#)g"-QVdӉ 96۝DamDR#3((RMӔڅir@R~`P*Y< нlfIw4A3ӓ"s.c9kԩd}\#<|9n9c;a9.1|?S[CZ.ղZq \a@hx.9x3)ۃV5ƀ4UeyJIQ'Hv'Q+jrP#Aӝ$3~Bg q7Ӟ-څ^BU]FϨի K#BL΃ Ӹ]]KjkgI anYVN0|\@"O\e~^\=p*T=WKrilP+bB2 +Q46K@,5%I9²#d]Q DlH C,hy{DA@hyNIq=IF?y?.%ܧ]CѸ-˧,١0>lAF0x!&!Ut9v?2mU]T52ʕW7F+}ε6onK&x,7jՄۇс!Κhu?hojIq+(}F;xmc[нN3򆗹v'~JDԝtW>0?&8:^JSMꛕRxw.Vjhd8fqS85轩m֖_*n(SJVB!{c5 ]Kԯ @+Y9u4y$ &ZS񯆳\ȩSVu@Q"#/Y-N!{o g#q%cD _v˹r_iˠTE*ɭb lMJZvbbe1Խ2J[.qnK$ѬR7*Ë$Z Ѯ)+S OV i**~qvb\ q>FCY,IԇvJmO"ʡO鎺ap>udE8RgRa*Pm5u2IRnZW 3ҟPKZ u4+//8k9,zIߤ_l!*)[d҃D{2Va'fL?f`2 ]5e㆖)Xxn&ڭv(gO|)p^"p.H[.=MSmVc&t^I=]QԜ992 =Z0Rkb@]X[׾ol[zq4[@^@T>/[^?= (tU=ZĝvTo:Ǽ^de5f*5.3趩mv;K38c5R:ȻgR>R Gk{Jp$'v6{܊e6Xc{($t{F8|^fα "g$bLXt/Ъ לNH_&NO1哺GM[Qצhè&pWԑ L{ SخѵgҎ(O`ɒw;J d>yWA-ՠbQ7j%[gvG mnetFT۰X+Ye"?vЮ>M Z\=^_V3}ٶf\Q0o%+Zx45KQvm9.FmU"$=_L>T=-jnfxZsZ⓱n^ATB4w|ZP#[j ;G8SdHH00a/*/sXJxY]E5bih^'-kXV~Nی9GtQ g>c@t!o3aYs] 2^XcT0Ű,)c$f MwG^8:y5E?*apKO*2qcDNu$ԇrX&_4s6wOΐf6K0uγ5&heשn50UiJ ziD]~ \L0ŹyQ+g? Vws׷h+C]c"z&݇a1܁8'Н$"H)k 1E7g|\v3f?l^Ÿ@wcA-W *ZelPJINfDvHt,JpJ]4L|IbgfmY ,oAkOiڄhMo[,Vrfص=.W.mЌіJ=!?ii(HKyj=L„9-<Q Dnޭwj@eU@&iڈ KO*[% ,ƚ?0LY?D{^h4( 5)._nN:&ɾΊE^J߰^ބ9Jǩ\MsՍ^9YҢeD 95FOEMSkBJ|<<<! bI{:mݎY|$ o/‡S6B\M. K\ejqF Ys0ce喃6-9Qd77N/όg^17>WM]6DO 4smh^x}i93W|0)v@@;eya|lMb.**{6Ot2>2L&>ULMxdJ &MnИK[-Y1Ի~xCq\rwڱA˥aNW2\_P1q] AO*g {{٥3m\ ~K{w6p|F+2-8>;JR—y>GiC@^1&Su U>cӉ_Ni'V~f +$;OW1unj~h{D6lWG$2msB/[Ds_3óC{0~Xq Oo1a%nz(ͧ/OYY8QeǂQ+Hr7p|KOYEKQt C1N疄(Ȣq!_E^ nsК}_UUe.s{31#UZigceO.ֹkOp!nN րy7|>絸-^ŷh_9/ l{_Z/d}enB,t\gG!HMT6TwL!6-ׂK" Ù8ya@ў޶T1ܻMٞ\A4WDRSb]v=z,9f2$-k4rY<(Yv yk˧%-b  vY'V%-yn6\,Zq,PVmS9Vd4}ܳ=OpE9WOMoKi۟N=Fk Wq}?ٖjp?p>zS]$ ۯQ/+X3nt@jfD&H\4SJZ;u..jŠlK@$bN`i1㏁G6/pY)˙L}zq1z_+.i[k=ݸ"xJ+J\+[8fbgՙrnW#1AF}\ .9aXyh i~:6eT#k5M x @)w=U=snJ%⁏2Y{ڎ)KR}m%9z?K~8{qc5}O 7P; ڜKջ+%\v^[YĞ2hkfsV`P3#DTЊT1XzDHZs|YC<^, Ċ+H1eXs( ln;cre T7.Ӷ8t(N#Sc1Msˍ]1Tǽo!DATy͚, ܞmX*7rD %K2 i<42{pəl|CDag䜈q~ E {A!h)3t&T6$[skhKӯm.l?E>BO1<$~rx5QJ6M( jn)T=)I6E8ǜ919`'%.J$FfYK ]|%^R.cKNтsHŶhLtڛ !y|?T֜/LN򯈖`+|0゙U5"G4=pN414 ,N'vͶw&rTLcFaa kɀ$8hQx?TD;bfhcjkI;Q(#f6'[Cayw⡱hcLvNM. aE1I8u+ףj[AjMڭ,(u_;湽F1TUsI3[n7>Ki5oG(ޟ'ՠxF67H >G`HJk3)JDžbiD&r(ZxMvuɼƁc3Mt ՆX%aH w~6v͖P:J!>~]gL\,Aw&SXv*@ 5ZF6#.m8t? J `;Ո&vR;bhFc H眬eӉHu=X'>tVg!V ݖTDuzjl5۳A4͚w3=h4qK?~&m='~)mlPmyP6ݞQjEd-IDž[3nAC&nTS/5-cxTZ,짜ƺ ĵʌ̞a @Ph9Dp3ftQĜ`#BAsn/BZ&kl/Db1KPinr@vf[f'UW0>V8 4m8 hd0g4M3ð7$2žb dv4?E- dkN;y;"[+A~XRInS.m3Pup N4{E$P ]LRXRb)W7 N j`>63.nuLm<Ui«&%K N !:d{TZ`M3i~}4BrwM(Q?V~i?Wu|q@j6 w@kSgCC3 MNa]USԳ6*qs ֣oV%,?.k%3[j73XV `B4 2Q*:NsH'\lvL3uc7)2Tin#f}㕐UVc8Pך&PZYj2Zo7RHɫ* fG%+#hsw$VO˾ӄYN6D-' τF9>h0x6"ƛ pa Ϥ1*nliK(щ#j SGRHY Z`}#h$ VyX`&c۴OLp:9y< j !0m_;eY g>n&(LPzn9/gp6g8'qaܛ].t#+NJHwqDdte;g\AJ4-{ 5jE@S7Y?o= E]_ffdv>fo=/,D +8:-֠RglBxYU]]u8)#\DY{iXy,wUٳA|'&\\/n8 k3*%71UDdbbۋ$:LA03BphiqZbt򮂩h{i7 f?Qo,MAaTᄌEģ| Ľ IaR(voH!N#j8g6jT ٖVÖs= c?Je+TEUpo6aW\GK3` >"yL`'`3| ĺ/UfnJ<`Jˣ%7NQH:3\xYԺ#q&hKݑvY $pÕ,ι6OQn|d*r :Fi^UboQE7/ؕ-Ap6"U9R>@^;56 ʹAlJhQJ.I)hn5iF%0yYՙoC)f.thnBEM\cB \ g8\|&fg)ʹԉ ؠAČyX_2/Dgvjqid! !l!y9nKV*n)YTUr{&uQ տk-yMc1 ǜ ߛopU &6ef:h|FJF7+%!ISp8Sua?6.6NW nH<`"JR#UMS&&`S9KfA3J?'4RO9{ &ẈՊC>ˬ>XI0ЮN]g5yZ>bh&'Q}\:4 H9i,:ҁ2H\vEcnzLyL A!piaM4F ^!^T=jtvlqZchIbEij&:-밚)pJ}WX?d D@C\G2Q({cz7j!"EGNpu밚ѩb"|.T.I =ƥw D9("/ ٖ 9An\5:Gq)Ґ@}80 Nl P6YHXØ_QK|&([n[W's AȻ3Zʞ E$7,Rs&vynH-&_kN|41q֧'4pK+Q*>qf˒;$iRah| R\w`E? (9#_#6tLn?Q&.ZH3@dXT645,t Gib\>.uxN8xM$mw6{g&)+ (RナOenI89ɲUv'ng+N8%Egy9$w4_'qx 6ϰ1+_Jڒ*:\Wq>ڥ&$ž+t8A} մ#Hqք#I~fQ~Q.NEzs­RwFv"\1(f\ԥbZ_V~Q.CRm"WZJ\OЗj%WANxE{8*ߎo 2@id-3 CA8m8E/Bs+ zl6#j{Jp/> WGw*3{h YOI'.M63+ûI\^ހӛ{""kG81^%83^H$5(ؒ4QE:jj~|Z|bYY?mE10!ة/h"pl"\|7>+mQ#\ ùߥ8/NcT0Z5%cM7b2yH]\0c ҝBr(d2pK;I wCFw/VhfʦIw-#ӷoNe;d0mƥ˔k@5t8awQR?R :XŧU X}Us_d[>'d龸Rhe+#qD$ 7N)F EfS%jtD&tt]1EuRƏCXb-䒤Ai,1q+6-I= xWIsFBu X鮏*,|8(ɜ%4<>&K|V'%UO^e2ЪF[8} TB0DuWn Uxc860-IE+sQܧ+U,~Wsp?A.%:󼩞!K<*[&^@CdưOv[b#ҟ#@~ĬnfƍqES=^k2Cjh-j]vuOp_r lP~ۭuLm:?̣q‡=V O0eƋQʕܻ7]]3=&8?| ]*KBHʞYVړ>3TT92F"_fFQ>b0,ičCq bHI dt'}f)8G/tsvyq4 f"GkȾwRb(vU7J ] '4 O6%fqjK<^uI{Ĥ:Q;yn%R>jVKkB9Cn~̕ZMVeM7޾#a/ͩ#8#ۤ" AK?%OHZxYhK bbݪWh.6ݫUs %f,})kܔGI܄`CT6'~XQc2;|ɮ?O`%pzm?N6iTB6BʑRyA8-QmD=@1 \\cr]LVS~#Ć!uq3Sg,9LJ,4wix%&ɀPJ+ HBTSjӄO8jv8枬b0DI ZJW9 k*(ŁD6MVeZ$2HSʗƍx\`<1)mY˰I"agMo˟7pc4,] )G`Zn4ʼn W#փB3 镟ٖe ۵UK` .O54f%pdLp{z|NJH,Qn+>4|9S>4 ƄPON(|0j#J\SP *ZᰭvCmq$+$Z-shǓhT[aV;2q"n&,#8^߂`N~Zwz ݕ H6Gi@jĭZZ R4pӔLiJ&E>g/-#hSvm,S0cam).*%(&t*"NeNٽpw#`}'3-|%H!3`.QVi E`1ޖP<` q^[(Bi"B7L{w [QF8E\< _L OC)j]dKs3( 0b72D.GQHp>pF;פ q7bZ&YJ1ݐ:49\jС}'Rp] :X&gv@k غV8N JN$^d=4>&6%)O1 wUCc1ʎ#&{`]DJaÚ!a5; _|Lepj8q{24|e0.!/{;4N~=&x(rt6v<ۇ+y8];QLIv٫ q"Y J_>raݠH9{4DYf\H&mҬTn8e$Kk 3 VLAHτ'0||[)S+1 uNL l,xGoKp8pëhXm9bǝg8vˈ}1~&D8T;7ș \iV XipS0y!e!k^?M&~JP/ iqI%i??"у\D]P)̠kشO.@tzrcr;HGggP̒#/ژJ<)&&u C|,mwD'(ݻhԜ_V 6-L|sWie:幼16xfqɵQ;EIUy6E5= !#B$\O,HQfM!( ޖkI'0ta,ɉ<+Ti4RK8AP0 ZO,Qs՛b4tܜXfR3pSLX_ v[Nt:Xv9†ٓP[u̒?[K;f8.QH#e䞺:L|6: h -%{l{PGҹ-Nkp) )IO09A8xFҼ:~H~hcEP@e0IHuLR+/36 Cv́P`A#*;? 綪$v0(W=Hk0Gd>)>~Ak;)12jZZ!'~:&ahu$6.#b8XJ->d5.{͵h}S6 EzV|x`:NYx1Ahz[J,*-Kheu4Q-oB1Z <$6v׳5Qi25})C;m^J8 V>һ+"}e`,8٬Zo(a*+Ά`ǨzѲ'YŶ-C?pAZ|錠9e+rQa4R?n@(glP%Γbpo[>9bI9ߦ^1ݍ\Gd+Ljx8[4Mw{OS#I\sl^}nhegDghQ 6Ql ŸA,/#,Uı~ ս[f5b\'uN| =ִ="l݅}?E:6#mS[~w3ǟ:Uc0/vDv2'րt ons9}p{1m1y vvL+ojki٬rh ۭ =aK7 >"C4ec\ _Z; GS|pm\2\}eiӕfG3Jn%vanc+DFvSsVhT-^: |4S场zVtF5jg«*+gmT`טEi籚š Ι~G~;*3Z`c8 挖`)GD|b͔Ģ C!cD4L[-,(5A\!ݚ?ذw/P3}*k~*8wX7sbME>lT/ oh!TZ  Pnl.g[bϱ>&69R>=9 6IfS/c荡f u8Ln5{_cNF1 {D3ԙBV)tz1'%igm| O>=8~is~\'w,e7?uA2&bEq=P)͕ȡ68+_[+fi[b[*[w 5 OA-=Mz>SJ(Zi]q/SLuE2䏧 _abR~ip wb<ۛLFLb2]Ђ'xs|lgF7VyN5G.pBٜס4hsØjؿmoEUcX17Y;[""X,~+<`UQ'?q3".E℔?vncp0=A:/Pp3qWKZo%VNs>:b￘1J>3l:PШ>0H\KuY :9_G3İ+Zf6k6 /ooÑd&]>|2<Ҝh|p|s/+oC$¥w'JZiH10Tjo%28΃?&9X@D <?S@,\ c6i%Y&vf2Ͼ}|}A<jnI ̜ סXᲟbќ@?~/̀TaM*%`Mùn%eʵXfOyBk )l'Gs72E eg=csOSűf@25S\k,bpـ"x[ǀrTqO¿ؙqd{|hޞ|y>#L;?"BZl>o"1Ok?'b݆jy١~1m̠[=m1BaPǹDZ}4p1 p?&Sifbu ( E3ŧ E_TΈxf#SG_L/%/a!/K>A'`)'7D1Ơ%nK|_LZH,,` q34x~e0vR"I,z'ɜx2I9hk3WL<?@`ofs\"H!cM3PS?{#ו  ֹ yҝBEЛ&0h.*8ih;6]4PR^B ٙR55自2!SksJ${1tܚi0ѻy*{˓zM|LX~~KS=$vrߐba]be%b厲 DO8sxJICa;-~-Yc(;43a 4b-}m{XV4<6&ƃ 0?[߳hӟnr&P&dЉ޴㼷;Mm8$>uIrdRs4ո:8mtGW,>I'X2aCX <2]"pOι&w3e %AE8 ^)ÚL8 TNf3Ungtc͈-7^sz^C>&5ypst8#6 @\# 3:^bfЦmSgltƝԓ5,OL +O5^ys74nx:MywĊ[#)=bt찵޲;;,u$sP&{ۉxҞ%lFc9앒Myv Tkϻmqg-78L ν  YEBl06Da#:\ՔODG.M1+~fm'{H\{j'fqh6 :#CC C>;b5ƌ,´jB)Aɥ["ꖅbQk,= &W j!l#$w 3g}nNe~122,[{Jw]!3oa+x6#+ Ʒ[}n~OMȮ7,z'YȖ]3tZ|,|2_ \iFZ w(2#]Wv말Wy5o[𓳆097XOu)!A 1,n0&7Hz9n"nrC'c̆\2[{x$>MV%62a]>28+TzLs ˾(` w"}&\is1"b C_[P[Xsצۘ𚰘rսe8ҋ0p 8UҧQocQ8`6xaCp8$d D'XW (i |vY2e8CND5 R<Bt17YvjN b[.L>yDsאa3 ͙Z* ;-?dž>D.B3bGEҼ$ fIѾ{3AqQ c' bWI,Md DKӑ9%,Ktطny!1mґA699BF20 JnVo-RxݸEoHC?z]o-P쒮_쩌gPxWg~1/*>'0[*S2r./kHVoЎj9Y687;ҋh qrI}I st̙| #|C rC q&oȒ򸶏2IΌ01XI"BUIh4]vdot'Ҩ >hkfFKEwↈ.! r%Ee~ib;8u,c,1JI CMz7 XF_^ģhT s,im޸/NHvPٴ`ꘐМ sga|$o6X]<&tl!l yJp//\A_=)W 6:geLÂv0&+d8AUoҦq롧!gu gd.wpr b"!B>DڱRq-l102z1-/ѕ Q5n<( r}4q1l2+Y7[FuI >emzZŎ$5*,RrW\&`;qT/p,IQVX{CM#2|ga!x2γcr" 2ã3S,{ q' ] m/  ˌ[fj 6E0۫l"ѽ̺=,&T6Nv#߆qCv^C /:Y*tOr%< zBZpIVHu!C1* ڝ[E+C2o5>Bq6ZXzT__e,;(] ,:0zx`Z[.r`-\i8A֛B* K)4R8''^F}x?A(oggv rxn ^+DtrZI*e$^MId[p:,NX&c8 k"y;aGrٻȬsKwkX;'+G2_ m3+(t53v.D8`)[#@ LΨڹkZ/"8>Q|ےpltW&F,g=ykݜr~!MES/i'{9_1yDZ;7: O.`2[žoHxѤ|rBcC)cb}Hm䱫4S)۩=pSYoMC9.#PF4x}$`dF"vm@ 39Kzw7FٓRvCFl "@Ӊ<έ$uWK{0Q)v):B}J}0F_Y!坩ܱZޛg9ԭNE<<JIљ;Iz(,#sڜv&nԅV)c۸Rk[%WM݁A;zTX&u︖.NEX\~Ȥή4Ctbf%77b k:=Yئ FJaz1$Z҃ĉ5 uep8gXA a4hŤH2]'\Y} X߳{7fΈEt.iőS`ap0 #V6?\'UhH$^yR:nӶ!;vQBh j&K\z_+ƥ k\&gĬ&LgY&K]lT'ftܠȊi rn HH+rdrm IϺcOmS]d\"uZNӫq~-&x*u./n5z|bܭ A`fw=;k)ٞX&hbkp3aF|ڢ[Ϛ=+V!iؗh4 bnjB í zeɛN|;ZWvȉՔn+ \P\W;1$w#%a{> q~R̍yy7aha^C0'Rux@tC4eF(TD!gy<: V+'L:^oǹ$d-;Imp5&Hs9xDi{SE.?ɦ_A Q3\8st ?nZ3"_@ /OY7MF,U:ϧ %bA$c&O4 /C9gV$lbd9:Lp=ki;Iz!1HZ.mxS$OPʩhO @oW?a-?EL-ZRSq[Aiz&5l'*Z+;+tMq"+{^f2@olYtmH a8Wt!ژ"sFP8H0~ }ɻ+h~g0EݩI]rcaVţp[,H"//3EnȃK:Qk@8hB # PRbyv/o"wKvna d空CQU໲6cIƘubڠZb}"UdeBW!O.BZ?$A dpi{j G!~wqJWZMg]^y>ua_mkhq|/U1lծZ-dt9ޣtgtRP|}_u=]H0#m ┫koY0uR[xMb&s531Ԗ$ -a%ALޖCrm:PRw[0/T+t߈RG.sF @jXr5!DT Zt!Y@s # Ϊ#Oa&lUJta9Wm̻ۖ='b@Ф f3V7u39MÃO]`.V7#/^XI>RgfI\.(3ȥh5uF93fd(o=r r5 9#-3|dG zOͫ-g pS` XYZQn%,؞TjZ#  a AK9Gl92%ԮI m+68BR.M"ZT5ztq1lo'&V<Z画BO[ꯥڵ$Ũ ;WdNvB}t=g=1 ('UKh9[P^1s"="ZGL[ppXJzXHb\5%~c҈v<'ѦŌT|X떠Qt\66}q% 9΋Z{[ghDd2uyb6G]&ri;r9[%̱KÅsO@/TG;K"v5y"._5byCzǦo:RxLR^pwsوE(.vEpՃd? 8ʋsA*;U^K;t\͖W-ܾ }͋%l!х50?bϪV\amX_:nir1V 9,%KI\{:9damTQj Pbrv+S?G4vKR'I J4!3HB_ pPex+|!!NA'Hl|6*j4ެ)-&@V ך^ aP OL&>'ġm˄K^F[j NQ\a?1'YDܒF4;׷r2HVIi}e(^dA4 Eͫ6r*˪I쮑 #Ay e8+)i^=K S`1sSs_T*;b6aMi_NcӰ2Sb1JaLvUۛSGt,xq85gx f mNIX'qפYFLZvoeṴ^" )pd.ޅ88o tp(̖5nB܈*eA.Q/G4)0I@/ת?R&4 7g5it~x> -{2Tq59ˋTjI8:{{ ָ4~ abM,x@+b֙kWf;ȅc7+" (J~oIkV /@CFeB;H;=fkXuUGSgM h3 [rQKsq1mQV mW]pٮbUQ9fFdO掺X*Yk@w8:BEFUKlM3%an[BA+rK'32np Y0WSwWVtq1вxa__F[U«gٍ):ްЅ1ն9,>7_ Y$/Ԗ =ݷvؚsC8`#igѕ?SR JG[uZ+>PԐy6#HoK9G$HecC7!-dy '5xdrmaLh) ~I=iʍj 2Td,jX,#1Ú|t g&'5su5g]2tlZ|,q9EÀɫL)^T#pf.];ʓOQ߫9O}&5@Ѯdu=M!Q'{rٺq1* "]"f^^,8!Ld)rm$du!CPP> ,Ilc f[]@+6}9<(_)P8+PrLL&{poC. cɸ>bphT*O+PtB'4(c:vipޖl2PQAل]$unQ؀bVNmAIU+Wb<$8zO!Dߓ.vs٩ӋN.sEmWqVdPǀ e#{Xd ͍r98_X4E+A]x`vZu*ؐ|!Nۥٴ< O гNX!>{ydȖM ϻ7_(O ~˧ =5S0VM"L(f71Ѥ vHY73 {=}fGX 8RI#B:ɠP#=RuQFH-]7NFp(~~T %>S%>5U%xC+-jE,)cH `CVOTWigG+^Jș⭎yZC."A|r. ~"̔k^/"b sBJ4z.B%/rLb-wKsd ˘iK-;)~JoMyy*泝Ja .NcMFÿyc+E|4y(iZf^ GBga,%S­ns;prTkY#T\Q&!ItNԩ GI5,Dz+ A/ŵb:P5!mm9+B=eG{9AVE(r@zaRFN:ޠԪ OwJ-.H]W5 ?ra;1WYE1(㵾ceAyvӤlHœ, Ltqޙms}c 8ÃXõ=hXT0io \\͋Y{f&(li2ƍ<( ~eָ3W5K-ÙW5l{]>4;Ď@VzL8]87@$V.-sq{T9s]Q% > ;8>DiY/0oLRsra]Ŋj E8LrS9uI:X یĜ,e;PVZMV2$̬WMYt"5ٸ2KdrKbEzWPUOG҆w9ʎOgb&M`z(LG̀ %3\l3tyq}T'Tj77Q֬ Dj ]g&?vBQHQnV޹ƗNQ.:y %a:Suڜi !Mzϛ+7[Soe σ=|_ &vR I7OE1sVEM @]+%4ŴP$im)X(m+Q(JjΡW“my(-x5?e! }$2Y1h<`GTԋcO'zG;5|"0RRyz{gNCoZCri/: 'r7 .9}E̡;ۓRg؇\#̞`Si2eXK3:;"U"uȜ3D*Şd#:iuG>͠QzEwd0F] t:a=`7K23>z#jћKsgB/gη삆ֳ6PWu1.P`=u6ta=DhM |mM.[?܆L~~ݎy֙;%چPYfN{ g!wSϯlc|;52S7llN)<8&R$i?Mzӥ.B p£wv4#h O6@B`3c=1A+ fӚL jFx[T|)Mk ^M'bqiGwMTXO/~{wZdi<(Gg_a]N? `aǑj[g<)/i득[0l+:3ɸYUT8jYCt v";oy6}g- ɽ!3(L,Ah0c([%ލz.,'DF:43fHQgf0 YRm.MHM;o&a og3#+zoDb:k;UN+<ٵxa@m\nO* ԎS PcK.ta2ˆ{fo&m,y&Oʟ';ސ@Fa xq &[.ו|Y ˨R\ឯ)nol*,_F8cb ^0h4^:!񜝓)p3aDV%$ws))a7i-Q4x Ɏ.FAo :^0B Hpbr pA.Y=.Ojk>`M'sub߈x3lӥ5:ymRBj9+ 2VN4g [(QQ IJh${ fPNvNOB6w ָ5m5l“'p2R&nOnrpZ)M:6H3ѢIDATx3H,W\ .s<w[&[gd3Rۘsu37M8˞~z]0xvȄm7 ̂a<tX#ӄܷo~H,%|{FI$i8ݻnl\*O glBp $G!NIn1s0UGmQqZR#UcBS:dmJ +c%CtldrNK${")ףZWY#um,sI!nPB}q/f Y<@ux>EnAe0`XnLxæQ- z;HPJ/L3"aq~s;[=qj8>"e.)>NAOf`/ .̥O:qᅶ}.s2$k5d ;H +,\H8r.iܯ#SNbNe2uyQMzߡ'VcEjJ,K%&J;*:Xb{ۙ V~ s!,#%hADFAy}wp%RW\wS[=z?Cq(qK i!wGC,<&-QQzJ:{cLTՠ4&B/uƫ/L z4dMCzteiMl+0Lrڐ݋1\V8ey"Ym7'Yls!m/RLqްYbН쐩w#Wgh<0WWlt~DMmsԪb03VGFvvMdLH{!›Խ zŰut1U|_hTOhbT8t2Ӫ Mƥ#E.wlsk ̄@LȺ .-a66,gtYZJ_*Uib{bpP=n+ՃpQ%_v/#(@V =R^vKrCbk# 0MxRԹն3;2c&C,,@EFZ2ڹ՗r Kuu2I&HGfy0/h3^`qՅ]@!90i4rp/yw%+LwC@mI. K5$ 'ZcXx|83'X\YtJfR)c&񣜴2<!^QW/b4Cfۙt$x°^#"&]aoAZA+xRd Atب{6ܘ>WoרS]#}-QwخN݋ق0lH6&xVd&jvb&Ux\#E :#ycilljE?J&q|a̓;*jy4Ʉ] Y:i4 !b$9v@i wct`U^9rWu"vu(:G0;VRiO4>=/T]L'Na<6VHu\3Fos拺Ha+>JCbN-4l's*0/JoI\[=\J";`axsȐ [j)PJxs}XdmٜڧaA%[tF%̡bp9'PS뿊'N(Yս3@NfilvxD ֬Q;LeEiҮs#s5MvIfqo2P'TEzb۫W,hk7c+s1+Z΄v<}y3m*i1\{-4FIc|h5q$\u_JųH(g/Ū^Lz~98a"NK$!&2\b5ڤ=Nu!p%gc9pIp/x5Y: <'8 WR!ä.y j_KiQΘ'Gj'gp"2 H9/ #|L袤rNH}0Ԓ_ݳS<5dz7dGUrq8eְ2y/ 6 '&X+h|Ԅa!Hdw}McOjvK`9r#b;{َd8Lhȳ/Df{uà. -VIR4^5\ZKZW488,)2NpJ ;CMOw(ZoމhŬ3S$WXxI& YI!aGe1v|Vb;GFs.Eip|o"eo'ɒNq>R^+1W"r!MoXi5H3du`x"-%h @?"kHY9uzŨ#mXiؚS9) LZ͙%^ORu N<kg! ^9>njFOWy =9kD;I0=In^u"@{%whfu<y7[͹ wLrG,Շcc,<Xӈ=fw[aiзJd4dZ#K.R]R)LRoN{_t+6<>0ȼT݆nBr(gm${$;g]:FK4xWz7bWbb8!l'g%·[5Ԃ,BAu1RkHsQޔuWw^mμ T.6gBQOP^p!8shNoL @bdKGzdy /u!2B~95v[`,54ᙅ#W?"Ʃs_kL Vm!wzSݝqS<$-DsqWgiat5 uq]K>*p<NIAy6BD=Bo U5s[=Z{=5f2WFd@l/~a`̳֮?s}Oݳo޲ZA=tgŗVQ<ǹ4q^0ǺSH!]2Ag09Όn B Z5Lܐ4vEe ^ KKQ0r(C^<5>g[#,8> Vt.άbcVXB-e#햠Pڧkw6mNn:Bzuc\Z \*S9vTZG7R ɀ>LGEĘ(5B4G{!`4얯Eoؼ7-WiW,zk˄X=\?펩@BrH Kj1u::1G<Ċ}l3.ohQc܉$dl}mRn4k<{< )ɻ[8۸a"nZ)L;F v.O%_0b=8HR0 `=dAXq#e[-7 [aqD01Ĵai?7 IpAʿ<74aE Wcrh]nγ`YἉ|X!a!G/0Gj%a8[ڠ\.)#]Ù4*SшOޘ]ݗlӣ#1?L5*9YM$ZNyӡm#J==IMPǔE\:/Ȼ %EE!qʽzM_a{}-%m|cN)yJǏ}FKoQVKǙ MjkۜyQ'q~Ld.JZMHoyEi{Ή 4Qr0`L tY67D/i0{:/%$dV.t,A$f{W\a"e;@5>Edsqʩ(OXkbt|5qԱKBÃM#f^|FzM:'ȋ껙yv̥H@!Nd(xw(yOul*~qiEY Ub~AvxFH 8;kf3b[ +Y:1`E4>K@,f4jq?`.My:e(TU]I+DMZܦ;rkj{Ԧc tx8Qq&zƕϐ0!γZo#Oo^LPХcEm5ncJ05n#C"jԺl< }3KbaRI+ o.v-ByP} DMdLw O|nHw|x5_gwL>6! g? EMr ѵ&t_AԸ@Ra.*q ..3 -" iICfyV?ZAo:3h. G"Ura.Ic8NmHz|4Jݞv FaZwaAy@),DY %9Skk| ^83m2Ӷgr, Z}Q SU;B(K4MS,_i]}u6M8  %kF噐Mk&=J<.5B>5VGP|s1&oʴ7bjIKa%6˸#ܒIX2u{;%C˥S!>@E7/pJNTbz K`Xؔ Gr[^*(>N&9spd{N'h"CK$0:c#_璶41<=LMLͣJMiP;TKχA@LF"h<Z} +EhfKo秂e.V:u \Zƙ3a|Z[lrZrٌ ᖨfD0Z*_6Q fSt0m r ѽ0-t߅RYr2^.`6!RТ:Do0U!m-Pٙ2>cTje$pS\zs>mÃkgFVL=w i`=hi~7_|:!NzΊ>JU3{#{=zh&v^|3h]%z>oK;kɸG~of'7vqLcno)~zW .}HicB.6F28b W.MG긝H~|,éa'"D?{Ӌ7CmsU֩'Bʵ/g!8kzsT..C^4LHV.bCuL( +P7g[2җ?w0L\q a|ա`4u@nA=i+f`3&?m1E3Kq'fMmZ\9w: Τٺ˽TgVкs\HZT+k# WX`k`QX&X9 4P\Ş|v'i}v&pHNm,0G@1EB 3!ζ:Ng*1OPSy$X<6:΄Igu>ҟ5f-Dim:zEW K<)rD)-j7_o$ASKWw┏X\Z-(qT5Fذ@ikrYʹ 9t/dZFMf+YvZR&dґ*YDTmD6gO)`ZF#B*8 .7L $NH,ݫδrZ_ʆ-{5\%{ӴW`jl0w5_k<:JS>U-bX4SF`a.&²I+d/ݪMssV xފ?dZc pd$w .Yo^?g?g?vs;͡#}"9'O.WTH]4s4_:N4>\*>VPUc-dgB7ۛ v\$5˲/ll̨x>Xc&:b]yĪC>OƧ4L\ezeEK u)O% 􄍥SuMnFw*+២Ep3_eJIJqȃ芲sdz wI%C 3d e?us-d(d"E̝CI2"nLyQǾٚ8n 鷙# &u 砘!Og}bd|j²|hIjrB͍NWG@ИP?:&9'EW)W PGb~^"/HxVDS5x0sgskq3U6bisfK3SYE"H*6cSğ$_tj>?W}.03[y h?ET ['ҘqϦ]kOA9O|?of6: O@gBQ 8u>—=5["Gn9+._,s|c;|1ǎtE@T< 8$1Z8^K ɸ0kdי׃9Ddش:-yS/a(3|NSi% uG=^W+_64KvxH~t8l!kVؤ}%>vcB~cX{iڙ\) :'lj|)P{uoȮ}̬c7=h2 Z5׼@o4^wܫ̻C7k0i-xqvaȮ-B(_#Џ K+ܩ$b.>?:o9EߦgNJnwFpb|  VK 9竛9nuYi,pL*ƒWO1qfcr%;;{sF{Zgl?>}ZꋺtCpMgִ~zzrlR|Ґ4Ti^XoԑP)#[t!AZ<u'ytձN@59 Л0Quqz\"TѥeAתxd}\?~7_ןgUGᝀ圙f?cD.lb^vrH0r;nϳdoH~g<)lw-+24LtLGR:1r~4k_qc_= P)׫ x nKK4gIN%f'' uF$Wd").%r(Nck-N2 ߘovN9ʶ,NKoweOWͧdY  vWRmI|UpQ=s,>pag֧pd#u\Zser̯\d:fy}7@Y(:=P\'}?c}䁋o ™nZ%aG辞pF;}ݪOym\,jrGhTZqMRHZ7uuAro~嗤/>T Yͻ YǴE97_=?cCI3.Aة)e፵ɩwձڇQ+XǛ w+|xlz]h}EToj<~%%835;~ aѱǵNp͋N wLX8!lןw?̧;#W R>[q?^CN{v+(+'7?7Pv{񣛞q}cԁM|יRR x<{Dck5dl#Fmg95h*97ҒBl\y/k8pqN^s#TmdTx$pW/7jgR:CD4ac<6o{?GdٙLMt4Z='ıwf.I5lH8O{K8EbknKU߿K>&lpQ_~dxזd^(WGɔaB2߇۵xIiCRÛˠǼǙgвu1ks8֙t* g#Y+)ix4$o/Յfk=pGA|hm>v-9t7U6$(( N4_Su* 2ΆPF6vh jV.^~/khW/΅2"ڐ.,$$͈lL-R=MYݝGIwgg$0/cx l̑VMkyjQ^my~D>cYڴb.. ߈]9QTy<6c.Muyml5dZ J#RŶ66?%]MBcW̿DGwໟ;{#6L9fugt9p̳-8Րs$gmKG2X?~T3ׯ!gv$Y:G"QEbRE[묌si\UҼU\Q]m k ~_?eSw+e VIC@y¶XEx}ն8cİykۙ; .-SeM!Ŗ| s״D!8}Zgb̺ Ϛ8UjGX ?s\j-9Fq+6Z?wHOkԌd3Zoʧp_}ɮ#DŽ+9379MvSN#Lَvvܑ=76z{k_:,Ȇ5U0u|'ުAi?ĩbN]VNz lt"Il~'Y038h\+:ez:ÄgC#1-A|yhp[ CuE6Y/A{?&9M3$%T/%{(`ց2 ]|򀰍V?_7[h*wNh<#qb>vƅ}ꮾeX;6=vng:u^W~.g_??,k1SՕ%y៳EH ɘX{X~6jgݤv?h߸Nܭۜ%Gp̄ ''|_TѫLP!Te¯j47hڂ*=ƨ(*+BP`;P2/(LCo-!7§+9-vuc]8;/: 5a6aЯ-N!8M&G#&R"Y5`NG_?iژGm*g7}u߻g}actGbvC 3!g>z 燗@ ŝ Q?on;~}mEW^+64.pAsjw#igU|IYun>Z>~=-v~uB^:׶νk<Mݻy$848.T 5WoyUBd) Ƙ{dRP# ~ ps8|pT5OW&iؼMhFT>IY*ͩN?" ,ͯ9LO"W /ampӗUZPM^_;M&;y iQwdaW47ܡ3N(>x\26[_͗^s P ]mVpӔ#N_ Y k;+M^쐅PF\@&}ߏ=~Jxi#M]LӸW8iY=[jivF̀%ƒz?sS #x,uFs+9Ղk\Hegx: Vvج;k't3/$2QRdd?g-l(2_eUWθ P$nyzfWS;"Ϻ{LkeBqtSteH0G9&~~GghIe@3þ?܌^plыG"GW?`Eo΂ZW% ٰ\ں6{7V ,a|>W5BVIv 2lQ-Tc38_YR p^}ψ\Jrڥ ڠ2f=sFfY=Bo3P=3ѭyD˚3xP5y@~ZוǼjJiv\ofVBdIMϠ!EBQ؂~W_biQm~OfJ"hL. "5K琛eqS_[vAĬNp%rs^z(~y<Ԭ4^eAdevaz} X4mNo ~P~Nbc_j ױ.~6]iuVɲui6hgvDIZ_@?l6qC|Q9 Nˣ5DN1y>cVql&]?_FoNͣj Ww3#eQ/=;;#!\_ٻ*1J9Qvq/aex?)O>m9(7訃`L1Hڀ$~$]HYsdtOt.e3Ibgr.f_޶Y$NH\2(gL1imA2ͅԨ۞ ҩv3s?PHLllcKKAA6NxsћL\D/BaDV.HZbLUޮ@ pKG Mg5vП/xc/߸_~yp0(~FE >I$^e˲|㐶޸?H>uKcݾ خݙXA |L3S_; ,(EVwۅ?)gEͻ=>|w>j?zDฟ{٣w~/?zG>G٣kk]{kqo?=F;M"Nl(<Ϡ~Ӄ__aOL4\ݥ~.m'?NNT(w.N" %]MckGVӢIp&@XV[:е1:NVP~8WXdffdd)l~6eY;fY6g$l$pS.:U֣W]}^}꣏_Ѽ ¶WD,iQO7(i$_|yӧ_V~9%ŗ̖o|>mg Ay^/zP%HbHx@ߧL i} ?8uZw'K}(a\$~qۆz>U첟sT_)):<{~#{8D<==N_ޥXߦ4=Q>G胏>>>xOG׮=W׷T0!!}{>7x{7e#.<ŘHu%`Zz`/I4?=(oy _}% ?kZ_ΚONٜq{)FԆ2>fx*n#$m^i#"!hN4l“E_hS}iWftJ;ٻ٫i"AWgNfhӫ>Ys{᫯Jhvu柭h QĎk֯WDRH͏/=&<IYwߦY)x;*wJ喱?!~z] _;~Aڣ`ےD{S_-,Ic1:N$}C[m l~ߟÜa"៘K7gv@.!=}s?-!Ӵy0[?X?C珈hlb_[{e%9FxC)5@~JoeF7zڣ݇xkolgYI .1x{p ppm| sAHr#C{;B&9駅DK8_Ff6w߯\=OaΌ.^v8kAݛGo]dg[ڵ~?C|sYǘ krku62nڝCE %GaO܇ Mf_S9ZHYjr~q&w,ϣ?8IA:e Ab']g_;໴lkٟusftڵ&ER~GށKшo=ry/1YoB)-IN΋z}wsG89O[|dY68e[ߖY!i|:)4ǜmyF)^/d؏aΔ^u9t]"/%;`Вn˭=-;f˧ٷ&ӻBqAvڟ"BJ,k6|߳?gb%\|߿)Ejϱ3`oZ9IS`~Sa$'c^;W,p|h xGv1v*zmUe{0w^9vs=7۵)I߻drZukQG7Df$V_w_{ke[~@З+wo\Y?EPKdw}Pl,ڽPex>={|lL/KN>r[Gfu$l,{F13{z\&n'I Wyx%-{C~%-T =XҒN?%@^Zf%-iIKZҷ#{i%-iIKZҒ%-iIKZҒ%-iIsZ2?Gc7$ܒ#-H=Gmu|lry:MwK!\s靯=,Db9}YzV-@J_|.CK¢坵=(۾rHD<-sY:Kl*B 7lyK%칇[ffF)ͻ?)ݠÉάMMRQq6}0?f+@ŷ z{XD8^.=4x{Ydze% #bk,#R㯔9 UI *Wv#C3bڴgqqH֡Wʻ˼Z'b[ wd-ﯓplQv@RI:4Z<| EImm)u|1^SqkSKR0ˢgXvނ[.P9 ]1 -EP<:^RG+eW}z/sZ.wbP[]+﭅a O[4LG&@^`-U$Z Y2K:G$NBܣji[mޣ tjn Yԕ@! .+`-@𽃾Ҡ}֓VFSv,eG5N*T_wl r8\l}G ڼ%Qi>r[yq1kYߋVkM(INWNB 1 ²V&M!o;F7 .` * e!=O[rWAMmxSPC h0 +C _KSoC mH'E[_N''䌍S\se-MkoLj}Cz䋖|Ǭ&d քW7p:5(#o2^k{Y{7s@ XAoWa@gV W8#ZVٸ.۹$m@\F+AY4Q㜛bt|>ʼnʻco\z &aWDw V(*9 Y q _ZgCm\i̭eW|F3xl 4}bK:ڑq+^1O ؟}3jZ}gy+fjj >Vq/TQk eb$tdE- U~$2P 1<Ǡ;(5[xfv;r8npl_AE[ANßy+ey" G܄D]}ϿsCg)f3"(%836{!D0q phsDF߷9eL!qi ŷ|[_ tf.X' Uwp=Ou'JS6{82vzI/J!RDbf\,S1CQLf2gH+ڸ2 iZ?6ɖA^` @1z_cc`' ?斚k&.@ [VV/]uԌz8vQ ~-R][k^txi[]f?5N 21e2 JJʸvGchEʶh1 9,; Ddp@LRר05RT:ymm)hJ=*O9T&hj%-{J5*䬟gIKZҒG~%-iIKZi2bI?DrgKZҒӠ%Y|"-~IKZҒ%}oɝ,iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒCd4t ", V\7 L0y8Mqﱤ%G14q(G\mTCWIJClr,AQn.|^=Β1ˎnGƎvH~UB\>^7zlAq榾S*.f\0y*L,֍4`/xa"^6/4K }|(~Gtp7~Po{;r9*3I{Y7RVeWCVCsv?OMOwn<突0GvP) zz= R;X½IOO. 27~ Hi$ʪJYRߏ7puU}{꧝5\ts@ uύ24V~}])g;m\U6l" |_$9`h87Vgn(ӂ[lFym*kO`mdTa%5)蔮hQWErİWEo ݀i#_}>R.5sVv@˟]Nn.ђ^V+7V=>7 ۟q+AG @r4 i w9TVC^QHx\$㈼舢=ujHXt+\\!?y{\Ays,$()c?^⡺U㦾H(I'fp# 7^L<:w=uPBƪ6uT]L7ȏL;TĂVt .~֍Zԫ;n?Ean,|Y8oImI"npP-n.dӧ\Lhu5(nt{&5|ϯHy+=U4Y7ʒ^B-CgęC[B>:-P?G}_dTp?gZ ho,O<bGWBeȍni0h81Oba'ckqDsVG:%2ũ>nP- 6/(cݜ"@c.iM?_x|ϳ%KM6=5`K b?eϺQZ&dxv)'ɒ]u'8KZҒ%-iIKZҒ%-Y?ʒ9~oN+ymaSn> _qtk4fnwԚ2k\[ay?|:kdL_Ӡ$W۰y ^1Wo@ڬ:,ləvee,i\'ˌ$l8]f3^~4Љ$m>yП|CL&چML&r+~/̩we/,SxOO/?yRZo|{~<4%ζۤ-3ʉN ;uԑl`/ /ғ'O 8 Y#6 1seo 0K q {O X$ Oّ绞^#~Kf!lw<κn3zYϬ_9Cg˭ >l21{.XqQPxc/?q'?c<{ vN=&ܵS[3UC?,ti Ưw㓂/6-5Qm| ZBzyx!IY;'d_p܄(ݫnXV)yĕ|r׼ǀ\:Y_9ԋ?tx6%_H+ڧ ox'[@t<rZIXue&hm]38D:5F,{IN/o +H=¸C"Rh-u1i_~c}rr;}+\];BKbb?X?e1&KUojWfK-ɃD$8(ugF/Ll=0q34q@߯A"r`z%izn F699wȹyp*!RHPp5r+oL/'1X1إE=_Տ9Xǜ|BԸ32(#Xy>' mb50# hrߧ_[gcw-p9<>)XVByCX{_|2!~9tc1O=8r"Y=}W9P<%.bl83e??1 :jc֯T LQ?歈7 $ d7d%_2ِ@@Filpi&&0|{/"2~Ϲ کL,eD̓`6sĖݼ'rEaszIp,\ 0r!^O;ė>|Id BE4}VqY#myΓc/9YKbcf7-qd=^5r84_8tkfd/sd,D?f'&| .k/=N>QA9Ov-8@VX꧔꟧Lkf:?>PM0u̇og`NJv=oYrn@+_#Fx EϿ|r]صO{a[{7Y MT6Skşf-1@D߽9d6;Iy[_4cA5|F[Q<ӛ|Lޡ#߯hq'ό`;)b>ǟ|.-8K1^_4P:SO?ԶS?SN3; i;$LԞxMMlu *ܲ宁ܒh}'w s6D`6c7ʫ'8M[ɐeT ౙ2!S OHŻͦm,lӣd!9twPׄhdj=zx=Ihp_׳:}dkoul})֯dzy-!Y]ZgjS >?{H6>;'|4#{On6%c8 YFd}iFFIm)GYnLc8t+m/ȋqo\t'v:djoם{{;+O'Ý|ůWf[wk4woLnH;E$? :tݠ!1oTyX][%bݬ{v&4v.|e+ D4Y g=dXdn2{[uSI#%c΍ymks7KWc\J2WN+5`R}{/ iYѐ-_gm˱e>5@)ӼEQ6_[RR޻eܘؗ綜K|͓=3yj^2% %p'Kt;fS2=mpM_ q݆)2Ot3 vNckY%?&_qF:f&}NN9kjeu55̀IkiRItI 0֖еz&}9XR*YR9wNe99 nr{vv»ö  ]sߖߢN>nKV2𐇈{v 5EgE> )ęªj6<✿OvLFCg~jTP8ǔ% ;oH06PpΘ0i(\,4Ѕ}͉|{VX˝ř-n~4m98oqgOYr.ސrֻZ'\+D4(gpY\+r]ovWʻfvo 8'I[{vNߔ<4X,)$AZ,ݼVZnͻn%{qoҦoq'c\`p՘K>tjkEM T~;G][Jl 2e6ٌeloNg5i,t3Z)Ȉ>s{& elq7J zOq>Lm筐'pe~ʶa&9@'̢3=VˡإDa+GCGޖcA:{XD2[Q3l 8k|-ˣE{.kkM?1]>T®,hO~\ Ճ3E SO+g ;v'jQP@s&spM䎖qqj>\\K7\t-!dԒcr yEKSAP\ujq A{HM:kn9Y?<4FyO;gY੸ m%&eQe9% ڕQŸE2hCJA_bOdW[$h='*_gw?Ϫ=N:QFaם~SZ{Ʒga}_C" }^y7%lܘKZBc,iI֖0gI?@:KZҹ$[Ғ7-~TK!R/H PjjϹ:|F.Y䍮"rS"Xwy9{&:Cɉ$ְl0tbK̩ sӤRg_"GޗLtń̷7"[DfLV&e\)˱'ҁ-\'m)1ygdYdC334'm~?ZE|Ug䠸ً`ղ]8W@iY~ʧ&'Θ7cϬ*(UkH\b|&>g%F|=g1asĺ+3=ͺ qH[1|/_c~]g!# LHru{+ON>݌ËxR6$bpsIr4;ܙtFOa0unBs)Nd]ƩVHO!t;(qN.`Ō'HYG&ma8bmb+!{[,iQ LG4KRpjsSOBm/|?]ͦB|[[=F/z=D&CX\ Bbl,2? Os~'G!o%9PAץlʮJeκUPX2˫'Oʖ tzy:.&"W-?43p5Gnp7ë>W#'9S5#ߚWκU8ABd ǯ,g{%g䝤<ZTݫe.dlzMZ3~0hs‡ê_.aœ/P[@#YRⷚ&S/}oLj9@N'T4"Fv|46/(V&2\g9ݦԲw݅* "C>6+{N(u\-]Oe&A4<A44 a-<%>d]K̇|rzp34G\fPK}~o0&ʹ_Y_^9t_RԋV*QGT|]r>%vc, 6gPK%%ZLεzN}=rޱ ]xb?of|Dp[ܫ<'}@m#߻X48|D?ɷ )kI(P阶r.쬲HOqFi^E]S.b2('\0/s ?Hb HHL;8g[Q0xjߜ7:UV i"v c)*WdmQ|I}?6vE(!y{>DaAYh=o@CBM%%z^$=9v:N~I/Ixlm~2_w3 {üuQ9<tl ?iC~qϟ7hصZQ?Ε۵g B;q ]bxQv-۵8mOQ썱7PT )ݪُy$$7upRYΑu1]|c)'9vӐ{:Zr_|->S ZrA|/lSw񕋌c/'d )o][G= _9Kes(PHNJ pNj]"qٵ4PQE} #?3TXGOk`?Wvd ߇ G,:v1W'NFտ/wo~So|{dR]Sp|>_83|- f$yaZfe<705-2q5/ -89tHno\L&broq:B_܈5t gx_'!g炒<|# ԹOQtM\/~Ғ%-iIKZҒ%-iIKZҒ%-iIKZҒ UyzE$ja&/>tG {gu :q ghD,rKUfGɓ?'OO)1{f=#|r֍qbߞHD޷ʒmgXg#wY#~§dia!ƫ,QHy˾2k>??k%%hnJ2ůnTLcKxL $cBf(9'VC3?NrVHɥY3~,wwUuHBм/ནcH֓'?y<_cE,s ]</d5ecz^|,+$"3YW_K ;`QpUNPL μ+ PahJsG?D?Wߣ6 uHI-)/AoON\#5i6ʙA/Kz_ 樂^7E>Ό}U*%,qǿ3?Eo) ith{v9m6+?WRYNP]iI'~-I 6'q|e4#v`{rS8gAߧ^V6kY6wYM,4)y{z-6muP REӬY(^~U=, Rz+2Kj5 CYĀ) "{ 2δsJމ'(^މo&f?#J>s'پy֏ JD9~Lo󲆅 l]NzT#Tjj1`@IXB\Պ*lD3ly$?FCNSxhԁeK^XcIb-ӓ;u8;tsEM&\8uuc'Mu["d|>`dmB$>X^|'ƁykSDWNӶ.!&&f&ܣq :;i\vRڵ'>7x6\N^;񘤆o^z i3$폡sنJW$~r=Y8=kK{J3)Y[v&!=fqhk3of~i&!/?Z&b=1O9O!% <|$* z罷F"> P8 5x0ߝ\ݝw~ ݫw/{;ihGҕ߷ :孖;8mR֝]^%gXNUUI;mzZnCJI1zW'ބho2Y';E?p2YDsM/A6_E/8.[FԒ)S$P9hk[ 13#[[ݥ̻}H1zK:/^XN:%-E2$ӄ KZҒ%-iIKZҒ%-iIKZwVaIK:mF!}&$EQ sE$F~'x՜1ѭY䒖ԤdnEb0e=A߮a .ʗ}K!?a;:=6 ExtV]~.oT̒`JӨZ7 XVmB v ' N&kڛ/GVdrJF7qj!hIKZ4N[`CWt`b؆ㄉ hHIWUPֳ @0.NQ*@~?{׍v_(Gg;ip#?/(=}Qv߳f1 a§Jq\p`6h#nUYH/iI@u_%rj>UF) f8.W(KSjZWFɕ;UݎaΛ};(xnkҏS uډ5jߏFsDt WHTtr \h z%-i$p}jP]f^T#!\9?}BbdTs~J2xn*&$gXst^!R0ۊ B߂`\)|86׵קf/{JͅWY?Β%-iIKZҒ%-iIKZҒ%-iIKZҒ%-iIKZҒ%.YY̿$%Foxg{݀Ir,5S3 pIgӟoGZƥuwʛg.orp8(wik^?̶{-6W7diԺO̢خYl갓5>_[}w} ˱e_:[n5ܧ^,cI{dŽT;=}?dvvɧK!վ]60igq7t?'~.˦vҌ+PgiϬ?g>a*-vE8wܙ '+iM{Vm8X;m^ܖߓe]{NK|]w}`u 1Obi ݙF#'yB:{f.`8oXco?~Y:ҡWT]yŘwI%R>cݙ+YYn!oppWwC*6&o}qڿWeU65lgz[_|֚?l\ЖA`W+k*lk6pNGR|!&ܼp"-ct`Np_uq|a?Oɺ>NŤ=HWJb˵rX0 ~HZ&ZyۈȔЕ{3XS_\^_݁a^ F]ѷ_1"Y^e&v7'2VmkIgILCapq`HۻS~䓦s!q'I(o]y4\bM:<İP`:wT ap.YtUEi9\x3Kw~j.WawG_wO_!wV2W2zFc  o}^*s;a{u so&kwKb-F'zXmeA{8l!BžowdƝugCHJN,%EΑu:X[;i3k[vT‡ vg' sm'2 'v By5a-wǻHfCfC+efl{#AY);vCd8lMtmS:'ݷ8Rh _bSQQ3>D'`;taNyR^=zl·BB7dٙ(x{\$5z] N2Cs.rˠw IP7WzBg!^6 P)-60f3YHx B r99;"A:d2nnfs9sLEގs^MoV*c6m }>"ݬq`#ẩK 9Y 6=ȃlwEM|͸-|2>l)US ï =jIc`:dَ֓_~mP#-gFl$ɼeYkNx~ڇ3p'mD;򼐀 3 ~ F_ E%<")e1R"=% J}tnf{({%ɪ~-֎5~7P[Ǣ@,v J2Y k~Zǁ̛ 7`d6]!]{ ⥧Ra*nnq>{W{O3|qi4Ho[}no7V[JF{% #=~q0}eqva~?l܂"o8+ x ֒CLsd-x2V;9zQ\;j{o᫳nIn1RK׍N9)jrHcp)`b;mhtv{Jڴu1/6mXZ*i[vk\/f T<ވ?ͧ_W}+7[*Xӟu[ίє)CPUS@C]7b r% qu>z%q7~n̈́.誟!2u<➳I2 mJd'"ǯj&6 usir*c϶C7 _!1&j7ZI'|̿@By8\!̽=r4˓&˝67(TG}çX ]Rۃ>ʝmGOA14K㌯f!'=2Dj2]n(]s;Dv%  ~] w?> }}c)sB?z<2A _f=g:|~08~o7~vܨEaJmİȜi~ mŴ8 c{W$>NU/.' C4妠t$n3|wc7 KjJޢW,3qmKb>y_|F*I=:|sO_b^ř> x|!/}=~WXL W~'ܫ2E EpG_.xf#_׍w%?d o i"Yk!B@{{4e7zCU]vSOpD.y?8iA].Ncaj N jy"BHκ8yUo7}zn䦤8JU#ҳPi"8^Z ؍] 5 >Y8/S[,M;3s'wsnAlw?a(' ;̢CZl(vyf[GűÏ"5h']%.Pxa>̡]91Qs֥s'?f!ﱸ597t} RFhNj*Ίϔzg„A%r>| V4v駞 džcKዧ/d_/_aoO7B'e;ؔi>KF>Vs%2p&_\3ެүUhmZ|DmJv_ac h(CINbWasn4"3RI|+0Kju<"WV<4>;Θn*d=G>ΤRsKprQ"TTF߾t6g ?4l]5v1Q7`mWgH_l6lbRoK/"cPv_;˫fIXd*H\@qm)+ٮ-:46y }%8Uխ< ;GW$xp.*|x?|kd+9_䨆BȲjZm |<^'6pglưK<?лCTwHYPlszKNFՔ,.AYZRg盞I2}DARi{{ZP:2|s`gG<بثFɚw UA&s&q C@$9lو0"</< ,T*+ѧE9 C%ЉAW,׺Sᣦ++8W W%ܔy1+;ld< C.i},;b[\ ;*VDY^{$~էq .Yn (K6J'60l~H s 1|&8鎽o7Pu[ 1X.:;lGS<|@"b朼ft@F ˝_|j#ZX!8Ti[,+6ÏPV[oHy@m6W$=%1[y?w_9ciӂHƂZaW{=#? 31r#vx'q g=ٍf'n⵵:V7;:P+7CKcpGï4CYg1YWV zFGČz/x\3DOÞ` Sf `\=ƛ5+c'\ɚ68g9NxeC=gdCqAAaeQFyJ=YwQ/FMI~7wGoBQ_v]))f-^LeTϸӱpv;i0^\5Y<^5.~ɌѭO֮fw- y#xnZ Gk7$>BR|FGUWvno]ӿsss{d%ӧuy#,)~L#W #S|Z?-kـcc7859(vF'd18;?96~l;~stLGtqiϥ}jm-*7އ%oC7P|o=*G*tsNr_Ʒʎ>=ܮC8ej\ٽG/O}@}Р:Ec 0/c6qTpol(W'%dMqvsNxKNJs>h"<*EY4ˤiN@3sJ7~t =@dsznޫvZǧPH ]0t^nīx U3&suf)\N {Buڗ{3ʧrʖ΅/-ƫ/җowOTǠm;'(rjv |`"W`o9h5OXHZ|9TL Yp}Af4UwL(~i@{,n`)~Ú7kHR_}y} $f&ݦxE&'#ˎON}N:ʘK CIUqS 6Pq?E(0a_9) Y!wW8-wasFj_CBxwq$5ԹKҟhZĈ5U-wܾg6hג5ĎmyQ{5q{i `+T=~ vNxNGTȊ{ދ}/mRv#t_u[n}"^P;2Ś#1v&Q;ye*93c^+~k}Ԙߺx~Nf⋇==D5=S_&q]*qVg%y3CQ! WEwySM͒2 ޳}%MBSX8+jO[CѼ7rHl`M iȽjl9֠s7AT~-T6avT}:CwUM* Ct&)IԶ$xG\#`ol{}f1#U,@kַ;#KRZxhbbYx`/:{˟NN\Jǥi9IA='^4|n'E\WǟN~k/9Ev}w<~{4 Q ӟb`r{5Y!s<,51ʨ3Ob`;v+ a x`m ~{,\1JalP.)sgt ).U`XiNL/)GlxNNӯ{vkL)U?%r$ (18˂neՌ i,/z!sɣ9>DVLjGx_/93W|)}eb\7nKg8ozxpk5TLedڡ1^x%Z`FzYڦZ|}wZLq |&<3XebcvE|Zzi jvR~ Sozy|A-x.;wE"cGfX#tɈFI)~jAdS. e +8BXd\-!~qT*I2x#c~$"ο"՞ldz9LrsiE ҉W]Ty@n= }\s"p?u=Ǵ1&S9e}݇)p28K;Waۦ"Jp)l' e>4n9ܒc E'e^ۉ2t>C}sړUMb?n d 2顖,^IʳŔձͼ0 fv"9+ljj;.I ;+B Scճ9K)>|)MbZ}ur~n VI.Y\ׁtnq+F 3g|S}YWeLTdueDBt eI,O.7,->HÏq)E l6&J+O˯]WCjE$;9j'$Z wК#YCv;:g[=ۣj-R}H xxzwvnjkiTa>MT&Up]y'b[:{.WyK%?BK0c&v`7\0V˰sI8~_lQ{R S.-{r;JN9Ą>qsKt1]ۣ)6}YU..%[ɹ;K25P &]7Cք~90\UF}$NlY'[L [axr(Js~}ONLܮye{tֺխ}M O*lE.̡]ȥ!7[vZs&nM+cz %o[HN_'j{, Hi+ڜ,s}"|%KX=2X {Ԧu.m`n_H j"901l$-We 0i;&DxT""@C}O@\8P'5 sywHaS9})@/)1/='k.+|sbdl COb&D:>ƌNcɱ9g\oZ+Iל?gw,b*WnGkwxth8&bf˦}{0F|%qJuB$9,M_9ڐ FT)hXpl}!-5fl\|>_q`7'l{XZ6q&]WaŲrQ7LmFι'Lrkd) RM#0={UeL^KZidC6C]8l㘗3dk5Q̨9xk.#ԨjQ5\_"sɅT9]kW8qIZL)#<=E'&7~HRkC-cpl $ lG|NǪT- f pRrxʅZR,<-~/;oWG\!n#|rx1J9:BqKL{񺂰q$.IMu3z޿:/^91=D3*G13*[^{hzq{w1[_~j:l1j7T[qF6VO#7ߟnMoo%EjGxx;vcָ65f> s_gY7~ڀ_<硔Ew:((b3HɊ E _8%1V*t}ѺE YZnY晄{s~x(8L^35Qɨr⸙}C?`t=+zO-Dy!]HߍX/Kb\ꮵI.>u2Z'ݜ RA߄yU<Χ Gq_GP>s7=C͵l}qwU}1ﯺ6 `vUN@Lp4_UN@L:Lm@5UL@x>{^y{kOU;M7G4H Pl4t+C䱆r+?Tq`Uƍ4.|ءF-EnȬ/DK$СQíF*`*]rDܗoT,c.-TO-^..LO+^;6ڽb]'ͧ96Hf$vD1;4P媟I,/DI&L[̓jsre(YlpFb njgq<]b!?6 ?>j#iLܴkkujEe xmr\f)?ޤr^mF&LLH/k5LMN501zS7+b C.u<3W> Or'RU|mQ,UNNXtf R*qځYqA%Iq>{m3Nޗ?dHpN.,@Y>c ;VI{ݗ͝Kq侰C'9&7SJtnfQo{),7*CAu{P$^sTuz$"',R8xٗso@ Rց+7<58g&ؔC"su)1g!#=w],#'N~6Yhm~G8ާ{l|W芽^'ꕋCD7l`Q1DL YB0d1 Lv(窕:0ml0sU.+Wܻ~)`K~vUw^|ι}beN!NAtx?sesqrN~?[.>?cՊ ׺ꇸԅj! |f*sR9sRfmR~` 18ep;#sH[VW%м\Z3k:BcC:{i\8fy')(tƑ \HJdW(Lݐyυ6ɻO{Z+ʡ sߘ"!=x_f{U/ƺXΰ4{{;pʫsu*/qYpx=z+#\6n?>VNrqA6#'In8N)6{sT#OV8&WcH[rP&΄;Gj'O^}nv6x{VnsM&4keTe r9Y#&Gc; *Ҷ'y6u몟XQ!IQA*6DOu_'n%bkiuX9^uސv/x9VcQWY`#NeעRت6=KZB8r42~s~(%W .yO`7=|r$~U\Rnnj%@#Aѣ M*Nmq!W[p',p)RA:}BҦxxtJGT_鉣58 KNvvw.õ ٲn8ibZUd{x>\uet֗.ɬ=JM^zoN,O_,Wa3g\b~;zw< )d3@];އs&{(y~&Ȋwh⬞!A־#3|u'n0w-m*N6ܚ>ޗi.)L92oz1\ cwUàL4!D;nky7Qfs3񘗆ڹn$S{8<mQ}vk#S>ZY?[J^^e}@<9- !rYJn=fkCz ue&$D.]ǫjf{@?^l}7Ps)RVnJջonu$W(w VeW 7m@U@ Adp }"\~~bTGisyW%WO?2Oog%L˔>x`- 8NG/tji_߇N66WʼnY@(ަeo)R͋Lђ86D.77Z;o'zoN%OOW.NWwF9\0EkV-?}rh(1Ϸ"ܨs@]o|qLnD)| \>[3y'ͼyJ*Eq>1b壯Sهya1'P ʲ?Xx(i9`#6q |c4c?tBqc9fƠ\up4+.T,I*\G^ӹ^DdO]Upt[UO?Uϐ猁Ȋv Lro:}<']n3rFQ.3 ; _%#eOUKt2+jnVuj33_[V). W:\-sк%^u5۲3ʯ'?`E|4A潬IEK#sbo}d!ӆl~od89'zǚ* HqZHv>m i^py"Q4aF99b6q,21k:nH)@Wy+Y7ݿmM[ v.2J#R(8&ȇ +nUVj;sii+!5_ϑ3pk5>p¾tqAD `έU9-iЍBU4W籮'絇>rw&G|.nhtmɞ,UV}fTqV=&t[I@w1u.[uk?:ʸIW^3 m\e@fN!{paTF#~!dC#8 `fk=N$JƚݍlR>ݍ'y YO{g77gP._|S.ňug?^ܣ35Vnv%!ЃUQ s%Du\6Q}^4Ap.~)K;L+KuϼR]/eg2sx"s~xn@!7L4h ȗjWQmCT*E/u;t;,YJIMso<=YR1bmsMNͬŬ:qǕh4S6pYܑrc(%]V So]ZhXmn"反IN!.=tf{fKEv,]tfom&vݑ(δb&ɮf$Ӯ>mR&nsؗN浇=%:k9N[7 4Tk{FAeEE#F5x'IGdTbW~ .j[I$+@=}RVҢ>]5I!`t=#l-$1Q64V[Z;vdIlDtNVͮw]i(r80ƨirʵFqchDWCƵ3yQ>>e~$ lw4{\W}ur+z,vvnrZ^w[RjjL=nۋwuk1-٭X٣y +#;FysAWt!WDǣn5zzwLnwÐo NCqf轏c  ~mߎVkﭶ7lҐl "{Yaqh hsO פe:uǦ>E7W<4s Isr7T<scuxKx3=sו߂ \Mq;7}HV] h}\ԹѨ~y77YSB7ͯ~?1W}+7n6wefpVSp5m'-w~R@@@@@@@@@@@@@@@@@@@@@@@@@@@lYCm$w7}r@-]9*~/O\x{I~}QH[NGp;5^\ηo+9}iN5{ߡY/\#T-Ad~*_oOL5;,4\鵄5k̉ޛ:}hwe4Ϧ'||7+󼓪}_w(0z#I2!؛;9;NȈ?pu@uaM'>/|+qvإ\3'_ͣ<3gO}a(FZPlIFej0N+tk5xxBk?7ipp0.speU?RJl>{0n⣙*W<* ތ?^Li:|5& J5NT }nG zcZyBPDx+r+xk.gKB2ԻiamD'n$9[sho}l\,9+׼*ܪħ?SO(]o%Ui|SsMuP'L9Vt۸0 o}.2uO|NE[3"뢣Ju[_Eh1c$KS)p{w&=,JqwO& "ݵ5䲝l8]׊aa;>F(k"cn>ϭ$zliSlU||ҾGKP+śp+9y"| PgsƺY)P˗h 3YϰmHؽ'3eє_xN4=Մ@XxȋDxCyyg/|P5$A|w'\uQ.;a$xYQ8{iWJ#^ﺳ/'nG6w(Z9Z`cݣv C5a}C{ 9WϐJM69D,E.#oFbDz"`ٝ;?'MWQ)ȰPiI ۍÄs{{}/O;$ӈluN-Z!Ž^T k[5ffx!gu5 [!b#S&oﹺU=-Ý=䅯,la57+q=W'WJ/Sߣ<'[Gcj`s-Mť d¹몟b߅J%}Mx8Wgz ˏɦ:ol cKzkP*1/Nl\pdZ#ڊ@uѯE+^K};GX?q6:@u<97&_n.u.Yelwu92,Z=ٮlaRx*lӑ. |_ ѡ9IWM7jtH_y/awofCIWz^akbK;,( Y8{sCg ˜EfJLN<;Qꞔg7E4ƑW+f`^U~B٦ʰx~WǪ=q%_9 8+]>&ɅlW-g!::wu)0St0讑'&z3NגDY0 bZ^'D7ܾcn J*L}[P.hyڄuv>8cewO{0$~r 2V w e gC\wC'<φ?q=vSmK$vNŹ=:B@wZ(~W?_UqVſ (E -m q#U{6vWE[ Ϻ{[?w%jJSTfR!dQ/>;շ Qni_UKo> `:HzjЎ7'!VݻV{ FW]Yi mjU1R.kN|3ŭ{@޽u"=A"U޽Xwϟ" "q'KnoLjŶJEWrC~{U׭97@yEnl Q"N>p[Lq-  }P^XZj9OC W핍6ueʀS@kAĝSyϔwvXw_M+d-f>)y2{g8ElҺorx)Ný{aB (Y܃BM&օI7Z0)+L06OEQ?݁|ߒzq?n?-/*~{@X- *G dC,f8 xّBq;2}2F}¼.~.gEdʼn-~ i+! 8gWJWĮ8+θ𗐃"B|-w @{{dE^SNpt'kAu]DV}kPZط&=DIs577t'+zOx_tnM/[^Tu-yǢ[` T8Ǖ鍉P CuIi$%*Z!j_筏u>4&܁$p*ѮXqnBr_QQ+}Ƽ7!m-X)c&~^ 6]ozosek#W} ܌%}INuNݕ4(x1ǗpQ?Xh9Q;Ǜc*ꄿxL=aa-I)1ދǼ&|#yҳ#dlmlONA6=Voc=g l.ߒMx#VJE8"owHH_䞋 S9RoVo}'$!W4wn0iW6>{]OiJ>a8،uJ* jKHoM*jX)D[ ՜T\{w YbR D'.A\_qj+,֯\W|P:&q3lOԤ2v^/oZ+ei}9?p,c:Vʑ"gzwsL& 8@ȁMuTĸI;fc谙ҏ WJ?~M FF:ڬ}9k7 gQ!}mE,ޚ佾7a{qmOAiy-9ɹ8qggy Dcw7(_UUz/7AC)vN*ʆ6ᕕ{r#>V-t.OHfvMJe@OD:Zu+u#Yb0RVYiW؞aol3[:U;D.o-H&7vy)Y.vB^z`f֎&- ٖמ۩o5/&o8g9 tLX155mbՠVQ8݊EaC`njueTmSjqdDds_>2~uvL gр=jǮ}Mћx=M+lxsLXю# QvK!3['V2ImzK围b7eڹqdxͣHjվx\ѮO3ʥCr*/ls>_0WжC5@}(7Kڐ{R oj~EØ0=8\v U3yYi[עUUW -R[aj|!NC>~ Srx|*/lS8pW`=?q_buC'02f8ei Xh;VQ4Tӷm^H?P6mweKeݣo%# wFz]k9\RLݤv_[\ֿ֫[t4}[}??Ln̜=,F?ssub*/l$?%x??8<~WODNۏ {jb&Rn:Ҭc|}yOF ?:hV} ks6iLJ݇UҴY>Btm:PM>.}mZ歵К!% sGyi/U2pb0ޓ_?$^?U?S] }0]T]x{HM}kL< /^0oN1s7=E-4imB*I8ۣm֚jQ*V,jxBr;rQ4M[de,RdjS%AQthiaïEwH.L _5.i,_kdG5L~fIֽ[1i둚kBY&#I@l%[G#&Mm&:@5Ѷ0^X`1: /5VQpm E'<#zԽvPe#& 1dS- 44mj b5${#3^-Ō/SեIf: eOT95LxY-ګn- SySr!R2l.)$LM~0jQT+I<JT^׎{om9{-Gm$yՈ.9D$CC<FQ\޿:QRօsJ5 /q^=x80]n-ޕWίŽ cPxad (g Dao ($V\de]7k7U.탬T,tY"5b\g;uޫJ/˘asKfbE;sX~ (Qӕm#tq/rJ~lb;S>0?z`JNs1M, e0q7}^|=؞2H:~+<S"72jYkqdGԛB?[W!"s[j/fbvZ;~T/e4Lxǰ{7tT.~ +sޯXxyrN5}2À5+v ]W׼ׅ[~ y^9fP%PбA"#̳AbHTKy_u wox cٳg(5gL}N.GEUDy$g$Wye+2ºl@>/ fuV>NtQLhv(,'pɦrR["[[;LELϷwG}3l;DDfλ _`5z̯FI+CJ/#҈L$)JX,pXv>C͑MUflαRg~MNeIS7ϝQ>[23O<,sG>վo̫px˞ V>I|N #wDY Åq=~(!DcM*?n'³|nŔy۵gaU|`I8vXB zחzˡ5L\gM*Hc>4+6-@nX>{ r<q}շ+G .4X[Z4Q+vl!HRpf+=0弰\:eFKWQ3rs[JνF}&aTy6kqb/Ԕx>%pz>_/p-3/ ^>.&$3g5ڥL`$FjC*C30'қbW'\AUZXꭣ=wj&6h2I37Si$ME99ajN┚nGxOG\8y?0j8Ԯ f@6=}QDsuk.7:RƟ6YIM{FJKc3ZMH^ cU0=Tts/r~L/\މnrɓϏhL-I=9ӟ 4tޒ@GtؾRYB?\'Ilp<|ȢCAu6g\3Rٵ''RXS[$|xev98\9;!a&4=7f@9'>5F:2JN.3#LT|ʼG$m˕ أdh^2"XLP8K;s_ LsnXZzZO|*5?1rBOK~Y'ŁNKr&&&*!es]Z9CN>pbiI:D0urF>ȥ 6QLbB9.( UP:btEk*~jԓ1AHIҽ8! &5EmdZW|6_iF)h4/w#W *sv:6BR 8px6KxY>zqCNIDAT麄n.9,PR/l Vas%XI[V;BH!uGx4`.Ύ9aދzr9?//\7U97eѪG#hC\PťGd(phzSI0T vyTY 5j%؞CDVw/ٜuw㚆>L\ܭf[sER/]^r319qAJs8"Ď/xZŹlO%dW w|b/L[ƃ/0V>vwZoCG]gM4!#Zr,KH2j07WQZr7zlOh49?wF^'lu99e)t5<],!g甗>?280k_yHZIH悅C.$^"|?7`mSE^VH J1;D&F_uŖbgGYj;S%w|WXTTwHfd*sλQDK\.VcOΤ}Ԓ#1QS%vѡ1lDᏃ[O {zUE9r;g;Djrʐ2cCg2Ґu=h۲m7iƠ76(pM*(%t?\, ٕR|"ID Ϧ09%'-풐 Lm! WI2Tw[ή9wwǔ(@ȟ+?BRsx2'<]nfWm((l(|Y B:?&0BS1ap&{زg;O%3eD(qd,[{pdk$aÖ$oŁ~ޜHq,wƪ`rHƴa~0'윳[=U D.ܿ~`yo[8U,!|W!vzG*iDÁfhz_3=jD1GYoqacC!/f2(m0~,)%H%~0seiDiV;J:gFU`(2Eנ^naU,娤"p۳bpq̷H#*Wd`STLna+F%<"'B79'ß !u3`W~9ը#KknߚcR ;Ϲ2Em__Nw~h6#.[;[+íխdv^l7InWWbI20~ &&'; kqj<6R;W>pZ\pKBۯ?g~gY߷P2 {6M xy~ b%~?yqv3Y=|Hy~~{Օle?jW+^idni1i$ o6{G\ pDH8|eZ/25Fu^Em^Q*~KSdiO{Jy$VEqƥ?*$U!_ 7w3LHrZsdQK p0JD *uup)hh*2_Ÿ}+%nNIpCqX'i.Uו-mZ]j#PN)G =|W6 }6l@m2ST ~ nd@`$_[r{Ɋ[w>ENU x kW+mL0p HV$xp{BM5/:Miw#BIޗߤ\ $' ܛw W6n kAg4:G> u|KVTs\qP?)8%u62yxGxAӢ7gy~$+%7:ˁnr;:+'+ wK?|>Nw~}zE.&-a71S ⥊=/ju$ R/e!J_B毞M>iW6n *@j2[c9*Pg8HU<$+NuH[Et};AF2|c[s蜇.T#M{Jޯwߚjؾ_زY_6 sIQKb 1kFÊ3VʰJ[~ui&78ޯxו{1fnӠΊԍ2%lrʽ}'OG9o^s7 e^'yVj} wfȄR!u>xpop;lS9~F~ +9 {Xۚl\&EZ42`JۛnLBR~3/~3|obtϺxs)|$~Odܸc|^} G$oyA<'Ljo+gq|N^;K2q ;oYu9g[M1oRci07|}1ƾfIѓg7++5/H{|wOޏΜ3D9~_fA$XqlA1*Vu#փx\h/uNWmF2ړ¨unvA/=Mrz71jkK- J/qgeJ _F >ϋ;_}~-*a:K 罬9 Qr- jXG6)Qv23^h>\U%q>d#%6+@CnX[C΋_P;l/~Ǜ&KWU"IP$Ý.PfyKPC׶[d'2FB9*n IsJcmH, [ i7mo}aNiY;g_}3h'qɩ #9 R#iaa4">sǵ{sGs~9 sp83\"c1^be%l˓;m)Z)`Kv_ucKwFڎ*-"gdgN9NS&!orE_bِ}*op}﬘y&_@"gPk8# _p∝CKX "9QCK# i b wl{iKȼKygn -s-:r_C>qGͥ`y˲Eрa?F D9"4wē_/{Ys>g%S_MM#J8~Ceu&y =~6FchqUZbMJ^OoUɋY !KVwP?!3_Wc&@xNc2blHQLxΉM 6:j> |Gځ)=+v);yWJZ_;vvolM9xC+QdK95 =bبA\[UNͧ^-|S:s1uRGcHD.:ص5v/byޣ #ךּ>1{vF}?wxb0p"a9]otbK_T?lHp^xvyVTK M|yG] RM:*;B(9xп}FgmPx~5?WۏHoӮy'kc@3b1AchRr;N/I{ֹs[8Cܖ59&Ӄ5:JVh*f˹w!sGr`QLQP8ϑ_s> m n' v^ȀL,txՍSh)g:, IDcXGc&om2irM"1&`?ȶ?(b}OWP/""/N:;_=#0`x. 9qѶ<9dRоr>6_;d϶q耼tfjEJ傷YmβYujt;^n/zv{.~Nv&b VoCJϢ Gg~$/FO.6/NDϞ}M!+9V3cKc6kMXbG@`cN#ת/Z-ޢg^ WvO[r7v MGzOnHY0%l6Y99_键\*CbYo_񦏅ӞgH_fu*XV8z`sLvߋs7v~-^7Xڻ7=?.uAoiNn K "3ghvtup_)fKU?iXTc߄r"\nUkpqg1$ 8| v}U?U@@@@@@@@@@@`ؽ{ Gμl^ iYe~ ^ּECɨwձ3Y2 `gf*S֌z\yQ2ݻܔoL}[|Q^V~ZUs9iVwo8 A䯻qdf@״2o<1 xghǝ)y}%@X&n?yY~B&?>ݼe  WN'n53/{ ,Ϟfv]U8VBMœu~B++ \QI<4 8ɑcmXKO !#y{b/|9\ AX&jgLd}#wd&m$wsEOeިD2ܣäA#<2j#-;Lj)l"^$7|K3HNb =Rpz$|!5>RC&^:&x3Cׂ̔Po]16 F}w|+&{ ے1gŔx/saRcxcxQ8D/>V/&frlG|!ǒ9d f>GNH"'Sq2xۓMsg2;!cTZ,~!W-WjHm珌 YB}iuT\!]Ģ:eNr:;8 OS7XDgȦ^0?xG lQoq^X)\#צGY00J$z(w.fGdb>6#YqZ.G-v3Gȍ93υK#پmY .og Q2n5 -TNR+] }F =:|ux4R~3͘[B&LPj\J#Gf짼d4dh)93k2Gw|ͤkrFX 4]&Z. ]. '%ZsS5۳ݒ:pǒҎ ;9(os+ %"فoyx3M;g -vd`+"{sgqbX|3g"oՑ ?-c\kPȑtPq{m*G2h<L0l25\wc6L FǗ]挛Kt׺Zgsfq7'VEN?R1Ex_x=fn$pkE1^TۜlcuU/36Թ P5SvHR9HõvYѧL-&5 |_3q_ ϝ#oyV1eγg1R߳xZ/axCT]*n֒f.RC=F>k`cQC H*owuM},˒;JbdWeMz8w7˾n`n%O+Cw8ҜwycK8 hA8桏-f|(ռ`̗NJm$s%8CCN#"2 q;|iݵS&*iOlaXR(gW(y|MR܋or_~ԃd2Aj= 'z/ܑ ~9ٳ羀gq~fe~WZvvD;?"vo7\R6PMIamm7P5#\0m?D(^(֊裪Yn ſH_I+X%=4$~lsN,Eꤋg;gvy_|vp0E}õ,|1:bJ1}gU~焹2ttdQX=.]Uf'V5{]M\ yO.nQ`A` QGĦK#o;gY{ AGv &>X6TP04ДjϑZ_G~f)w `gxygM>2ɢoh=ZCZb hhRl qmi%(|dcm*2|:ϘPW*ݑb)uJQǮޡy9ٙNyk{Xh8Z6:"JxsGyDxj\)/gu"@  B3vX:jhiA!{}mFÇ*M4#]8 A%Z.MʔпelƪV*.0g{k$\³tE _Gb?{lwd(8~+%>_Ϗ:-pGh4ͅNn(XaG+sy\6ƀA40Cyfʡ̩n)Ɏ)]fcx'z˟;|p1vW;g}O& b>ݡ²_D >iTUc=Ɨʼn׵Ew ?c:(l֙q1P}]ʖ5OxPqL/L=>1< zbk>>' `({ikܽ  .q nufęjﹺ9;s{[ݫ<:Y|"`OOw{3ï ݤ`jm(z gGp1lš駟~)gy×g2'9A>ZNnZt rS{gzݻJ~} ^31~rSn[V.1RUvD:9)a/ԧŞ8[.T`ܯy4Dc0 WQ )?iGSto榚+u۲ϝzN Ǿ;Df:*PŦ~moѰH=x|9IQ3ddP)ud5J^+h=C_vΧ?a}Տp1"xM wPiNT7}eSB[_߯$'W˩._4p $\$Mgܹ.5>;1PA= D+vdAꇸ8O%g*~]-Oͦou/^wte _!չ3vȆe-TݏL(Zd]JR{*UZIf_`Kj k` O@WNy?O1or=LQwE8;$HԊ u&.YuvhDWQC^S.NZes ~&ǝ~ |}OBn3ƒB7ELb_AN!.|%r8yk?'? FA`.U5_ӸD\jI,$)HB %SFI,LҪ"(/>SP:FRuYހvM${zR2[QwOv{}mI{. /eKrpHK*@x}[ާ2g(=fQ=m.)aiWd?iӎB~i5TMJ@\/+"CE2\耫[w31s8alH"6o~(y1뫣tz8ž7n_VǼדCGDŻu,1فxbm: ^Kx?X1WUTS[~-PԴ*P͎-u:[몜$hmlq ׃P{0b~ӛ1;ig=1eCOVw:;{m#5DρC=|^7>{r8x^C\ θM B~Nf* Lͪf._rbBC_1T0M Y+txe&d.6Qd[eCϜ-tl͓9E1Af2`ݒ%MRe"W>.;hrʺn 0_uܱb;+(}mMM2xW9l6Զe IAhj'u*W h.ANҾ5kw{8S4|m*s}'ob;K+C2#3ƒw7EI{_Obyv>zus%mɜem-SOl¾cF}]leZm:MK:(JT;(]^5,nfTGpU*VS|#1QlG] Yw!/-O.`uպ9 xx}YX|q1?*U8=-*|OS[P;~mUxO.cښ[D=ݬ{U Z!QvDq+ߔ:n5,=zk?{mSg 팛5dcd"h>̍Qۊx|q1,=z:Q=Eu0 5>:dcAgYR6$ޒ+bO&syNVA!C0B9Bb 6ܘ`+;e>Og.Wv}I=(8[ލZW7~peK_xLY\?Z2s\28J}MR; &t/۫J˱V눝SJY=ej(vV'28DOh8imU?ĵ)#SPš.b!rWMp>ܓW/ns??swr1t{6ϳf"uݬQSnm/tw-ߟFV+3( ĸw䣊̴s_ck(xT]뀋nob.mnVi[rokUZ%qxx_J|>⃴\OY?i =YY$\b%uᄒlkGqXe]372N + LX0RJ(X&"VEH@+*Վ[I+!T{+.߯V[$G -,=0׽Eۜ %s3[< ; h5)ɍ-ݺ 8 x`C^\O[nZkig#Oֈ7wGoKiAwW x5 x?R2wO>^nޡmۑW\ІoRmt>|B{~շ&z œ Pytg TYC]YivDe<-%&GQv7&IڵiiWny`o ;#֞<꨷/_ķU?ը)\ڙքS4ZNT(HM_AzNX),9IZ=ԞB'߁C ǝ:f44K'+46hRWq/Α(FЫ]wN}% k8V{U}Nk؉HwuI3M+D8G1Sw2vO윤Fnj#&; Glet#ك b{ p-}YvO "P>}=\]nS|&îŊO;|)$pkrGq,]H3fi9N}#I&ռB5beK䓫zW-ϼ}txN߃8+{sthlW{5 6WbM=Qj>wH65wkb')諉hv4uKš"|tm2>q>ۡ=ae=K-KSn״&/iuzkO)A!IѰ:x})Ь֫}F+={X.gާ^+li=8ާ#Vm ;U;B*qLR7МT'~E<ޫYt0Eи#nC<ŐٵTOBjv=eЯ5?z︈{?K_B8džIXq8Z!nXrN ɏH=fS<^Z~*1Q;!td" kT'%:K{sO9zF{(b-\TudjN>I]+Q;wZd-n Ϗ:hSLWb# cj /}ꤎmjǏErn ^43li"r|"_k4;pm .>*zMUCQ[æ2Z,AڦmAӇEWc~K_PApZDKS=^ OsR;Ivy<\71{e)~-H4xW>1.%]{IFO:&#j$v2W͑%cjg{8wcYUT fN@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@M4܂IENDB`DNDd)55p  C LA4Tables & figures\xi-4.bmpbMN hEWL\MD8nTMN hEWLPNG  IHDRZgAMA|Q pHYs.#.#x?vLIDATxm$y55;9 'G!AZ>}>jjwڀ@e]´iv?;7;i^pglݏ;CfnԄPel eМ G~DdDfFfe}tO;UOEFě_ oXvI!әHf"=Ez$H(#QGHD"=Ez$$HN V ^>\v(d- OFHτaX,$OJD2NLT^2GHs2`YV !PD/ a }rw%BY.125D%#AЍn}pe!y*~rw}pҐHGґᆵl\i !w-ᒑΑe!BGfٵH%"xJKAbS$zv@#q&~Fd/ش+( z?ZL, n2]H>;98,;βlH[$̲.2$#&֫L5/ IvlHqd? l/ u!yO$"*6%˞{um>Ip4\x$E,쮃t<8B2YިO%`ܾ=B̐ TtiLJg@'@ⅼ !$+\:`i""*~x@{H/ !v e# qxf>Ge"!WA,߅"!?ZFW@dAmL$l]EXAC/IjHV@ů{YX5$ C_1$ =Ez$H(#QGHD"=Ez$H(#QGHD"=Ez$H(#QDA;eiɢ qAQ<o{r?g|X)$%rMmuN]oOwH~2 GRvßo?в")>߽͙,A-:!Y+dԩ}mPǮHszN4ɅGNb#w'h8XnaTޱ}w9tQS|LOudt9TC#8 ٓ=IS]M$pљ`"zYuI 鑔#QR(HTWA΄j$$Ƴj )%sHFIDAk$O^BגQD[V0aD>8{G HWy zǖ$MJAb7FB@-z/G7 -"qkOɂeC Jt6H ;w$Gȇ~7HjQ|!y*-A!2$GiQK$aH>M[%Q0D y쒐] e#@Cvm9?GgpCN :0 0T!(#fD2Hp8؃a?FWrI>#&" E<"Hk@`CO"yDlBDőfCą\I4D 8r'JeHFB΀C À*X&HbКD=!mc5ٷ-"!u $MR4qEb tYfv !? =υ"A.PZ cZBҡ$r$N~" *n 4 |tvB`H"3bm=_ I-yHZ$G Hq![zR$kG!6Pj ɀ!`y-i4 %0@'"m$M5dۤçH=m.%ج&?ߐ"IHș͐DځgEE#% CX~Ct rCB:z!{p{ȑXE,vX[Yݴ 0u_!Mfv}1Ѡp"!6m{Ԥ'rkH~À!!uJDB{h6$Lx6C␎0;k. ^Ad}xDR$wE~H =d$r{ w =I i-tCT+Cs$p$GbQt  o$HNdFOyHBؘ"B3+yco蓎49^$ EBkN0 bb"q]⫬x6& m1$dTTIJU$ &&HpHR|2$WBcH!k8uHkF[$>ơ9!52E ϡH.jӳ![hÁH2iDҟ y}2MD7(GC'5%nZad)HL #3$w9;C<$0EC%!ApyL~&'*tQ$.c+d>1$"(A<+RCe$kZ)nu pH,Vpⅳȡ>Q\Iu&H3.1Ƨ''H^$z$2@_'{!!vwHTEp$e}{H| I!odT{g({-C } G7-rX( (qZ7% d $6+8!įFUDW {$!! Ro kR$r_WN;LoE2c-aP$Wmo"]B "h2+b6vh *xol-QN䔺ܑMrodP vE@Ϧ"p]&Hvc;w$0xqv#}2'Aywd tt*HIt?5_v ِܡ% P{C^<}o G@by#0E2$ސWz%#I$Cϗ?]@ܣ=E/vx}AY8wA}mbKl{6i8'Ԇ63$lQǬۋtH[$o0Ő [[7y8Md!A4!ɽARk 5+MZCAHG0OSo1$;O9燂{?V@[/T0$!!ڍ"Yk-7.ydH>#apHQ[HHNҡHM]9l!IS_HEP$Ah}-CB/:zvE4 ^1$֢oϧL QAp}C(ςd\ϯH"= HBD]O玄m*\ Hn ˿vnZp$% SIW~>O8ly60R(:K]r4XP[ Cbo-5!qlC¬W kWeq$I  h=1܉BSYK) @:ơH"I8m&^"2 ܔE> bgR$!i/4$YuI}pǁzB] AB !W+lmzPHt<$ˀ򗋏H!]o7%@򬫜@r t&HrG /=\T{$$."{-(:H KDIGKAr6$^$JA: /=\ 8H7#D#o~;3$U($rׁ"~@]w^'\#lfH[13??kW+:6zyUwzySJY 3Љy9M<_'s?W?ݫ^Hw뵗~3 ~c?>;QbB&H;+z$-dL@l8ހd??1wE2eE;w$UB>s??2iZ$@FR#'޽wGR8>s$I\6ko4GnCw ,rD#$'5Uߊwo/BH1#J[#yH+Gg߱)Ě\ $e֘jZQYR(CI×; \ $ #_I6~OO$!< #9mDm :3r/"`l;h$p%ڰi ?#A}q*Bc$;پq[Y $!9Wx 7_ސp%E[ӾH, )( I޵7^/(ʷe ɷy:;Tː֎|K8kr\٣K$7^mӎdO?=nхBr +)<'M-z|`IM mIzE)O\p$]#66UMNQZ*"HnHHJS-CnjM5!J4 /$%n\",ym&ٮhFhHHŻBbVKiɫ3(\᜴F2LH"+ cy#ſ1Î@]* n8mk. ʠ3C"%`+ϊ F\fGɇBĪ_Y_&TKs㯓|}zuH>A)x8P/ tH|'u:/G"١H6f@usv(8ݴ Hf@JNHnK7bM3$v0 ;d;#xBSDnCDZH#8CTKBHP^ IH⛭쬂.ɐ.7tkۤm$dc.[':]O~/A&.4ቷh Iv2wS$!34=N`%)ӦH@d6?Z@r^kF0Gޥ@n6gɵDZQ!9.CAHƺh"^zŗ}gi/GSWɴ9 =H9ӳƯ}+GGr ~kP~~#Ye* q`uUhΐD@goHƴER-i4d.UN $N^:̐Еz:S*2ER3mD㰣*sX .0 gq -D-z]R]׋pb+u?GbKHmϒ4E$0a=iS$U(_mw"P/#a !& yn|E"HU-ɤ1z$.ɑ8m@|%d|b. lfr7F~ِarn3_R1MHͤhKNhy J; >dg$Mį/a %$(x#Ibj"ٌّfoHn\#MjIS$XEyɤBL2=ކsh8XD|$]#$C߆Zh9["[!)i8p̳ϐ|61$]:7뗷aSORsk6[C/<(+aGmIM)qW;S%$`"y5amZ$p%=aS$%#aT AJts͡DCٻC +n$3N!}AtX7#qVʶ7u9 B0 m܃`N4NRIjE"LD-RC;ZL4:HbkKN9dƆ#Η\CxJr%6t|޵ZS$R oy`@ =}Idg%ƫ`V懤4FgCKg. <.ynl$U@ӌH|k ErDmX]YCB"=4wv IZPx)Hl:HƭҖ2@ivB\$ j!Bg(}5l~k$HlJ,xeHlD*p}-I"lFjNl "|}-YJX0$"̿, %,ϚD$]"[!Mkǩhf!΀^HNi&\$g %3"i IV挤|s 'NCbc]ALy"1.C$^+m6_R BgDj?fu) >_Bfk2ʯM1)T8 8U_πdZO Id,%5 o8_"I钰xp^3$WٺNdꐜ(W2yX$v h2uHl+  T`a_Z2$):$dIn}S|%AquHTmjp$EqxՒaDɕ?ƿ'ɧ%!s^p$"v,Z?C<ɗK=6>ՏӢ"!MEgE"缾HԐ|4k$:HI "K<+7h#V$\t jDBR7DWks$B9.tmT1_r,5@R݆=1ȬjrkA2ɷ/ NȓD t\v:1&Eptpo1ȬnHPBRncWk#3$K$)7G">H!(Ga'bn%о{4BH# Hȕoq#|ks;<!y\QA/!9Gc!)30r :af8'Q$ի Hi~`rhRa`3$wth [DRq\Z7vMןmvC#_IK$Cr < D$ g""iK|@PC$u?:o,;gJgxt0*BFHF̑y-eH>T= k&$|U#ݒ9Al/H`uƋD$Ə yi:_*숞VP0!S]q-Yn$QxE$ofrHB$lAy錄ѶUF,XF2D(%J$  fAK5lZ)TW^oZ#Q-H"3BrSp:n)Fq|vd~cG##$OZH&':%! tHT4'yerg,kD:$,'2 3:qgY-iK=$\G ~L8+_JF&HɭMD?gA%,a !x0|C$N1`Gp`AS\pP>|aXqLqŰJoH>\8` "!$/0%3'QD|$kC]R1}[ ){G H:{ڪ#{HsKA<-Ezj>ġ:uL=/2*:$"p=֒&HQLHt5-$ ԩtEB-$GgdT@2M ]N$p^枮) el"q XT!.#Q؍]ZW@2Qod/]jfC)s[ $UT3>;"}|SIguv5A2TpoXDͨ#.R1̬Wx *!Q$IXnЃA(|"(AT$bدGD28Kgc$0PD) X*i=˄X>D7Ñ 5u H< T$匩+?SW>dylO`D^ #9;NDŽ;$V  dӚ zmdpƿJTӘ4sG3%Sm-5(;=o% CB H@$H$e䐁\k0F 4G㖕0A߸2BPx\5j_jcd$ Y@%HP͐S$0E$!Y-Q yy;siT6r WհdH9W?{Ip5]V`ˆ(7V p H\DCɁ2$\ռ^"H3YrxO·3 > yiD g]LyLc πD$zIáZZL|PK3@jP$@+IMD9.uW Xed7_J/_gF{kykvI>kX$[) a8\Z H3''E#"ٙ Iҁ|G%Q) a|nN$Aġ<=a>%.JKs߁ꐤY"4E>|W@#%7fai4Jj$Q]!RDX|"9hdtR" \Z"! HmO8 VD,F'J-CU$'˂Em {TV >+/"):$B$CR7Fi>rPEya@rɉ=>` G@2º~@-otK$!>@p0ɑc0di[g2yWLH{KďH+|a+p`y $9HB4}7%G&=?P&մH B!OFfLuS$iY3]#I @J"?EefRH>6i8"%Hj䩔Z[{4,m8mdaWHe/E";A(unxeAP f:$>ߏJqf?ɳ EDRПitAr9ld=IaǬ I![J5UH"S$_NԽ완JnpHX*TPx6$ U&BS$!I)1QI!=|GJ!U&d5t"I7D"5?[%Lp4eVD *i]-"#|T89O"9HiUa1aCǬg;5HZ9RgHr'mצXnglG31jSdEm%x&ϚL臔n!+gtiKm8-E$P)QiiI޻$7(dN줮&XZ!fH>D4EC Iσ$ɄpscEMd]KL,T !BΩl(\7+̗dS$U@oX%gvtD'~"q_-i<}"]z]r$=wഈy(A*X\iDES$Ev eKjطIHvһzZDjGrD%OwgH؛F( rHdX8bߑFD4u(NE Xl8f-y! ٖ @ϳ'.t9J%H<:T+J$bk+jo "B$?|LYiLn/o8`"9UHF4SĢzX)m@ IҼ $6 %wtm,)ɨ 3ΆWҜ[8m&GBC]%s]a^p RBg_ |q|!(p$d6K8E% !9Px²")Ml$\);/wwMxY-?3QvYT%L ,[fɵ|'ӯGGnVB+#SFU;bzv y}em! 6HvLQG u46o8`kJ$G냎"kd(ͫݎy.O0ߣN2ag)֐+૔/zw`1m$-C\Bu kIf#L iK@$ XDBWi dQd(\_KҒj O'MK/yddY;']EPaED$Bygar81F[:W}'AƒdURM'N."a$|sq) ;._UFRz((qqs #$M#dH7CцeDh%1Pw;[a羈ķ+*K5bPbl4H<1gjACI,#4@٤իX=[w; _#4HVzV-w\ +',a)K̐ύ*Hj D"e,]px* 8?r ؛<5O! $k&ikc$!KL0o,,,ޕ/9.(ĵŒN;$~!ۥ;f2n4QT 6O$FȤ%k"%<х`ta6JBT L)a^K&÷͐0jZۆ+*.  3֫ZPtNYG[$. V5tdf*Yh_(IɦŭDzvo|NXkirU_TIЌ6d#$F`I[$Ҙ_?U9 ̂DpsYsmPI[$..o~Hl؂pEʞ}?/$ʕ"ŖTD<途NLB0']"=3Kv]'HJ%lR zHbmk%p$r`d.HNKlp'py[lZ舦n+$>2FbVKJSmkMZlX&d$њ]R|Ŕ=,C"= A{IH<ct5hpy&S'\- lmd )%dEy\`$R]m@<=y/5M_XKHk^`m-Q'6PBΪeHcFDvop6~t[>;g'X/] HȬ]RD"i0 _^@ɤZ7 `DMzA6Cqi+%qa:eSuj<64$lV ac) N ͽ%+ER=vu:ڠM$iH&eFҤ%7N) HJNaR ˋD/1}I'k‹GR}E'tIHsGR%r" )G͐Lql41ugKxNi ]H:DmzԷo3\p8':/'>g-73J|KgHdHD.7@BCv  7rHGj#jH*E٬uQP@8 zJ9Qz7r@ Ml4EB§e_JOkF⢸Hp$ "h&pfxfɷV7qYxC2Oˀpp$R(d&$H0UvIaFu|R$y8&Z!1DR; =߶"vDI!iKV IiHlɒ뒉,}!V/néBRg(şB`Stё6qsX..k-9y%0Db.IIeI<G2i$7%fV$NJ3^$N% k]3E; =l$u3H;g ܵɤ):UΫgE#cHL 7n/y4; YCS8_+Gbp̑6E஑D Z $\BM GrnĮM=aa+$\tI@3-ڡ.h.0;r^Hµ%s% ^C$Ʀڕ&##$-׷Q $7{>vI>U?ј21n8{,\;u .۠oha:7/-}ɇD+h1Cl.yHXMW"[o9Wf )]ujnU'͑ג!UER74m9•A}-hs#IRyrWI MWIi]S$h5tpL7Y5yCYRHJ Q7B[۽ijE2i&p.kCݿHT hu<%BE[ j0UE!#_9_~[qaLVuQdp˯ocMİ@U^[˟/׾EbVKNWffR@2)K{>&3?~^D2+ĨpIu釿xO]7-5z$S5DBL쬆z=dH 3e Hn?xN[<$N࠹"qLDx BѯO>:7Kw"dF$&_O#D, Szdu'|vk_4$sWK.O]HD"z-MG#ɤo8HTI&}'HDn[?Hb=z(?bayƎ;x.vmDh  |c˅$<{7BAly'6C3gg9MA~qmY!(laH9!ӌfFit' N?!ݏKqY>FIvLF68UTNj1)~ލo;;>ُM#ip<;ys= 9gHҠ)xXLHM}R >EbEpS$Á]!ɖnPv~1k:AϐQ4dlHZ"TH% IhHv}d:ߠHn#d8HҌIਨKB4%%Hnxv| " "mGI7IMi4hKXK(B3zPJ fHB12zEBK`x I0'570i}S%_IJ/C@D#bڣUGdstt4nY)_."B&'Y1Q =vyj?ʤ%rYϚ"yV8W> uo0 y!Ƒ-d䗋эS$Z˾"YsŐT#v =nq>H2 ?XRFلΗiMnĐ G8vdE+Aǣ $1NUꊔv™ٞe%%x~kI8^ %Qds%iF3uX" @_ H!F.%w֬ޝ&2J^3͑7{nHج 4b; 5FLjZd$ $jw^jDt7 ).::fD<HJD"=Ez$H(#QGdejIᄃH_K(#QGHDR$EdEGHD"=Ez$H(#Q$'&0>{FYƾP I0 ?aDB$k0;}yCؤ.1<;zIs. BG&E.a{[k/ GѦ{m" 6gTdn$qD`ϑ]oc ud|ES$@om6!@>~G$?qfQhh=K >=$b"vhE!A2ʑ4 !S9^ǫi bbv$}yDBOd)o ""=>Iccjs$@ H1>lzPDF~o3$lϐca~W$t$L}Io?*DGw~ 1o}pɐp9?&{`D2HTk"=Ez$dD"=Ez]蜬>s#QGHD"WF=H$IpƑ t"p;:gא^ڂ/%&rO^p3*=Ez$H(#QGHD"=Ez$H(#QGHD"=Ez$H(#QGHD"=Ez$H(#QGJʆz:IENDB`o)Dd' QQr  C NA6Tables & figures\xi-5a.bmpb(,Y NjG]K:(8n}(,Y NjG]K:PNG  IHDRFx{SgAMA|Q pHYs.#.#x?v(IDATxoHpf(Q}؂ u^- >X1˰ 27 }^`eߚY٨v^ 2f6-`TY}/ SS|@wAI2 ބ 5Hh$T4* FBE#PHh$T4* FBE#PHh$T4* FBE#PHh$T4* FBE#PH!1-w%8q͙Icss$Z2+a j'ffHBG=!;-NMԦcsڂ6OLF$͔ CHxDmzSSIdqjqD[aPJINl*'Y3*ř:t 7SV^qfq'u&Bo0C"& aΦ7f%ڱ=o6Z'bC%y\ w5qυb;Jؤwc8F^L/QLZK;f\aR-zfzxx^DKJ@%c2ƩqfgƙIOQ0=|j> a/ 뷙!WB0bSRb>! wa:^3laC{Sg 4F j)PvfC ZnPUOe:|6'ae0c;H%egפ= bYD=ju]mbf$֠DI/;~|EzBuKC Abk3|]Ix(aŤ*$4FgT"Y>Ht(=MC Jtۉ%%`zT(*n@"N*aJT̩ĺM%k"a 3 A>囒SG4MGBW7&;D쉔IK3z%0E_wd:0P1yt"qz87^Z0Aސg1 l8'%roؘK-ٟ  aC053.;e+D:vG1 P&'&ؠqg(E#~ j'F U1+tӠG?$-KhyKHˊc8]watE ; T=IA}rWbHh$T4* FBE#PHh$T4* FBE#PHh$T4* FBE#PHh$T4**%IB["vʼn0?`n񡫢Θ $V̛<l닓ke Z%vaeARy#)Ln j2^gKC"~Y/+'}9NN0e;),<)1̒h%~ +{Er;UVKj˦~)iA%Yu$m+cfA~r_vl߫"wlx\#sm>LcÜKՓMnP%3;0U[-Kxc]zN$Y Uv^%JJ$>ηUI諍s}ՖYDI eI/.ٰS808t Ϛ-X6/s&/[N@k֫kGay|U|l\= _v B"\kDW%y /0u%Jn-.xJxI+׆?s c% 8h'rU ]}wz/jRvYVXы}o&ƹ>ʍB,1HVPvT!>s8!~wS`?<,6)ipBKܩDR"a_T#֮Dzܣqv3Dل8WB욈ݣ%33yV5%Q}H9W/߭Rbfoד ԫ Vy^Z$bnzD,HZEL_8)w 裿b!][!‰I*gIк};XdǸ~ =f1z#0g-՝lY6zhuI _[ʷX#Q^,KK.;%VDD#HI:Y`lx(.,$$k8ow+LPFb%zi~C1/8]DV,WI5W(QIK=mTXolK9 WKI8֗($R"YDu߱5 ԑ?!ѭXREDɍA(l L ĒcǔyfTb^ޯXJ *&fjǒ}g[S;l]& ?JX 9SgΖpW(1,JDus"~zIFH%%/J k91]TD-mN"N%XQ Rk;i'g#Rx3-&!q Xp)I$E#)@Ӿ%܌ċTJDDY%TpF'}(N@H`` 4(2P91N{\V;D_I<$$d㼄+%M%X*rA-̙=j<$9- > NVZS3 ]];.*!Y$6vRXvYO’/ssa#)1Js#N/š sCȎ'>B0'LB[gCeԖċC ǥ]_Ih"c! U;zִvZ9A"H$xWH%ݺ/.:%F *qIhdzK턣ILB"͉.Jt9JtQ DZX愒S ;YDI!p_fH*AKf#4+bFzz7h3 ÅJ b'JsH$x3]H? GJPl!RbW$VJY.=LS ۉq*$x0/Q?'hϰhe"J%XF* &(q?C,0+H|$TNlځr2مo%l)AO$\MV24'>Hѝđ~-$L3D;8u q"'|PqG؛!዇PI%Ej$dG;D7+1dg'#BH / )a TCsDW$L-oP&YXmL Sǁ/z*i;1R9AN A _$X@J؀$S&1$zF;vJ|wol1ī$`NDl%0}YWKD6ie$łDa<-DT“83%[LeN9%['5!A!aI"5 :jItST”cP"sA ch@8iȭ 0hC H}4m!T!qJ<_ yDkD슅6%$, RaM$ỷD4UHG vtl1DLH gW-fS%Ax 7ϹO/)Hnud Dg,$SؾuY)eGR왐6- "!oBP+$^}&M%)ёAZ-=a- 3ȐHAN"Nމ@IL$v@NXeD,$nO>'NAbg( ga;v߉;Lp،M?G&.BXR"bTR#xAˉTF& H.}9u )1  9ęVIĶU[0ða@ $+ApdC-$d _DHT%r&3Z(-$Ӝ  =%8TD ˯PŽ/azIT +7<7$HxwbJtg7g\I %>W %@;$BbOP' H a˺ސD@ap\G1H̞J8BڦM&Tzi^!Hxq{c&$?rqV³PJ? Lh4GN|Y򦞄H <uǞ8IT@O2Q^;n0 !`NHFhNBBϺ1vꭔC-5Q ~*L$q0&β8 ;%F/?5 z.%nLՎrCi}!a 8E eijS%hwO7`[$ID|A4!Kbj}h,#({w 9HfKI\*bJ(1R 4X@g `DjI$`9HB"J%DUIMn=q0\MCBc?CGgvㄧ a$ȑD_HH CH 12JHՔpxI@[݈, w"&1)Acw?r}@•%7Վ+/yjG+7( Z(œ@ (q/@bs"4L\JP!a"$1 qP"b̔JsoC̢DŽ/Bτ87\ƒ1[hAš`@I%~( :] ~ F$,!ѳwį,qRxӜ(cHIةZ}jco=9H9CaR_$EgOCۜt ^},HX F6C % Bڐӥ$(~q'+C |j?컷Vp&h+pŹ$ׄ&J?J7 .Z]0S聄5+$|ή0'`EyBL%)9;PX[zU*8tQ–6HD58t w@ w*1nh3(Kކ>/ioC֒(+ OXMQ.WdP}`hOl%;)l@DN=)qr"a}}zG oPO' qí86RWb9VJ2WG.'  +~$kJJҫV 9{c\<+B͜_H2TH`D B8ا:((#/AS %%Dbإf;oB#6TG\A$UH #2P]<6T$Tx}0H|~~wQ&1u)J؄^:~*+y#g KKY]'GP-({;x@BG;J=W(aFmS ϞH ؁bƸkJ"Yiq>IIjK\PpEJbv*A-®P'%;I$܇$Dk8xI'Dl*6tR>l$o0|$pJq>zsD2DJJ2̒5pcKw}~u`Wu4R?wTqĨ) O %1_.*jǏRK ro6-O%܁l]b.-x}Dq!'|0nWp֕vȜAXńܠˬO9џHc?x2J8+g-%؅P"s5[I`fJvbXW"-0gH+@WN hc,X9ɶHFB}Ĝ He/q<#OTIP!g|5&$ȑu@\G 9,xLsb'e˗~N0B]Q$vIX.xJ JX|5ϓ}n^Wa+E⽐n]İb)j@*Ŏ%^uV*ѭ|ͪ$VxI\V!a8OTbcs"Xİb AVD%Jp*bқ.+ 7=ĪïX*C#M#S0Ux4!aҺcD]0:IK:D#5 Μl{[%|WR [J?.H(hyXI rDquJ QbvbL<#Jv\<=H K3%~l%l_.Ǻ!Q̉'fD?/v-b-f'@W(ڑTI_=Dɼces'@B{|K$c̵K_nĪe-6Jc%DWDաMϨMH)k ,6iI]V|n#gKx 3Q._$NQ=;9W ]1C"޾A9c$.(sy.}{}qk%f>Fu|y];oxQ7{8u 98[+ΟkBjU~J/.|^7x?kI_ؖk|ɘ)!'Ϳ3#oǛS.'׵3k[rسV%זfO ohg.?jyÂiĕ]T~>P^:@iR(Ђ?qkY$(eUxu:s0<)A 7 1 m*AKhHh$T4* FBE#PHh$T4* FBE#PHh$T4* FBE#oku eei@IENDB`2Ddr  C NA6Tables & figures\xi-5b.bmpbT1%1Nl5Re01Z8n(1%1Nl5RePNG  IHDRTP.egAMA|Q pHYs.#.#x?v0IDATxOh-ۚW:cMeJ2%Yv۔dYXyX$фX$Sꗾ)w"G+E1 ]`cd(OOc/qBۚ塑%J'oMxɒH\]4 Xb}YbbM;4]A5 XX9^V`q)ݻ_E-q e-KPM GD $č- SBtz: =& JI3KO]Ŏ#`q8LҘ! @ I& Կ d%%,!~O세$AJbbn omhsJGe!X G%$p`H'Y|+mn=}ؑ,05ómro Ŷ`!0JRbq< ,v?=SvѶ^l;t=CRȲ`c$Ȳ# &۶uy ].@|סlHmzc+X奕K,X~&^Y%%\h܅YR~[. .H0dq$K,b4?F-,dŒW HvׯFɂKPٕ,1̣\`ڽ#~I% #,4 h?&¬Jt~I8EΣRveS\8 v!YRX+F+|Cf_h9oa] Wi`=nK4kz]6 Rl~u[P$$v-`KO/_$ e~^ͲXC`Q6A'h`y >),!N;]KEX ,`r,N!,`ۂW.E#. %}ew>tCu>ZpX% _\a *߻!‘'أ>K6,KP ,|EL6:=z=${z\^lc炾,galYXǜYfef$3KgaZe YfeSmֻ32<-YX{oYX///4Ba,SbK92%Yv̲;,hfò2LIN)_N~fYfefƲLN,ӗefIeҜdY~7Y /?ͣ:Ds2uXze‡$'/|'~/?SKJ|;տ_U]XW,~ ]/j oʬw>gަ_?_ڷ yn(,I KB'_%?/Ø,Ŗl7ԛ C1\=E'olrgu>#ƨt*t#T]^}SXцdwY_fyƲLi2ш,/Sdnz4gf2)GSbc>A5_c6~a8,cKz㰌1F+y&+72K {Duc=! 5څ: dbP%-Nŏeq\ݯQY;ŵ&Y{ʽhbV^@ ST@'r~a+X;Udg,ůodW<}ְ7߯Ӝ.?C0'.9cg8zˎ,gh ` {bVf1" ,><$;/.ݿsF 9 $\N:H1C켰o4>tK_z~LZۣf~'}0RP nGх?Z% /axbFY.CLw5W㣰 1⣤K8#K;K%!/,QΣq@=kK8~iϿݖۈ MScV\vpE+^ʋ6q֏QEQu-%yBE/%KO{owFG޴t,C?_sғCڥ XeeдW+*/%Vpy} ofKXLP)mb%ɺcm ´b־Q Y^,bRQ9_J`,j\~&v 3§4͢BK,Vgbf/'^ #DW& ^_bciΓkKBslB00U_GLG_I]TEġ l6ybhͽ-7T$ I=QPG [71uiNN`37 .nbWw OWbIf:eKPzE e/Y S31g'/Yl */S]%4/?,e:T~ſ"S0iFƌ i#EFdβSw#7)ݠ jŇ:'E0=מ?H X~N3{Oc,qƒ+][jD]R]v!YDvQq:>;lUa5RV Ccc( q/ՓEFB%KMm!Ǻtw9*)|0JD %U5,̂y:SRgP,A/,,E5ED Vzc&(R.(A .G/zWIkN#G欥m'UiT뉮]3L Oſ#?uo~RXLFzq6VMԠ/,S#c7%/WYמsmoIvrNYQvm'}dY<;Z Ksm&d~JvT،qqiYHtNSD2rJ9m85e-[e[=9Ͼ9=5 d׮&۔n^,jBfFN;Z__j>Yl3ԳdE]*t@‚UqwYN]ԕh*-L;ZOy}*|nIDtpՊ'Kťߋy;j2WQbЇiUy8N'`3qweWj?$c%6*gte<d("x4-tr=4ħ*/aď%mWm=FV䪝e)c)Z*{nb[RZY:F}2K QFyV%Qߕ"neAʼns]  FM`#v_j,HY2;9l5Xʸ(_nEq@:AtuyIM[fy& ,e3&:FHtlX 7/$q1ţi5\U+QQ\JU^b`Rv$+K5Tb7DIrG5˂~<_C[ })c:F/ G~1wQ@}I0kS%mdwZӻݎ׻`?,>,6]sSg?re䨺7Q݁-> -\ |, 2XɱD ];ۣM1i Q= ŜvQ$ȅ(h;q*osS=(~ZqՅcƑ WE-KMhX.[ra"tOtDnɴs1YUG1F5ѣa]'Y^K5dBCJ朘8%%cɕMvJA%\US[`y Q$g]YXr'Q*32Ό=Q+5Ғ, '_,&\Qti$xy <+ξ`ٕ%rhAWI9d#h%Ľ{+-I~ zט|dQ~*X/,$ F4f'"@o/r711: ;-{ ~KpúO,R 1K]cPEqs<]_dz%LZr9lq0~zy;ͳ$*9Q  /Wr*#Բh)a.!(\oY#췄l1\f9 Yq< ++LӅXPa{>9fY-r.5/WǸCօN/e[(,9hOv ` Y|¼fAE׆z ,r^d1̦gpǂh{h* hryLT$_ܨqq}\fm)R fL1Be" ̵pqLzo}u,`eMy'%(zyмX l)c$\r1]%|uAc$j^yмE :l"{I)W\ߒjSc5Pr/]ȑY "=kQLDf ]՜a OA8FbRJ cڷw xeᚢ#FˎXI iY~3_|HE ."0ׂMr_d97TQ$iKtEɋ$^Ze]'8~DсGXTn񖎄c%61Mַ)*Ի0! =*` B 4S%cy!W{Ot,5.pa^1zbh⋾Nt^ǂ3[FR c!l5<.RKU_dNT$z`ɻwہX-z5A "Zʋ^|c<As^J XZbjā2n0p*hte,A# v΅V t/zKG1*6$&%;s@APJ+{αeȢQu;BtCw܈*F|ڍĢ?^jpԟi[~`u~/$N; *ש_N,zhLeZґ88 I#7jh6ʽ'!!.*9Y>͹ jQZȞ^,ќb*@w`#ڵ$}[VPfH=cdVt!&Zh kS)+,f/%D2)OWrٳH.Mnڭ*5j_pS%^V78k<؀)0>);,UrH>2=!6 tׂ( bh>X>*,7;CO+v"_?&q2[o(ӀvLJ ;TK/+0gGd`9ij`.'U1K$kPvXP{DR%"*]~@EƋZEu*ೣBQJO;ڮl5xJAluﲐ@kLg0@Y..KAh1PQp#C, j~Q:X` ՕTuk5@E[u-1A8Pd>x{-zUTlrƄ,O5)/;,Yr:UqsPIR*s5h ȆJe1Eb^Ye`y)baeK hJilMżjy+utk8_? 6h::^U_jS1I{X|ʆ%J-z?mgHWeExY6֟e~a+2ڗ^ W?WRX^W!z|^Jo{o%Fd uG,<eyzξw~meFXzۣh1X3'p{y?]~~ /x/%ubOdXeW>_M=Ͽ fi/ŧ,_R _ i%ubZת,iξj׉h,4W9a]s\0lQՒ߮fqd?vjgeW x-]>#ܻ2yRr?!X,/OЦ/3˚,_U_jjgV]bN'!I Z^\"B,7AEUבcveI5XjKc9n~{kKG:]y; *h/ uĪUΈT,K,.KãKOZW:,X~\@E< ?P٥^E{Bi C4(<ঔ%e'>xf̍͜JM̽M1CB,5qfÁ`Wp[M0xףg~juy(Y .X(!|<3Q|< 9hA#p"Yz6#C!K"Y<<.BwYBیauB ˹gd߁rd9ꀅH;Zu:,ǎ8aD}=wYν^lУ~/1eOc 4#Y@x(L'wx=;||G$W7Sϰ8S?qإojBe8V%BdT,a0ecã( ABMiuL ` 1< ,\jxsm@ L#/ϚY8y$Y=G pSBv c" , XI|um⇧5;vb| +W%c'Ew)C}=Ǣ ,rY9]Wwm|ٛ}ē. ȮZB#|NW|ux,{k|C l° E{2l8-/,BXg0cĶ 7vڍ6n>Ç  _JK[B^ ^x_NKNgK|̻8Hu,_gICK׆rfRnȿ,OyT߆ƧcY&2%yy)陥2,3׊e~RYgZ)єXgZ)2K}0Է2Le3׋eJԔe612Զ)Rg/ӟSeTZ8:`a/'d=,<;0Um?Wҷ[gSțGIrvsT8m= c+ޙMgcA32,32,32,i32,j29>IENDB`EDdp  C LA4Tables & figures\xi-6.bmpbD5:pU+L-mvDt8nD5:pU+L-mvPNG  IHDRD"gAMA|Q pHYs.#.#x?vDFIDATx_$Izξ^: flwl@映/u2'gɼi(Vsc;iUqũ37]549jZǶ37o*),mrgq]N鯄7q46%ST84C"àώGT6.hdEeq*))&uS\2HJeW% M雡6j8>79/iб'V+ &d]PerUL7Gm"8 B !1BKEid'L$ OKq̰pX2AMYv@!mϷ8 ¢=KG<19Ŋ8xĖ9BDҴ Ij:!?*d*N` µM'h#䂜][,i:&,>JZdD @!Ĥ( MRAc'YX5gO g>wwBsrK<e U8_"GpFMӄ<2k% . MVOC0EvpN}i Ix`{[h-Sp$d}'t-0Y`6l+vn 3 )]iCHezm& $&{y4O%Ӷ2Aq=T2Ő T yGoyj v74%1 SSf&M25ʄ9 z~.ޱCu]^%̂fZ`D̢cδM;4?'0ez!+8vl} t Vǎͱ t݁jw,rb[,mAK$MFĥ)JMS4AM RDƘ"b`Iþı_@~9S@H Eg`M:i'O'8+xsBxEEH\apّ&2y}_oZv[8gƓqjj T+nG9)ݿR=p'"np}R쏷abazx*٘'?E^?tb_.`6-Iqſǀ43hM>nTu4%^;Sڬ]dLsԙ ԙ:SgL+4݊ȰYwBKU9fLIsu5jI Ne$܊/5ɯ4ń8+Si>Ex]*;4-PMB'bppO0!v+Ŝr@/.Ў8aۂRq;ٵ3YD]e; /=!ٰ )A c݈%YC&yNxUU^L61yi AV&L>\\ebr>"B1y$T?ʻ} IQlSyMV2v_e.pH&;8\Pr#*/J9^S&?7} hxL L >C+`VM `[+1$ϿdVLoC\Ln1rIGvpesWL9L'0Y4`J0 UxU=O[5fr!`"v 4EEP&dM$L}4t J NΚub$xI</"}رeT?4Hf\m՛w`ggLڵaq'warj̺ފɭv8N}jg[1;:BgL3uԙ:SgL3uԙ:SgL3uԙ:SgL3uԙ:SgL3uԙ:SgL3uԙ:SgL3}L9.jZ8u91,&QTؖfMLW|L?_7SbfQsK|B^Tl)S@f>~TgJFaasj_xFaθI4fɲ\r+K:=ӏY/fڊiۿ.: FSlWl8:yWgt1Ry(6ŜGOMqöe!S(MtsUmÐ&o U310M j_c49`cBsWũP9W/ML )il\8Te SaG;qn{` LU~jS8)6kz"-7" YJLu<3cOզ(BY)pK/3dL> B՚&f&MuU-O%V4U})~Ԏ  -4t܎)f4B||Yx&Y#c?79[A_^GUdEӋOr!4qTL.@TIG6\4յbDȒsb-LIR9]SL %Xhǰy8ᩪز&3NL2NA!*Sz R6xe; &:zGt9M48d_ ø@=+j+6aI2D3 |)zIܒ(; _fLG/iPMMjѮ2N1$$~XdVTS$MN|Di ɾӝ"7HYӢ30q7{&x_v7iƺVL6{**h: o̘ƨ2yKBUf:q1+ӌmK) ٪@}i}]i(iמ1j!gF$ ^Xx23 S'S $sL'郹7- E-nWԧETaIqG/x4Z;6ߧKNS#'e, @>{$[1d}_4ź7\ݰxMbI?*OnnJ'gT^SQjҏÄO_349&W7;+|l t]^X"VM8Q\֓I)XeYc+^>N iǠ7L&1֧)!kb'L5!&2@Uz oơӏpնTz=ASN֚xuEUz7K Ŭe) Wݼ?'N !0?Wg8Lyg Jޛb8y:4!X4,N[ ~'N,Qs0}PSX2ELo gvzT6%dM5-z8 IVf^ bc02J3M0ߍI5g Mi睦ދbiE ¬͝%M^-iLqei`)#-0ELӰK64Rvc b:~l*[.;OFSӠFB?H}'M}Hم3s˦lP'x۲>}2-sFcr%/U4*]șzEȿ#oH_Sd5MmpiEmݱmɄ3a~enS鸷qF>Oo6NXܴuũP^W򎵅E8MUcO%7n|נ M Oc\*>T(~}?y/nMLL'C5si=1.Et"77 T*3hy6؞'8aSaR46ٗҙ) ^zJLBB%3&tygz!SBLAT~9MMpmLp^Apl”w7^scߝ޶O6ZMG&wAs_U4҂)Xn4?֔]I,k̞W#3Ps8KL1y8izUp8p)1f:nl &߀eN~RW"]``U揓H_qf` ^[2)Ӏ/gr?irco&e&KNM2K4N4bLFqg4Wbf&6Ubm~y/o.{qk15&gse+DSr!41--`r)d}[L-} L{Dg*SLqV~aSMlĄ)tx)L`$܄IgaS_D.|)0iz]Ĵ)fWx'`M07 whb88HOLv.3Cy*(U^FPL/t 7MT"~X͘TƵrKsDLx#vj„iW1qS LoBMvAa=n˚e&&O]A܅A0ֲt:l7`uL)RF㋘bf g#K94&L\[a1k!zh4q$3T!G< 00٧\&M/1&oh$EL[2E` -\Ԗ;5q`>vݡI`sl,C9v9.զT\/7LJ_)aI[%Ӱ;3+\zܔi$*LiN߈GPSb 3ڸMlFKK5KkSl w4pe~nXB2&^4AnITZpwȑw/>MEv=:=[˵&/y֣y M]Qh2bin SXaIi¦> *}n^tצcm-kb` zCUicsujMlK4`/JsM6Ǎ50Ul[$toM kYx1x OcSR2{LA|d874EMGBq" ۻvMnCS^- Ԕ?Ĵisih701a*d)i f"&a&NA4԰>%3MMsACæ)h>3kd[45K=TuLLzSM̨wM}3gd8g75e"Mfl_%6b2ڧ+'}ߒ)&9F$mFL&:,f|)Sd&N~ڂywCVq~;AtOm;62oj\vzNz_+#pavkSb Rx-X,N;6or}@vMq3S/3:&gӵ߂EKP\4Q\ J)31]Q[qZbIpo:L~Z2´5cCjhmZb^5'g޺.N㭚u49kgjoDףz53ŮAĺd=ǟ0ڧ+Sk$rMX4G5SpʮxlٚIӜix|W4m45ڙ.>gFu i~)=11_/ӵ2VvKW&L 9񝋷?8M I>ќiTxoye͚'3qa0 H>{6/bQu{.MWIl܂Yf=L=a:nSlGaK-i\P>2Z7U>qI(Sj~6t#w!^S7y`u I0NyLs]u$#M kLi?raԤ&}Ss^7P2HUF&}S{4K\S* %~ϼLb'ҭ7Eސ/cz.%Yodt#]{oЄ+M6y8wD> °^z`&jx&K?@pS2~. d%ziNfؔ>Ĩ 1lЂ)vE#=42`<M{}mYmq7Z#:%N۹ (S?i{F~ŀL| ʚI\yK69sbcYS~yQwM[t-M[Ba:L/lR6BgoRoжs5V(;Y)g_F&K,Vy51bʤsPX|]/,_v4[vKs]oYI4{eMqԼw yk T=&_otضxyӦb#M8#0ϏM/.a/Gc _m8'M 919!t N쒅MsST}R1:<ފ+DӰh/l*Mgֵ-Lhzt*IpI!kۖY&|9˦pqKȮk׌^yFd&31b׷u&6˄(.cueG1K'u|f)Rn#163Qv$x+qBq&1NtedůiL߷65銈=});o#3&EEkl{0<-|9H)@^>1'MץKM |FDf5\Pg2{NϻYxo* LW&3msJЩ7Juf,>IǛA'M*kM|4\ʔ_bbʑaJ4޺]ʔ?zj4+JcZ2y4lv4{2hdϜ( .7 tQ&WLxHFrLud+e (7OM?CO_/sëLdu;Y!,=vzm/G[?hH\$e-u],p_z5hID)P}i/=yنwdHdg鹼Wݟg~g#Zh*(jƜ ^ȎOoѓml _|(p;"Ks2R*xtţg~焓 _(g&Vc*/+^ ],hydTc8JS|<>מ ^)L)6ce3٧^JSX0{QiqSGv+ Mp-j7 &~$M2KVizYLXTSK֛渦?R^(00q'Ll)֦4',]o{"&.e~Sh_36vLAb?ngk1N)S2Lk[X@ԙpdMn/Sah+ ʦP8 1߯6U1 =VZ5.K(; 5)JM MI&ԔPI6IM-_lh LV$Nyo[="f. /ZLr,=E'~eoCamM4&7_DzbRZ65Bdƴ?niWSqMq)NM/%M@4ԶMN {~x^#݇)!Mګʅd̤I}=cb0kX3?Wʠu1tt$nD zSfLA"M:Jۧ ie[mz״"L>_Q;J2_LJA]pw܄NM(⁧u:!7֫DZ^X5oS?Q&_ǽaDn Œdr>Hi٤OJ T2XQ{tPQ2acd2I_eʋ&=pTR0 S Z?C&Vm&<ӵOAdžk'&rAqP W'{SHT?7hR}02 Oyn!0m%:iLx ::&g_6c:ݝҾ2Aq@a oLHȆ;0dJ}dզt%(gCPӯ2L#c&,+tS=a[9(S6^_4U;ۖJ#x%P|~sL=&\[CdOܩMx5F034aQ;Xer2S_JFYp1S8n& n Y)1g}_\'oˤ%S$>T5a S&3]7u\m(K%;$0/ӀL)S\U KZ pZubj\2BS>YV*g3 |m:hSOWC"T&uA\dq I^P4+N?7*; V[Oa!R?f*Lm̔.)pB0ʄ|T>"&:>L1~n™.ib lh@Y5s}y\ 4qOMj m#]oy㴰)4r%9tSeu&\LԤOrbN-"/M]yY6ǰȫMUo^{ (ȟ3Nx]bj*Ezim2"vսlHNK4sy׃]Mj)JfTgE x֐LNjzƨo0NWu_krZ5mҐ}1ꙪV./ʥM)A.K'M8žT)L2 iUd8 |;4򢳜8y1S es槫176D ߉ 9n/L7Ҕo2ݣÀSq{yo^{&&:'l}*9i;VnKnr$/`lSm^ 7Y\iؠ2AӢ)+1US`xOcrAp i<,7Zvzyc>F-M:M=N99;+\&^eiLY k6orl.3Q4G ̖E4YvL*SOұ845MtCU<4]4Sez>S`q!t2m}}V08}XmXv/݉@8QZx`rn炡3s0N_*Mds^< dhzoe'og0{m4~jؤۻIo"cu<"0OMY}zj?aB)WW N](!U=5ZuiT6jOEܴtٹOt?s$ Wzb" {ԅ~4rv L!L!K&;V4]GWhmk6ΨLf;iJŅfMi9N{mqmRӟE?1A77J0 u|Lr̷6nGB$ &ʊScW~_O-ih&#?qDS>-kr'MʔnΛǽ BxvfX}Ki2_^Gӫtз@f?ԗy&7I`ZW -Mwl *䋯!$Qjm*/7FCUq{ o7 i"W 08M)$hlj7Q>31ȑ:GK=q( M?L6A 2Ggd/mcG #7ޙo[ͽ7>Bk;=Z׾lL{kG/volP{g›_?Kݿw%?co?V'hK&)7:> ]+_?g?w=8}[_w?I-FM_@4¾JU(dlp޷g_ғM36wp߮6qeC`ͯ1'06cmwږFM{#4Y&/3MKeU?|o=5Ld?5]slt勇q>8˲i1B;{22q45DM:NSTqP-q4^l0ݢ=W6Ahݨ"3E K5m%z=ez}I8% wM )5}m"_ *}i9yqnedgq:M|.A!NN/;;d]ȾҦ1B03} L6wyP˅3.馡OiImk \48] d&Ҥ~n[ҲSu|Yi/2ItAYN-ygDv>s8$-=SZvD}4a.xX6r^_qmL2NMVn=mPaDsӎ348G, ]Ϥy1W0YOtٍȞOaDdoϻvLجHS&` 8A7.3'Ԗ=]vDtX(;B'|޵j y'*Y-&L@Y2?Aq=Ӹ R?A6ހtewۙ/$Sycmul[)N &R4%%tBZ*;k88d~J;kf`2 'Kd ߄w]!ֶp颐1m,SL#*vsʙDϫe r KyOz}ߘa]䌛68(֧"4oeKy>M)U*;5Km3R_'8qsOvj ]6MjgyPyAbb{ʴGr}} ޷(6a&4p,%]f]ニ&[ۏO˦pL_wn&r|H p#g8ۿ)ݐ74%%Ӯ#b?{&!IηOom!L4-|XTX3PQòs&BEI0Hn?k&?d_^I,wKJ _8} ClmM5?&;f ˮd~4ӇcR_YnbhjW@3٦1y _ޖfCpI,ٳLbASDHd납b9MB>I0V2 iGSlgZWaӾ#;%5\^BzŦW"jO8ōL¸wbJV&ߪ{;1ZS~]ݻ1}7Tt&&sm9S4-޲&`rK?j^+5鷎#k(7]w"Xu,gJMHW}W96qR/H==e;Twf*ʷ_ʔzRJbRN3i}BrKꍖ/H7&7Mǖ&qA&2f J}GTϻ6f 6(SMѱiyZ[q3{ڰMX傝Sj7珛B}FGwM6qKu@Hg 3saIMH7MM;x´V$38?"&˲]eH_&jKMxT)'%dĔT)"*?D vy8;km;L}nT̈8ڴ+s$U Su8%WLtUy|e 9!>*~~+. :杩3u&C*r:i":u4Uv>GiUu,ԙLy5cuϯ䱎cu4cu.g$Č{µZr-ŽjͅrGb 1ɖe+_~Q{,_t4pJ&R0)>@6ȥHdk`V2Ԯ1'zOhDg ĉci+zY=_vt+j#^B}FC k8h!&Vbk񛹩d^xwi`Gp &/E%,\}1l=|m8u阄$&, nU܇:f۱#KT򓰟RHٰHr&L> !1}r@1956Т)fhЦ=e%4faW᥋+~|HKi=r~*M "[O3-}Ots\`{J!fh v?r?؂hϴy&MXgMK6HB&G6~3:vx~YM2ab|L?| קԄwbڈmM1OB4(鄠 s{tA7\P0ϻd Mǹ rQŴ\`'[vG.R rgn~A3IN(|U,M+~(MжcY|'5=vctWW%) 1LIZ<T~ C}ibVD"jPhM8Ac{(,0'}:Cg^EóMGS詾Jf CSg#DeM-L!GCeC<B~KDӴ:nr%_HaQdǖK('Ǿ rAf[*>L<벟 }bHf`J) /?M|1ږ6$nXhTŹ6.p3yp&,upuΔx%S/0T3ך+;ucQr/Ꮷ63%rd8ٽo޸|#;3^ )v z!!^DUaST6E=bi 6W@i]3RKm"`"FSLxSrޢ X%6g=~,h Ӵq\4iYA~{f:0swX 7\#,\B<ۘj_i3m2W&Y@@#۴8 `NCW #zގi4JICrl$lieؔҫAxq~qpnPje: vצM|v4vd Ȫ貜`/ΣS BvjOcP<&LĶ;i*tk '! L1_Xڄu|oYHh&7\&zW :<032e NR&)$\23IXG^J{kQ&r]4atm@Nђ7h44Nژ|UO$ /yw _7 އm0 c>SKLyޝb`{Y2 sC7t^ eڔaB<)y8 m/72I 8(þ l$܈~A-MsXx1%3˛xo-j^w93Lrw&Uī5Vb݁i3uԙ:ӝҝ w*nje &M\O٦M4;hݭ)ݥhJVf??Q8";p"xw%?-_^!a> p]|ك3gzu/yك_G">B]4"FQ l>y'hB4s L3f &?^H4טٸ8=_81Ɏw/atLM!p6㻻0Z`s{Mǩ6*|)=ӂ$5i:̀r0]l4n>vwg:%LvѴsPǃNλSIisK&' W\7y6(Q&̙h *εMǧ`\b;Gpm9 -p)7mjX?z:hhoG>.yŏԙ:SgL3u7U>^SgL3uԙ:SgL3uΔqXA Ed/ֽ]O,] N'g&o/~!Ӵ3{O"$6!?|-rx}LCmNEHU^^4y$"w[ֆBv*J@( Title$a$CJ0:^@: Normal (Web)dd[$\$&X@& Emphasis6]>P@"> Body Text 2 7$8$H$ B*phDB@2D Body Text$7$8$H$a$ B*CJph"W@A" Strong5\RQ@RR Body Text 3 7$8$H$56B*CJ \]aJ$ph.U@a. Hyperlink >*B*phe@r HTML Preformatted7 2( Px 4 #\'*.25@9CJOJPJQJ^JaJ8&@8 Footnote ReferenceH*H !"FLmo9FGHUVR S 12qrtuBC !!sFqrV78ZI;<Yo p l!m!!!9"l"""o###$$R$$$&&'e''''((P((((()1)N)O)q)r))))6*7*P*d*********+++1+8+Y+Z+a+f+m+++++++++++,1,2,:,A,F,P,f,m,,,,,,,,,----&-C-`-g---------......h.i.00000024609`9:7=9=M=====AE=F?FHJJKKKKNPT.WCWDWEWyWzWWWZZ\\]]``bbcc2e3eeeggvkxkElGlnoWoXoqqsst tuu9v:vvvwv+y-yjzlz@{B{{{||89eg݌ތmnopqrstu^_x͒ !"#HIB8ÙęNOšÚIJWܜ@9:z{&'ܤݤWXFGJ000000000000000000000000000000000000000000000800000000000000000000000 0 0 0 0 0 0 00 0 0r 0r 0r 0 r 0 r 0 r 0 r 0 r0r 0 08 0808 0 0 0 00 0 0< 0<0<800p 0p 0p  0p 0p  0m!p  0m!p  0m!p  0m!p  0m!p  0m!p 0p  0p 0p  0#p  0#p  0R$p  0R$p  0R$p  0R$p  0R$p  0R$p 0p  0p 0p  0'p  0(p  0(p  0(p 0p  0'p  0(p  0(p 0p  0p 0p  0O)p  0O)p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p 0p X0p 0p0p0p0pX0p 0u0u0u0u0u0u0u 0u 0u 0u 0u00000@0 0@0 000@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 H@0 @0B2@0B2@0B2@0B2@0B2@0B2@0B2H@0 @03@03H@0 @0T4@0T4@0T4@0T4@0T4@0T4@0T4@0T4@0@0@0@07@07@07@07@07@07@07@07@07@ 07@0;@0;@0;@0;@0;@0;@0;@0;@0;@0;@0;0000=Jap<,X]jsux{}m%,./Y/a///10:000111122E[u2Ԩ,Y[\^_`abcdefghiklmnopqrtvwyz|,Z1222%3,3&4142434<4D4I4r4}4444;;====>>e?l?T@Z@AA!A(A1A2A4A$B*B C'CH%HI&I\KhKLLWLeLfLlLoLwLLLLLLLLLMMMMQQRSSS SSSSSSSSSS9T:T@TWWXXXXXXXXXYSY^YYYYZxZZZZZZ\\@]N]]^ ^ ^^^ ^"^(^2^8^:^^^^^__``aaa"a7aCa`alaa bNbXb_babzbbbbccddeefff ggggg hh!h/h6h8h:hDhKhMhOhVh_hahghqhxhzhhh*i0iiiiiiijj0j¥htJ092949`9<n<t<<B???@AAA9BBBBzWWWWWW]!]eejj}nnuv|vv7=ceO|6+=BH'Waܜ2468g@C,3EGIK XZ<>@B_aceJ3333333333333333333333333333333333333333333333333333333333333sscgC:\Documents and Settings\Administrator\Application Data\Microsoft\Word\AutoRecovery save of DP_Phy.RefsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docsscgC:\Documents and Settings\Administrator\Application Data\Microsoft\Word\AutoRecovery save of DP_Phy.RefsscgC:\Documents and Settings\Administrator\Application Data\Microsoft\Word\AutoRecovery save of DP_Phy.RefsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docsscC:\Documents and Settings\Administrator\My Documents\DynaPulse_PMI\DynaPulse Document Center\Physician references\DP_Phy.Ref._101308.docPMI'F:\PMI Info Docs\DP_Phy.Ref._101308.doc0$Giq.{ :ݪk2}W=ŀl)3&D1SS=^`OJPJQJ^Jo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(808^8`0o(()^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.808^8`0o(()^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`o(()^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`CJ OJPJQJ^Jo(^`.pp^p`.@ @ ^@ `.^`.^`.^`.^`.PP^P`.808^8`0o(.0^`0o(.$ $ ^$ `o(.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.{ :2}W=)3&D蕎 0SSiq.         dD        qx=        v        F        fÌK^<%      )7*P*d********+++1+8+Y+Z+a+f+m+++++++++++,1,2,:,A,F,P,f,m,,,,,,,,,----&-C-`-g---------...J@h1(H@4@UnknownGz Times New Roman5Symbol3& z Arial7&  Verdana?5 z Courier New;Wingdings"qhsFsFf2F&!20dd2q DynaPulsesscPMIOh+'0|  , 8 D P\dlt DynaPulse ynasscscsc Normal.dotPMI2IMicrosoft Word 9.0@F#@Elc@"dJ.@"dJ.2՜.+,D՜.+,4 hp|  PMI&Fd  DynaPulse TitleT 8@ _PID_HLINKSA MzrDP_Hemo_Report_M1.bmpiN7ATables & figures\xi-4.bmpI~=JTables & figures\xi-5a.bmpI}NTables & figures\xi-5b.bmpkN.[Tables & figures\xi-6.bmp  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDFGHIJKLNOPQRST[Root Entry F@J.]Data 31TableWWordDocument"SummaryInformation(EDocumentSummaryInformation8MCompObjjObjectPool@J.@J.  FMicrosoft Word Document MSWordDocWord.Document.89q